Development of soft nanocarriers from novel amphiphilic hyaluronic acid derivatives towards drug delivery by Eenschooten, Corinne Diane
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 18, 2017
Development of soft nanocarriers from novel amphiphilic hyaluronic acid derivatives
towards drug delivery
Eenschooten, Corinne Diane; Kontogeorgis, Georgios; Stenby, Erling Halfdan; Longin, Fanny; Schwach-
Abdellaoui, Khadija; Delie, Florence; Gurny, Robert
Publication date:
2008
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Eenschooten, C. D., Kontogeorgis, G., Stenby, E. H., Longin, F., Schwach-Abdellaoui, K., Delie, F., & Gurny, R.
(2008). Development of soft nanocarriers from novel amphiphilic hyaluronic acid derivatives towards drug
delivery.
Department of Chemical 
and Biochemical Engineering
DTU Building 229
Søltofts Plads
DK-2800 Kgs. Lyngby
www.kt.dtu.dk
Development of soft nanocarriers from novel amphiphilic 
hyaluronic acid derivatives towards drug delivery
Corinne Eenschooten
2008
C
. E
enschooten
D
evelopm
ent of soft nanocarriers from
 novel am
phiphilic hyaluronic acid derivatives tow
ards drug delivery
2008
Development of soft nanocarriers from novel amphiphilic 
hyaluronic acid derivatives towards drug delivery
Corinne Eenschooten
2008
1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Corinne Eenschooten 
2008 ISBN-13: 978-87-91435-84-6 
Printed by J&R Frydenberg A/S, Copenhagen, Denmark 
 
2
  
Development of soft nanocarriers from novel amphiphilic 
hyaluronic acid derivatives towards drug delivery
Corinne Eenschooten
3
 iv 
English abstract 
 
Drug delivery is an important pharmaceutical research area currently facing 
limitations such as drug insolubility and instability in biological media, poor 
bioavailability and unspecific targeting. As a consequence, high doses are used to 
achieve a therapeutic effect which increases the risk for toxicity in patients and health 
costs. The design of advanced drug delivery systems addressing these challenges has 
therefore become more and more crucial. Hyaluronic acid (HA) is a natural linear 
glycosaminoglycan ubiquitous and identical in all mammals. Due to its native intrinsic 
biocompatibility, resorbability and biological functions, and the possibility for an easy 
chemical functionalisation, HA constitutes an excellent starting material for the design 
of advanced biomaterials. The objective of this project was to develop HA-based 
nanocarriers towards the encapsulation and delivery of hydrophobic drugs. 
 
However, due to its high hydrophilicity, HA exhibits physicochemical 
properties incompatible with the spontaneous and stable formation of segregated 
structures in aqueous solutions. Therefore, HA was first rendered amphiphilic by the 
covalent binding of hydrophobic groups onto its backbone. After a preliminary 
investigation of two different modification methods, the proprietary technology 
eventually selected was based on the grafting of octenyl succinic anhydride and was 
optimised so as to develop a reproducible and robust process for the synthesis of 
functionalised polymers. Fundamental properties such as the structure, degree of 
hydrophobicity, substitution pattern as well as intra- and intermolecular interactions of 
a selection of derivatives were then studied. Submicronic multiphasic physically cross-
linked nanogel particles capable of solubilising a model hydrophobic substance were 
prepared by spontaneous self-association and characterized with regard to their 
morphology, size and surface charge. A multivesicular model was finally put forward 
to explain their internal structure. 
 
In conclusion, a molecular method based on controlled self-association was 
developed towards the formation of HA soft nanostructures. These represent novel and 
promising biomaterial templates for the fabrication of stable and multifunctional HA-
based nanogel particles and could be valuable to the industry since their underlying 
production methods are aqueous and easily upscalable. 
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Dansk abstrakt 
 
Fordeling af lægemidler er et vigtigt farmaceutisk forskningsområde, der i 
øjeblikket står overfor begrænsninger som lægemidlets uopløselighed og instabilitet i 
biologiske miljøer, ringe tilgængelighed og uspecifik levering. Som en konsekvens 
heraf, anvendes høje doser for at opnå en terapeutisk virkning, hvilket forøger risikoen 
for toksicitet i patienter og sundhedsudgifter. Design af avancerede systemer til 
fordeling af lægemidler, der tager udgangspunkt i disse udfordringer, er derfor blevet 
mere og mere afgørende. Hyaluronsyre (HA) er en naturlig lineær glycosaminoglycan, 
der er tilstede og identisk i alle pattedyr. HA udgør et fortrinligt udgangsstof i designet 
af avancerede biomaterialer på grund af dets naturlige biokompatibilitet, resorption, 
biologiske funktioner og muligheden for simpel kemisk funktionalisering. Formålet for 
projektet var at udvikle HA-baserede nanobærere til indkapsling og levering af 
hydrofobiske stoffer. 
 
HA er meget hydrofilt og besidder fysisk-kemiske egenskaber, der er 
uforenelige med en spontan og stabil dannelse af isolerede strukturer i vandige 
opløsninger. HA blev derfor først gjort amfifilt ved kovalent binding af hydrofobiske 
grupper på dets rygrad. Efter en forberedende undersøgelse af to forskellige 
derivatiserings-metoder, den endelige valgte patenterede teknologi var baseret på 
bindingen af octenyl succinic anhydride og blev optimeret for at udvikle en 
reproducerbar og robust proces til syntese af funktionaliserede polymerer. 
Grundlæggende egenskaber som struktur, grad af hydrofobicitet, substitutionsmønster 
samt intra- og intermolekulær vekselvirkning blev herefter undersøgt for et udvalg af 
derivater. Submikroniske multifasiske fysisk krydsforbundne nanogelpartikler, der kan 
opløse et hydrofobiskt modelstof, blev dannet ved spontan selvsamling og 
karakteriseret ud fra deres morfologi, størrelse og overfladeladning. En multivesikulær 
model blev til sidst opstillet for at forklare deres indre struktur. 
 
Afslutningsvist blev der udviklet en molekylær metode til dannelsen af bløde 
HA nanostrukturer baseret på kontrolleret selvsamling. Disse repræsenterer nye og 
lovende biomaterialeskabeloner til fremstilling af stabile og multifunktionelle HA-
baserede nanogelpartikler og kunne være værdifulde for industrien, eftersom deres 
produktionsmetoder er vandige og let opskalerbare. 
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Preface 
 
The present manuscript is a summary of the work I, Corinne Eenschooten, 
carried out in the period May 2005-July 2008 towards the achievement of the 
Industrial Philosophy Doctorate (Industrial Ph.D.) degree. This double diploma is 
granted by Danish universities and the Danish Ministry of Science, Technology and 
Innovation (VTU) to Ph.D. students having undertaken their research project in the 
industry. The Danish industrial Ph.D. programme has indeed for purpose to educate 
scientists with an insight in the commercial aspects of Research and Development 
(R&D), increase the R&D and innovative capacity in private companies and build 
networks disseminating knowledge between universities and private companies. 
 
This project was a collaboration between the Technical University of 
Denmark (DTU), Department of Chemical and Biochemical Engineering, Center for 
Phase Equilibria and Separation Processes (IVC-SEP, Building 229, 2800 Lyngby, 
Denmark), Novozymes Biopolymer A/S (NZBP, Krogshøjvej 36, 2880 Bagsværd, 
Denmark) and the University of Geneva, University of Lausanne (UGL), School of 
Pharmaceutical Sciences, Department of Pharmaceutics and Biopharmaceutics (DPBP, 
30 quai Ernest-Ansermet, 1211 Geneva 4, Switzerland) which acted as a third party. 
Most of the work was achieved at IVC-SEP and NZBP. The rest was conducted at 
DPBP within the frame of two study trips in the periods July-August 2006 and March-
June 2007. 
The project was co-funded by the Danish Ministry of Science, Technology and 
Innovation (Grant number: 07-001687) and Novozymes Biopolymer A/S, the 
employer. 
 
The project supervisors were, from IVC-SEP, Doctor Georgios M. 
Kontogeorgis and IVC-SEP director Professor Erling H. Stenby, from NZBP, Doctors 
Fanny Longin and Khadija Schwach-Abdellaoui, Science Manager and Senior R&D 
Manager, respectively and, from DPBP, Doctor Florence Delie and President of the 
School of Pharmaceutical Sciences (UGL) Professor Robert Gurny. 
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The overall purpose of the project was to design and implement a method for 
the preparation of hyaluronic acid-based nanocarriers towards drug delivery. 
The dissertation consists of five chapters. A general introduction (Chapter I) opens the 
thesis and is followed by a review on a subject related to the project area (Chapter II). 
The experimental work is described in the following two chapters (Chapter III and 
Chapter IV). The thesis continues with a conclusion (Chapter V) which summarises 
the work, puts it into perspectives and suggests future research directions. The 
manuscript ends with appendices containing a record of the educational activities 
completed during the Ph.D. programme. 
 
Chapter II, Chapter III, B and Chapter IV are written in a recognisable paper 
format and will after a few adjustments be submitted to scientific journals by the time 
of the Ph.D. defence or immediately after. 
The experimental work presented in Chapter III, sections A and B was entirely 
performed by me while that of section C was partly accomplished by Sara Sparre 
Kofoed. Sara was a master student at the Technical University of Denmark, 
Department of Chemistry (DC) who carried out her master’s thesis in collaboration 
with NZBP in the period September 2007-February 2008 under Associate Professor 
Charlotte Held Gotfredsen’s and my own supervision. In Chapter IV, Andrea Vaccaro 
(UGL, Department of Inorganic Analytical and Applied Chemistry, DIAAC) 
completed the light scattering experiments and participated to the simulation work. 
The compilation and writing of all the material in this thesis is the result of my own 
efforts. 
 
During my education, I had the opportunity to evolve in a multidisciplinary 
environment and to become acquainted with exceptionally knowledgeable and 
inspiring people whom I would like to express my gratitude to. 
I address my first acknowledgements to my supervisors Dr. Georgios M. 
Kontogeorgis, Prof. Erling H. Stenby, Dr. Fanny Longin, Dr. Khadija Schwach-
Abdellaoui, Dr. Florence Delie and Prof. Robert Gurny. 
I wish to thank Dr. Georgios M. Kontogeorgis and Prof. Erling H. Stenby (IVC-SEP) 
for their support and encouragements at an earlier stage in the process of finding a 
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Ph.D. project and an industrial partner, their following-up on the course of my studies 
and active participation to our scientific discussions. 
I address Dr. Georgios M. Kontogeorgis (IVC-SEP) my greatest recognition for having 
given me a durable taste for colloid and surface chemistry and entrusted me with the 
mission to teach this topic twice by his side. 
To Dr. Fanny Longin (NZBP), I express all my thankfulness and acknowledge her for 
her large availability and dynamism. I have learned a lot from her about 
polysaccharide chemistry and modification and surely, these years would have had 
another flavour without her optimism and positivism. 
My gratitude also goes to Dr. Khadija Schwach-Abdellaoui (NZBP) who gave me the 
fantastic opportunity to work in an emerging and fascinating area of research and who 
benevolently saw to my educational and personal development. 
I owe a lot to Dr. Florence Delie for kindly accompanying me during my external stay 
at DPBP, contributing to make my study trips fruitful and enriching experiences and 
sharing her expertise about polymeric nanoparticulate systems. 
Prof. Robert Gurny who generously welcomed me at DPBP and recommended me to 
various disciplinary experts to help me come forward with my project also deserves 
strong acknowledgements. 
 
I am grateful to my present and former colleagues at DTU, NZBP and UGL 
for their contribution to a productive and pleasant working environment. 
I particularly wish to thank Dr. Kristoffer Tømmeraas and Dr. Birgitte Mølholm Malle 
(NZBP) for sharing their knowledge in polysaccharide chemistry, modification and 
industrial applications, Sara Sparre Kofoed (DC) for letting me experience my 
fledgling teaching skills and for the quality of the work she performed, Dr. Charlotte 
Held Gotfredsen (DC) for co-supervising Sara’s project and having Sara and myself 
benefited from her expertise in nuclear magnetic resonance spectroscopy (NMR) and 
both of them for pursuing NMR experiments even after the term of Sara’s project. 
I am obliged to Dr. Christoph Bauer (UGL, National Centre of Competence in 
Research, Frontiers in Genetics, Bioimaging Platform) for having acquired the first 
transmission electron microscopy (TEM) micrographs and trained me in TEM with 
great patience. 
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Dr. Andrea Vaccaro and Prof. Michal Borkovec (DIAAC) who shared their insight in 
colloid chemistry and made ingenious propositions to explain aggregation phenomena 
have also earned my infinite credit. 
My gratitude finally goes to the administrative staff at IVC-SEP (Anne Louise Biede 
and Patricia Wagner), NZBP (Nadia Ehlers Nielsen), Novozymes A/S (Asta Wielandt 
Pedersen) and DPBP (Myrtha Copin and Florence von Ow) for their help in numerous 
occasions and to Patent Attorney Peter Würtz Lindum (Novozymes A/S) for carrying 
through the patent applications and mediating my disclosure of information. 
 
I am especially appreciative of VTU and DTU for their constantly evolving 
and improving educational structures and their following-up on industrial Ph.D. 
students. I also salute the quality of the complementary learning and networking 
activities organised by VTU along the industrial Ph.D. programme. 
 
My kindest thoughts are directed to my family, my mother and father 
(Martine Aubert and Richard Eenschooten) and my friends in France (Thibault 
Roques, Éric Piel and Laurène Champalle) and in Denmark (Sylvain Verdier, Mette 
Fuglsang Larsen and Michelangelo Dall’Ora) who always supported and encouraged 
me. 
 
I finally gratefully acknowledge the Danish Ministry of Science, Technology 
and Innovation (Grant number: 07-001687) and Novozymes Biopolymer A/S for 
funding. 
 
 
 
 
 
 
 
 
Corinne Eenschooten 
Lyngby, July 2008 
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I. Hyaluronic acid 
 
I.1. Origin and molecular structure 
 
Hyaluronic acid (HA) belongs to the class of amino sugar-containing 
polysaccharides known as glycosaminoglycans (GAGs) and is the only non-sulphated 
GAG. In vertebrates, GAGs are essential components of connective tissues. While in 
vivo, most GAGs are synthesised in the Golgi apparatus and are added to protein cores, 
HA is produced at the cell surface and is directly extruded in the extracellular space 
without a protein core. This process is carried out by a group of proteins called HA 
synthases located in cell membranes [1]. 
 
HA was discovered in 1934 by Karl Meyer and John Palmer in the vitreous 
humour of bovine eyes [2]. It is a linear polysaccharide consisting of D-glucuronic acid 
and N-acetyl-D-glucosamine linked through -1,3 glycosidic bonds while consecutive 
repeating disaccharide units are linked through -1,4 bonds (Figure I.1). The name 
hyaluronic acid originates from hyaloid (vitreous) and uronic acid [3]. 
 
OH
O
NH
O
O
OH
OH
OHO
CH3
O
OH
O
n
 
 
Figure I.1: Molecular structure of the HA repeating unit. 
 
Depending on the ionic strength of the solution in which HA is dissolved, the 
pKa value of its carboxyl groups is around 3 [4]. As a result, HA does not occur, at 
physiological pH, as its protonated acid form but as a polyanion which negative 
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charges are balanced by mobile cations such as Na+, K+, Ca2+ or Mg2+ [5]. Therefore, 
HA is also often referred to as hyaluronan or hyaluronate. 
 
I.2. Industrial manufacture 
 
Historically, HA was first produced by extraction from rooster combs. 
However, this production method is expensive (poor yields) and requires an extensive 
purification of the crude product to remove antigenic avian proteins [6]. For these 
reasons, and more importantly, due to ethical issues, alternatives to the animal 
extraction of HA were pursued and industrial techniques based on microorganism 
fermentation eventually emerged in the 1990’s. 
 
A key breakthrough in the HA production occurred when HA was first 
obtained by the more sophisticated fermentation of certain strains of Streptococcus (S) 
which naturally synthesise HA as a part of their outer capsule [6]. After this major 
industrial shift and until recently, the streptococcal production of HA remained the 
golden standard. 
However, S can be difficult and expensive to ferment and is challenging to genetically 
modify. S is also a known pathogenic microorganism in virtue of which the final HA 
product can contain both endo- and exotoxins [6]. Finally, the streptococcal production 
of HA requires the use of substantial volumes of organic solvents. 
 
The newest progress in the manufacture of HA is the use of Bacillus (B) as 
expression host. B strains have long been used as industrial workhorses for the 
production of specialty chemicals and Bacillus Subtilis (BS) was recently shown a 
superior system for the production of HA: 
(i) BS grows on minimal media in contrast to S which is a fastidious microorganism 
requiring more expensive and complex media for growth; 
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(ii) BS secretes HA into its surrounding medium and HA is not cell associated which 
simplifies the recovery step compared to that of the S-based process; 
(iii) The BS-based process is aqueous thus environmentally friendly; 
(iv) HA molecular weight (MW) and polydispersity are better controlled, 
(v) HA yields are higher, 
(vi) BS is a non-pathogenic microorganism and the final HA product does not contain 
any endo- or exotoxins [6]. 
This last aspect obviously makes BS-HA an advantageous alternative to S-HA for 
applications requiring HA internalisation in the body. 
BS-HA (Novozymes Biopolymer A/S) was used in the present Ph.D. project for its 
environmentally friendly production process and the ultra-purity of this novel 
biosynthetic polymer (see Chapters III and IV). 
 
I.3. Structures in aqueous solutions 
 
The structures of HA in aqueous solutions have extensively been studied and 
only key elements are summarised below which allow to understand some of the 
fundamental properties and biological functions of HA. 
 
HA is a highly hydrophilic biopolymer capable of binding water molecules 
and expanding its volume up to 1,000 times [7]. 
In aqueous solutions, the macromolecular structure of HA is not random as it is 
stiffened by a combination of intra- and intermolecular hydrogen bonding, hydrogen 
bonding with the solvent and intermolecular non-polar/hydrophobic interactions. As a 
result, HA exhibits several preferred structures referred to as the primary, secondary 
and tertiary structures [5]. 
 
The primary structure refers to the sequence of HA disaccharide units [5]. The 
secondary structure is due to intramolecular hydrogen bonding and hydrogen bonding 
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with the solvent. The sugar rings being relatively fixed in their shapes, rotation along 
HA chains is only allowed at the glycosidic bonds through revolution around the 
oxygen atom joining one disaccharide unit to the next. Although the substituents 
attached on both sides of this oxygen atom can in principle rotate 360 degrees around, 
only limited configurations are possible and each disaccharide unit is twisted by 
180 degrees compared with the one ahead and behind in the chain due to 
intramolecular hydrogen bonding and hydrogen bonding with the solvent [5] 
(Figure I.2). 
 
 
Figure I.2: Intramolecular hydrogen bonding and hydrogen bonding with the solvent in 
aqueous HA solutions (adapted from [5]). 
G and N stand for glucuronate and acetylglucosamine, respectively. The dotted lines represent hydrogen 
bonding. Hydrogen bonding with the solvent occurs through the water bridge between the N2 acetamido 
and G1 carboxylate group. 
 
Two disaccharide unit twists bringing the original orientation back, HA assumes a 
two-fold helix structure [5] (Figure I.3). 
 
Finally, the tertiary structure stems from intermolecular non-
polar/hydrophobic interactions and intermolecular hydrogen bonding between 
neighbouring HA chains. Although HA is a highly hydrophilic molecule due to its 
equatorial hydroxyl, carboxyl and acetamido groups, it also possesses a number of CH 
groups stretching along each disaccharide unit. The corresponding axial hydrogen 
atoms form a non-polar, relatively hydrophobic patch. In addition, the 
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hydroxymethylene group of the acetylglucosamine moiety can easily rotate to 
contribute to this patch [8] (Figure I.4). 
 
 
Figure I.3: Plan (1) and elevation (2) computer drawn projections of HA and view 
along the two-fold helix axis (3) [5]. 
 
 
Figure I.4: The hydrophilic and non-polar/hydrophobic patches in HA [8]. 
The blue and red ribbons represent the hydrophilic and the non-polar/hydrophobic patches in HA, 
respectively. 
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The existence of the non-polar/hydrophobic patches in HA explains the association of 
HA chains in aqueous solutions despite the dense distribution of anionic charges along 
the polymer backbone. Indeed, the curves in each HA molecules (see Figure I.3, (1) 
and (2)) closely follow the same course which allows the hydrophobic patches to 
closely engage with each other in an antiparallel fashion. In addition, in this 
configuration, the acetamido and carboxylate groups on neighbouring HA chains 
become within hydrogen bonding distances [5]. 
It is noteworthy that similar structures are possible for other GAGs such as 
chondroitin, keratan and dermatan sulfates and mixtures of two or more including HA 
[9] (also see § I.4). 
 
In vivo, HA occurs in a wide range of MW from a few thousands to several 
millions Daltons. However, physiological concentrations (e.g. 1-4 g/L) of high MW 
HA can result in entangled polymeric networks exhibiting viscoelastic properties. 
Indeed, due to the fundamental structures in aqueous solutions described above, HA 
networks can resist rapid, short-duration fluid flow and display elastic properties by 
returning the integrity of the shear forces applied. They can also absorb a fraction of 
these and feature viscous properties by partially separating and aligning HA molecules 
under slow, long-duration fluid flow [8] (Figure I.5). 
 
 
Figure I.5: Illustration of the viscoelastic properties of HA [8]. 
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The viscoelastic properties of HA have important biological consequences. For 
example, the presence of HA in the synovial fluid contributes to both shock-absorption 
and lubrication in the knee. 
 
HA networks have another important function related to the regulation of 
solute transport: small molecules such as water, electrolytes, nutrients and waste 
products can freely diffuse through the network. However, large molecules such as 
proteins, proteases and pathogens are partially excluded from the latter due to their 
larger hydrodynamic dimensions. Since HA chains are constantly in movement, these 
bulky molecules can in principle statistically diffuse through the network but with 
various degrees of retardation. As a result, their concentration in the network is limited 
compared to that of the surrounding HA-free compartments. This allows to avoid the 
spreading of pathogens and unwanted proteolytic damages [8] (also see § I.4). 
 
I.4. Biological functions in the skin 
 
HA is ubiquitous in the body but is most abundant in the skin where it 
amounts to approximately 5 g, i.e. a third of the total human body’s HA content [10]. 
In normal skin, HA occurs both in the dermis and the epidermis [11] (Figure I.6). 
In the dermis, HA is mostly found in the papillary dermis and, in the reticular dermis, 
at the level of the skin appendages (e.g. the sebaceous glands and hair follicles, 
Figure I.6, a). Its concentration in the dermis is around 0.5 mg/g of wet tissue [4]. 
In the epidermis, HA is present in the extracellular space between the keratinocytes in 
the stratum granulosum, stratum spinosum and stratum basale (Figure I.6, b between 
the arrow heads and Figure I.6, c). Its concentration in the epidermis approaches 
0.1 mg/g of wet tissue [4]. Recently, Sakai et al. [12] demonstrated that HA also 
occurs in the stratum corneum (SC), in the extracellular space between the corneocytes 
where its dry weight content is about 20 μg/g of SC. 
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Figure I.6: Distribution of HA in adult human skin [11]. 
Human skin sections were stained for HA using the system biotinylated G1 protein/link protein 
complex. The binding of the complex was visualised using the avidin-biotin-peroxidase technique 
(brown), and nuclei were counterstained with hematoxylin (blue in b). In c, the dark precipitate in the 
extracellular space between the keratinocytes indicates HA [11]. 
 
In the skin, HA possesses a number of important structural and biological 
functions. Structurally, HA provides a matrix substrate for the distribution and 
organisation of important molecules of the extracellular matrix (ECM) (Figure I.7). In 
particular, HA constitutes a backbone for the organisation of proteoglycans (PG), 
fibrin, fibronectin, collagen and elastin [13] (Figure I.8). For example, HA is thought 
to associate with chondroitin, keratan and dermatan sulfates in the same fashion as it 
associates with itself, i.e. through non-polar/hydrophobic interactions and 
intermolecular hydrogen bonding [9] (also see § I.3). 
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Figure I.7: Scheme of HA matrices in aqueous solutions [5]. 
 
 
Figure I.8: Scheme of the organisation of proteoglycans and collagen in HA matrices 
[5]. 
 
Due to its naturally forming networks, HA acts as a filler which maintains both space 
and cohesion between skin cells. This facilitates the diffusion of nutrients to and waste 
products from upper skin cells and the movement of the immune system cells (i.e. 
lymphocytes and Langerhans cells) while restricting the movement of proteins, 
proteases and pathogens [8] (also see § I.3). 
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Finally, due to its strong hygroscopic character, HA is capable of retaining 
considerable amounts of water over prolonged periods of time. This contributes to 
tissue hydration and lubrication [14]. 
 
Biologically, HA triggers fundamental processes by binding with cells 
through specific interactions. For example, HA is involved in complex signalling 
events regulating cell proliferation, differentiation and migration. Such events are 
mediated by a group of proteins called hyaladherins. These proteins act as cellular 
receptors for HA. Two major receptors have been studied: CD44 and RHAMM 
(Receptor for HA-mediated mobility) [11]. 
CD44 is a major cell receptor for HA and is expressed on the surface of a variety of 
cells such as the leucocytes, fibroblasts, keratinocytes and some epithelial and 
endothelial cells [15]. CD44 has been shown to be associated with various cellular 
processes including cell adhesion, migration, proliferation and activation as well as HA 
degradation and uptake [16]. 
RHAMM is found on the surface and in the cytosol and nucleus of a number of cell 
types [17]. This receptor has been demonstrated to be involved in the regulation of 
cellular responses to growth factors and in the migration of fibroblasts and smooth 
muscle cells [17,18]. 
For more information about the CD44 and RHAMM receptors, the reader is invited to 
consult references [19] and [20]. 
Another potential biological function of HA is the scavenging of reactive oxygen 
species (ROS). ROS are noxious compounds produced as a result of exposure to 
ultraviolet (UV) radiations and are known to cause damage to cell membrane lipids, 
nucleic acids, proteins and enzymes and to be responsible for cancer, chronic diseases 
and aging. It has been demonstrated that HA effectively scavenges ROS in vitro 
[21,22,23]. ROS are now known to attack the C-5 hydrogen in the glucuronic acid 
moiety [24], the C-1 hydrogen in the acetylglucosamine moiety [25] and the carboxyl 
38
Development of soft nanocarriers from novel amphiphilic hyaluronic acid 
derivatives towards drug delivery 
Chapter I 
Introduction 
 
 
13 
and acetamido groups [26]. ROS clearance from the epidermis is currently speculated 
to happen through the natural rapid HA turnover [11]. 
 
In summary, these selected structural and biological functions of HA in the 
skin show that HA is the most active guardian of the ECM homeostasis. 
 
I.5. Applications 
 
Due to its unmatched natural biocompatibility, resorbability, physicochemical 
properties and biological functions (see § I.3 and I.4), HA has been used in numerous 
cosmetic, pharmaceutical and biomedical applications. 
 
In the cosmetic industry, HA is a well-known and widely spread moisturising 
and skin softening agent [27,28]. Indeed, the topical application of HA-containing 
formulations has been reported to restore skin hydration and elasticity and thus provide 
an anti-ageing effect [4]. In addition, the incorporation of HA in sunscreens could help 
protect the skin against UV radiation damages. 
 
The biomedical applications of HA are currently considerable [16,29,30]. 
According to Balazs [31] these can be classified into five main categories, namely (i) 
visco-surgery, (ii) visco-separation, (iii) visco-protection, (iv) visco-supplementation 
and (v) visco-augmentation (Table I.1). HA provides tissue protection, lubrication and 
space during surgery, prevents adhesion and excessive scar formation after surgery and 
promote wound healing by regulating cell proliferation and migration. Cross-linked 
HA can also be used to replace or supplement defective tissue fluids such as the 
synovial fluid in patients affected by osteoarthritis and possesses filling properties that 
can exploited for tissue augmentation. 
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Table I.1: Biomedical applications of HA [31]. 
Biomedical application HA role 
Visco-surgery Tissue protection and lubrication 
HA provides space during surgery 
Visco-separation Separation and lubrication of traumatised connective tissue 
surfaces 
Prevention of tissue adhesion and excessive scar formation 
Visco-protection Tissue protection from dryness and environmental noxious 
agents 
Healing promotion 
Visco-supplementation Tissue fluid replacement or supplementation 
Visco-augmentation Tissue filling and augmentation 
 
As for pharmaceutical applications, HA has been widely studied towards 
ophthalmic, nasal, pulmonary and parenteral drug delivery [32] for which it is 
generally thought to act as a mucoadhesive compound retaining the drug at its site of 
action/absorption and modifying the drug’s in vivo release/absorption rate. 
Recently, HA was envisaged as a potential promising excipient for dermal drug 
delivery. 
 
II. Hyaluronic acid-mediated dermal drug delivery 
 
Dermal drug delivery has become an important research field due to the 
advantages the dermal route presents compared to the more conventional enteral and 
parenteral routes (see Chapter II, § I). It has been estimated that the market for dermal 
and transdermal drug delivery represented 1.57 billion dollars in the United State (US) 
in 2002 and will amount to nearly 5.67 billion dollars by 2009, i.e. approximately 6 % 
of the total US drug delivery market [33]. 
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Due to its natural presence in the skin, HA represents an attractive 
biocompatible and resorbable excipient for the dermal administration of drugs. For 
example, HA can be co-formulated with drugs (first generation systems) or constitute 
the building block of more advanced biomaterials (second generation systems). 
 
II.1. First generation systems 
 
The use of HA in dermal drug delivery is relatively recent [34] and has 
mainly consisted in co-formulating HA with the drugs. Co-formulations of HA and 
therapeutic agents such as dichlorofenac, ibuprofen, clindamycin and cyclosporin has 
been rigorously investigated in vitro, in vivo and in clinical studies and reviewed in an 
excellent article by Liao et al. [32]. These studies have shown that HA significantly 
enhances drug partitioning into human skin and drug retention and localisation in the 
epidermis compared to other GAGs and more ordinary pharmaceutical formulations. 
However, the exact mechanisms by which HA, as an excipient, achieves such 
performances remains unclear [32]. 
 
While HA/drug co-formulations seem to sustain drug absorption in skin 
layers, drug release, in this configuration, remains non-specific. In cases of more 
challenging and demanding therapeutic situations, such as when the drugs need to be 
protected and targeted to specific tissues, more advanced systems than co-formulations 
are required. These form the basis of the second generation HA-based systems. 
 
II.2. Second generation systems 
 
The interest in nanotechnology in pharmacy is somewhat new and is mainly 
due to drug-associated issues such as poor solubility and instability in biological milieu 
(i.e. short half-life), poor bioavailability and unspecific targeting. As a result, high drug 
dosages are used to achieve a therapeutic effect which increases the risk for toxicity in 
41
Development of soft nanocarriers from novel amphiphilic hyaluronic acid 
derivatives towards drug delivery 
Chapter I 
Introduction 
 
 
16 
patients and health cost [35]. Therefore, the design of advanced drug delivery systems 
addressing these challenges has become more and more crucial. In this perspective, it 
is believed that drug encapsulation in nanovehicles could allow the formulation of 
improved systems [35]. 
With its unusual and beneficial properties, HA represents an attractive candidate for 
the encapsulation and release of drugs in biological environments, including skin 
layers. HA-based advanced biomaterials such as colloidal particles therefore constitute 
potential valuable second generation dermal drug delivery systems. 
 
III. Hyaluronic acid-based colloidal particles 
 
III.1. Microparticles 
 
The preparation of HA-based colloidal particles towards drug delivery first 
addressed the development of microparticles (MPs). HA MPs in which HA constitutes 
the only component of the polymeric matrix have been prepared according to a few 
different methods which are reviewed in Table I.2. These methods can be classified in 
two main categories according to the type of HA modification involved, namely cross-
linking [36,37] or hydrophobic modification [38,39]. 
In the first case, HA and a cross-linking agent are mixed and emulsified into mineral 
oil with the aid of a biodegradable surfactant to produce a microemulsion. Cross-
linking is then initiated in the microdroplets containing HA and the cross-linking agent 
by addition of a coupling agent [36]. Alternatively, two auto-cross-linkable HA 
derivatives can be used [37]. 
In the second case, HA is first hydrophobically modified (HYAFF®). HYAFF® 
solutions are then spray-dried into the form of microparticles [38] or emulsified in 
mineral oil with the aid of a biodegradable surfactant [38,39]. The polar organic 
solvent in the microdroplets is then either removed by extraction with another polar 
organic solvent [38] or evaporated by mixing at room temperature [39]. In methods 
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[38] and [39], the particles are stabilised by hydrophobic interactions between the 
hydrophobic groups grafted on the HA chains. 
 
Table I.2: Preparation methods of HA microparticles. 
ADH, Span 80, EDC, DMSO, Arlacel® A stand for adipic acid dihydrazide, sorbitan monostearate, 1-
ethyl-3-[3-dimethyl amino] propyl carbodiimide, dimethyl sulfoxide and mannide monostearate, 
respectively. HYAFF® is Fidia’s trademark for hydrophobically modified HA obtained by reacting HA 
and alkyliodides in DMSO, using the tetrabutylammonium salt of HA (also see § IV). 
Reference 
HA MW 
MP size 
Principle 
[36] 
1,600-3,300 kDa 
5-15 μm 

 Emulsification of HA and ADH into mineral oil with Span 80 

 Cross-linking in the presence of EDC 
[37] 
490-1,300 kDa 
10 μm 

 Emulsification of oxidized HA and ADH-modified HA into mineral 
oil with Span 80 

 Cross-linking in the presence of EDC 
[38] 
unspecified 
1-10 μm 

 Spray drying of aqueous HYAFF® solutions 
[38] 
unspecified 
1-100 μm 

 Emulsification of HYAFF® in DMSO into mineral oil with 
Arlacel® A 

 Extraction of DMSO with ethyl acetate 
[39] 
150 kDa 
10-100 μm 

 Emulsification of HYAFF® in hexafluoropropanol into mineral oil 
with Arlacel® A 

 Evaporation of hexafluoropropanol by mixing at room temperature 
 
The applications of HA MPs towards drug delivery are numerous and in vivo 
release studies have shown that HA MP-mediated drug delivery presents some 
advantages compared to conventional drug formulations. For example, HA MPs have 
been used to modulate the nasal absorption of insulin in sheeps [40], enhance the 
vaginal assimilation of salmon calcitonin [41], the oral bioavailability of cyclosprorin 
[42] and piroxicam [43] in rats and the production of growth factors when injected 
subcutaneously to monkeys and dogs [44]. These examples show that HA MPs are 
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currently designed in the perspective of targeting all three drug administration routes, 
namely the topical, enteral and parenteral routes. 
However, for topical routes such as the skin, the size of the particulate system is an 
important factor for its performances since skin penetration is an extremely selective 
phenomenon. With their large dimensions, MPs have often been considered unsuitable 
devices for targets other than the surface of the skin or the skin appendages [45]. 
Nanoparticles (NPs), however, could present more favourable dimensions towards skin 
penetration and their interaction with the skin is a currently studied topic (see 
Chapter II). 
 
III.2. Nanoparticles 
 
To the best of our knowledge, and as until January 2008, four patent 
applications and three articles have since 1995 claimed the preparation of HA NPs in 
which HA constitutes the only component of the polymeric matrix. The techniques 
disclosed are reviewed in Table I.3. As for HA MPs, the preparation methods of HA 
NPs can be classified in the two main categories described before, i.e. according to 
whether HA is hydrophobically modified [46] or cross-linked [47-51].[47,48,49,50,51] 
However, HA can also be directly complexed with the drug to be encapsulated [52]. 
In the second case, where particles are produced by cross-linking of transient HA 
colloidal assemblies, the parameter which seems to allow a size reduction from micro- 
to nanoparticles is the type of solvent used as the continuous phase: mineral oil for HA 
MPs versus water, water/acetone mixtures or (mixtures of) light non-polar organic 
solvents for HA NPs. These solvents or solvent mixtures are much less viscous that 
mineral oil which results in much smaller droplet size and by extension particle size. 
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Table I.3: Preparation methods of HA nanoparticles. 
DMSO, EDC, ADH, ODH, Span 80, HLB, PH, NHSS, Span 85, HLB stand for dimethyl sulfoxide, 1-
ethyl-3-[3-dimethyl amino] propyl carbodiimide, adipic acid dihydrazide, oxalic acid dihydrazide, 
sorbitan monostearate, hydrophilic lipophilic balance, polyhydrazide, sodium N-
hydroxysulfosuccinimide, sorbitan tristearate, hydrophilic lipophilic balance, respectively. HYAFF® is 
Fidia’s trademark for hydrophobically modified HA obtained by reacting HA and alkyliodides in 
DMSO, using the tetrabutylammonium salt of HA (also see § IV). For some of the preparation methods, 
the mechanism underlying the formation of the nanoparticles is explained as claimed by the authors or 
in the absence thereof as presumed by us in Comment. 
Reference 
HA MW 
NP size 
Principle Comment 
[46] 
unspecified 
500-1,000 nm 

 Instillation, under pressure, of 
pure CO2 into the HYAFF®/active 
ingredient solution in DMSO 

 Calcitonin, granulocyte 
macrophage colony stimulating 
factor and human insulin were 
encapsulated. 
Nanoprecipitation of HYAFF® in 
the supercritical CO2 antisolvent is 
induced by DMSO solubilisation in 
CO2 and evaporation. Insoluble 
HYAFF® in CO2 precipitates into 
nanoparticles. 
[47] 
20-2,500 kDa 
20 nm-
200 μm 

 Auto cross-linking of HA 
carboxyl and hydroxyl groups in 
the presence of EDC, in aqueous 
HA solutions 
or alternatively, 

 Cross-linking with polyamines, in 
the presence of EDC, in aqueous 
HA solutions 
Cross-linking of HA in aqueous 
solutions converts the initially 
randomly coiled HA into spherical 
HA nanoparticles. 
[48] 
200-
1,500 kDa 
200 nm 

 Cross-linking with ADH, in the 
presence of EDC, in water/acetone 
mixtures 
Water/acetone mixtures provide a 
poor solvent environment for HA 
which tends to self-associate into 
nanoassemblies. Acetone catalyses 
intra- and intermolecular cross-
linking by breaking HA hydrogen 
bonds. 
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Table I.3: Preparation methods of HA nanoparticles (continued). 
Reference 
HA MW 
NP size 
Principle Comment 
[49] 
unspecified 
50-200 nm 

 Mixing of HA and EDC with an 
emulsion of aminophospholipid 

 Cross-linking with the 
phospholipids in the presence of 
EDC 

 Paclitaxel was encapsulated 
We believe that the process 
involves interfacial cross-linking of 
HA at the surface of the 
phospholipid droplets and that the 
nanoparticles form as the 
phospholipids are consumed. 
[50] 
MW > 20 kDa 
10-160 nm 

 Emulsification of HA, ODH and 
EDC in a non-polar organic solvent 
with Span 80 

 Cross-linking with ODH, in the 
presence of EDC 

 Fluorescein isothiocyanate, atrial 
natriuretic peptide and green 
fluorescence protein were 
encapsulated 
Despite the fact the authors 
mention the formation of an o/w 
emulsion, we believe, according to 
the Bancroft rule [53], that a w/o 
emulsion is rather formed due to 
the low HLB value of Span 80. We 
therefore presume that the cross-
linking reaction takes place inside 
the water droplets containing HA, 
ODH and EDC. 
Interestingly, when this method 
was applied to 20-40 kDa HA, the 
size of the nanoparticles was 
reduced between 10 and 40 nm. 
[51] 
174 kDa 
200-300 nm 

 Emulsification of HA, PH, EDC 
and NHSS in ethyl 
acetate/propylene carbonate with 
Span 85 

 Cross-linking with PH, in the 
presence of EDC and NHSS 
The droplets of the nanoemulsion 
constitute nanoreactors in which 
HA is cross-linked with PH. A 
mixture of EDC and NHSS was 
used to catalyse the reaction as 
cross-linking in the presence of 
EDC alone was too rapid and 
yielded nanoparticles with 
uncontrolled properties. 
[52] 
102 kDa 
100-200 nm 

 Spontaneous complexation 
between HA and cisplatin 
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The preparation methods of Table I.3 present some advantages and drawbacks 
which are detailed below. 

 HYAFF®-based NPs [46] contain both hydrophilic and hydrophobic domains where 
hydrophilic and/or hydrophobic active ingredients can be encapsulated. In addition, 
HYAFF® polymers are biocompatible and resorbable in rats [54] which makes them 
potentially suitable for pharmaceutical purposes. However, the nanoprecipitation step 
requiring relatively high working pressures, the process might be unsuitable for the 
encapsulation of fragile active ingredients. 

 The NPs obtained by intra- and intermolecular cross-linking between HA carboxyl 
and hydroxyl groups [47] do not contain any cross-linking agent molecules making up 
the bridges between HA chains. As a result, these NPs are potentially completely 
biocompatible. Similarly, when HA is cross-linked with aminophospholipids naturally 
present in biological membranes [49], the resulting NPs consist of fully resorbable 
materials. 
Nevertheless, since HA assemblies are randomly formed in method [47], the size of the 
resulting particles is quite polydisperse. This could limit their use for applications 
where the latter needs to be accurately controlled and narrowly distributed. 

 A common advantage to the methods involving HA emulsification [50,51] is the 
possibility to quite precisely control the NP size by managing that of the nanodroplets. 
Conversely, a common drawback is the use of organic solvents and surfactants. 
Organic solvents raise occupational and environmental issues and limit the 
upscalability of the methods while surfactants are known irritants which complete 
removal can be problematic. 

 Native HA-based NPs [47-52] present the disadvantage that only 
hydrophiphilic/polar ingredients can durably be encapsulated since highly hydrophilic 
HA represents an unfavourable environment for hydrophobic compounds. 

 Finally, HA/drug complexes [52] are cross-linking agent-free and do not require 
modifying HA or using organic solvents, surfactants or harsh conditions. However, the 
technique is not versatile since HA/drug complexation is not a universal phenomenon. 
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In summary, the preparation methods of HA NPs are still facing challenges 
such as (i) environmental unfriendliness, (ii) potential surfactant residues, (iii) NP size 
polydispersity, (iv) poor versatility of the encapsulated active ingredients and (v) 
limited upscalability. 
 
When comparing the evolutionary development stage of HA micro- and 
nanoparticles it becomes clear that that HA MPs are in a paradigmatic stage where 
dominant designs have emerged and research has been taken beyond the investigation 
of preparation methods towards in vivo release studies. HA NPs, however, are still in a 
preparadigmatic stage where focus is still drawn on spotting out dominant designs (no 
two similar methods are described in the existing scarce literature) rather than on 
investigating the uses and applications of the nanoparticles. HA NP-mediated drug 
delivery therefore represents a challenging research field with room for innovation, 
intellectual property and application achievements. 
 
With the exception of Pallado et al. [46], there are no reported methods for 
the preparation of HA NPs based on hydrophobically modified HA (hmHA). Despite 
the fact the working conditions of this method may be too harsh for the encapsulation 
of delicate active ingredients, the concept of using hmHA is innovative and currently 
not widespread according to the literature study. Indeed, with its altered 
physicochemical properties and HLB, hmHA constitutes a more favourable starting 
material for the production of nanostructures and the durable encapsulation of 
hydrophobic ingredients than native HA. For these reasons, some currently available 
preparation methods of hmHA are reviewed in the next section. 
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IV. Hydrophobically modified hyaluronic acid 
 
Hydrophobically modified HA is conventionally prepared by targeting 
reactions at HA carboxyl and/or hydroxyl groups [55]. 
Historically, Jeanloz and Forchielli [56] were the first to report the modification of HA 
carboxyl groups with diazomethane, acetic anhydride and triphenylchloromethane 
towards the preparation of methylated, acetylated and triphenylchloromethylated HA. 
In the late 1980’s, Della Valle and Romeo [57] patented the modification of HA 
carboxyl groups with alkyliodides, in DMSO, using the tetrabutylammonium salt of 
HA. The resulting derivatives currently form the basis of Fidia’s trademark HYAFF® 
which has frequently been used for the preparation of colloidal particles towards drug 
delivery (see § III). 
Other more recent modification methods non-exhaustively include modification of the 
HA carboxyl groups with: 
(i) alkylaldehydes in water/ethanol mixtures, in the presence of sodium 
cyanoborohydride, using an adipic dihydrazide-modified HA intermediate obtained in 
the presence of 1-ethyl-3-[3-dimethyl amino] propyl carbodiimide [58], 
(ii) alkylbromides in DMSO [59], 
and of the HA hydroxyl groups with 
(iii) acylchlorides in N,N-dimethylformamide (DMF), in the presence of pyridine [60], 
(iv) alkyloxymethyloxiranes in water/DMSO mixtures [61], 
(v) alkylalcohols in DMSO, in the presence of potassium hydroxide, using a p-toluene 
sulfonyl-modified HA intermediate [62] (Figure I.9). 
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However, the modification methods currently available for the preparation of 
amphiphilic HA present some drawbacks. 
First, the modification reactions are often conducted in organic solvents or organic 
solvent/water mixtures. In addition to raise occupational and environmental issues and 
limit the upscalability of the preparation methods, the use of organic solvents or 
mixtures of these often requires converting HA into its tetraalkylammonium salt or 
preparing reactive HA intermediates. This not only adds complex steps to the 
preparation methods but also often results in HA degradation [59]. 
Secondly, the modification reactions involving HA carboxyl groups modify the 
distribution of negative charges along the polymer backbone at physiological pH. This 
could potentially affect some of the attractive biological and/or pharmacological 
properties of native HA [62]. 
Therefore, simple modification reactions in aqueous media, under mild conditions and 
exclusively involving HA hydroxyl groups could represent advantageous alternatives 
for the preparation of amphiphilic HA derivatives. 
 
V. The Ph.D. project 
 
V.1. Objectives and challenges 
 
For the reasons outlined all along this introduction chapter, HA currently 
represents one of the most attractive building block for the preparation of advanced 
biomaterials with applications in pharmacy. 
While the superficial administration of certain HA/drug co-formulations has been 
shown to enhance drug partitioning into human skin and drug retention and 
localisation in the epidermis, there is a lack of truly biocompatible and resorbable 
solutions for more challenging and demanding therapeutic situations requiring drug 
protection and targeting (see § II). 
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It is well known that tumourous cells generally over-express HA-binding receptors at 
their surface. Consequently, these show enhanced HA binding and internalisation [63]. 
Anti-cancer drug-containing HA-based systems therefore potentially represent 
valuable and efficient multi-functional targeting devices towards superficial tumoured 
tissues. In addition, due to HA’s natural presence in the skin, HA-based systems are 
likely to interact with the skin without altering the epithelium’s physiology. 
Therefore, the overall objective of this project was to design and develop advanced 
HA-based drug delivery systems such as HA nanoparticles towards the encapsulation 
and targeted delivery of chemically instable and/or poorly soluble drugs in aqueous 
media. In the first place, it was envisaged to evaluate these devices for dermal drug 
delivery and later extend their use to other delivery routes. 
 
The methods currently available for the preparation of HA NPs are still facing 
challenges such as (i) environmental unfriendliness, (ii) potential surfactant residues, 
(iii) NP size polydispersity, (iv) poor versatility of the encapsulated active ingredients 
and (v) limited upscalability. In addition, they use native HA which is unsuitable for 
the encapsulation of hydrophobic ingredients. It is believed that hydrophobically 
modified HA with its altered physicochemical properties and HLB, constitutes a more 
favourable starting material for the production of stable nanostructures and the durable 
encapsulation of hydrophobic ingredients (see § III.2). 
However, the current preparation methods of amphiphilic HA present some drawbacks 
such as the (i) use of organic solvents, (ii) potential alteration of some fundamental 
biological and/or pharmacological properties of HA through modification of the 
carboxyl groups and (iii) limited upscalability (see § IV). 
Therefore, other important objectives of this project were to elaborate simple and 
easily upscalable, aqueous and versatile techniques for both the preparation of 
amphiphilic HA and of HA NPs. Focus was drawn on exclusively modifying the HA 
hydroxyl groups in order to preserve the distribution of anionic charges along the 
polymer backbone and on avoiding the use of surfactants to formulate reasonably 
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uniformly distributed NPs capable of encapsulating both hydrophilic and hydrophobic 
compounds. 
 
V.2. Experimental approach 
 
Due to its high hydrophilicity, native HA possesses physicochemical 
properties incompatible with the spontaneous and stable formation of segregated 
structures in aqueous media and the durable encapsulation of hydrophobic active 
ingredients. In addition, native HA displays a poor in vivo biological stability and 
residence time as evidenced by its high turnover rate [64]. 
 
Therefore, HA was first rendered amphiphilic by the covalent binding of 
hydrophobic groups onto its backbone. For this purpose, two novel proprietary 
methods were evaluated and one was eventually selected for further study based on the 
superior versatility and functionality of the resulting HA derivatives. 
This method was then optimised in order to develop a reproducible and robust process 
for the routine preparation of functionalised HA polymers with tailored degrees of 
substitution. 
Fundamental properties such as the structure, degree of hydrophobicity, substitution 
pattern as well as intra- and intermolecular interactions of a selection of derivatives 
were subsequently studied. 
Submicronic multiphasic physically cross-linked nanogel particles capable of 
solubilising a model hydrophobic substance were prepared by spontaneous self-
association and characterized with regard to their morphology, size and surface charge. 
A multivesicular model was finally put forward to explain their internal structure. 
Finally, methods to prepare stable NPs based on the chemical stabilisation of self-
assembled HA templates were explored. Indeed, while the methods currently available 
for the preparation of HA NPs rely on random collisions in the medium to create 
structures, focus was here drawn on the development of a novel molecular approach 
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based on self-assembling multiphasic nanoarchitectured HA templates potentially 
yielding more complex NP configurations than single ingredient or core-shell 
structures. 
 
V.3. Thesis structure 
 
After this introduction chapter, the thesis is organised in four more chapters 
written in the form of research reports and/or articles to be submitted shortly. 
Chapter II is a review article about the current knowledge about the mechanisms 
underlying polymeric nanoparticle-mediated (trans)dermal drug delivery. It 
investigates, among others, the potential of this delivery route, the research gaps and 
the challenges still faced by this branch of research. 
Chapter III is organised in three different sections. Section A reports the initial 
investigation of novel modification methods to prepare amphiphilic HA and the 
selection of one class of HA derivatives for further study. Section B concerns the 
optimisation of the preparation of these HA derivatives which detailed molecular 
structure and solution properties in aqueous media is investigated in section C. 
Chapter IV reports the physicochemical properties of the selected class of HA 
derivatives and the preparation of multiphasic nanostructured HA templates. 
Chapter V reviews the work achieved, gives a conclusion for the thesis and outlines 
some possible future work. It also suggests some potential applications for the systems 
developed. 
Finally, a record of the educational activities conducted during the industrial Ph.D. 
programme is presented in the appendices. 
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Abstract 
Due to their unmatched properties, polymeric nanoparticles represent promising and 
versatile devices towards drug delivery. In the field of (trans)dermal drug delivery, 
they have been shown to enhance the percutaneous penetration and/or sustain the 
release within dermal layers of active ingredients. However, the mechanisms by which 
such feats are achieved are still not fully elucidated. Understanding the interactions 
between polymeric nanoparticles and the skin is nevertheless crucial in order to design 
suitable systems towards specific delivery scenari. This article reviews the current 
knowledge about the mechanisms underlying polymeric nanoparticle-mediated 
(trans)dermal drug delivery. It appraises some technical advances to assess skin 
penetration and examines the research gaps and future challenges of this research field. 
 
Key words nanoparticle, skin penetration, drug release, confocal and multiphoton laser 
scanning microscopy, skin sandwich model, differential stripping, nanoparticle risk 
assessment 
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I. Introduction 
 
Due to its large surface and significant advantages compared to the more 
conventional enteral and parenteral administration routes, the skin has been recognised 
as a valuable possible pathway for a variety of penetrants with heterogeneous 
properties. Indeed, drug administration to the skin presents some technical, patient-
related and societal advantages such as the circumvention of the first pass metabolism, 
convenient and painless administration and overall reduction of health costs [1] 
(Table II.1). 
 
Table II.1: Advantages of using the skin as a drug administration route (adapted from 
[1]). 

 Circumvention of the first pass metabolism 

 Direct access to superficial diseased sites 

 Sustained and controlled drug delivery over time 
Technical 
advantages 

 More efficient dose management 

 Easier dose termination in case of dose adverse reactions 

 Convenient and painless drug administration 

 Better patient acceptance and compliance Patient-related 
advantages 
 Reduction of the side effects associated with systemic toxicity 

 Minimisation of peaks and troughs in the blood drug concentration 
Societal 
advantages 

 Overall reduction of health costs 

 Lesser need for trained personnel 

 Dose reduction 
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Consequently, an important market has developed for (trans)dermal drug delivery 
which, according to some estimates, represented 1.57 billion dollars in the United 
States (US) in 2002 and will amount to nearly 5.67 billion dollars by 2009, i.e. 
approximately 6 % of the total US drug delivery market [2]. 
 
Dermal and transdermal drug delivery follow two different approaches. On 
the one hand, dermal drug delivery refers to the treatment of pathologies within the 
skin and requires concentrating drugs in the superficial skin layers. Transdermal drug 
delivery, on the other hand, is related to the treatment of diseases located in other 
organs than the skin and necessitates drugs’ systemic absorption [1]. 
 
Due to its intrinsic structure, the skin and, in particular, the stratum corneum 
(SC) naturally acts as a protective barrier against exogenous matter and constitutes an 
obstacle for the transport of drugs within or through its layers. Strategies to circumvent 
this barrier and enhance the skin uptake of topically applied drug formulations can be 
classified in passive or active methods. 
Passive strategies have involved the use of chemical enhancers [3], supersaturated 
formulations [4], prodrugs [5], metabolites [6] and particulate systems such as soft 
carriers [7] (for example, liposomes [8], ethosomes [9], niosomes [10], transferosomes 
[11]) and rigid carriers (for instance, solid lipid [12] and polymeric [13] nanoparticles). 
Active strategies can be classified in electrical (electroporation [14]), mechanical 
(microneedle-assisted perforation [15]) and iontophoretic [16] methods. Sonophoresis 
[17], phonophoresis [18], thermophoresis and magnetophoresis [1] constitute 
additional active methods for enhancing the penetration of topically applied 
substances. 
In some instances, passive and active methods have even been combined to yield a 
synergetic effect [19,20]. 
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Although efficient, most active methods and some passive methods, such as 
those involving chemical enhancers, rely on altering the skin barrier function by either 
chemically or physically disrupting the SC organisation or mechanically by-passing 
the SC (perforation). This can induce irritation and possible irreversible damages to 
skin tissues. In addition, such methods are inefficient towards the protection of 
chemically unstable drugs and can alter their activity [21]. 
Passive methods based on particulate systems however represent non-invasive 
techniques which can enhance the penetration of topically applied drugs while 
minimizing the deterioration of the skin barrier function and preserving drug activity. 
 
Among the currently available particulate systems towards (trans)dermal drug 
delivery, soft carriers and, in particular, liposomes, have been criticised for their poor 
stability, low encapsulation efficiency and rapid drug leakage [13]. In contrast to 
liposomes, polymeric nanoparticles would be more stable and offer a better control of 
the drug release [22]. Therefore, these currently constitute one of the most promising 
modern tools towards (trans)dermal drug delivery. 
 
Polymeric nanoparticles are characterised by a mean diameter inferior to 
1 μm and a matrix consisting of a natural or synthetic polymer or a combination of 
several of these. As anticipated, the choice of the polymer(s) is driven by qualities such 
as biocompatibility and biodegradability. Certain polymers present these features to 
various degrees, namely, poly(D,L-lactide), poly(lactic acid), poly(D,L-glycolide), 
poly(lactide-co-glycolide), poly(cyanoacrylate), poly(alkylcyanoacrylate), poly(-
caprolactone), poly(methylidene malonate) [13] and polysaccharides such as chitosan, 
dextran, pectin, heparin, pullulan and sodium alginate. 
Encapsulation in polymeric nanoparticles is usually achieved by dispersion in the 
polymer matrix (a), concentration in the nanoparticle core (b), chemical conjugation or 
physical adsorption on the surface of the nanoparticles (c) [23] (Figure II.1). 
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a b c
Polymer matrix
Active ingredient  
Figure II.1: Drug encapsulation in polymeric nanoparticles. 
 
Some studies have shown that polymeric nanoparticles can noticeably 
enhance the topical delivery of, for example, chlorhexidine [24], octyl 
methoxycinnamate [25] and flufenamic acid [26]. However, the mechanisms of such 
achievements are still questioned. 
In view of this, the objective of this article was to take stock of the current knowledge 
about the mechanisms underlying polymeric nanoparticle-mediated (trans)dermal drug 
delivery. First, new and improved methods for detecting skin penetration pathways are 
reviewed. Then, polymeric nanoparticle fate subsequent to topical administration is 
discussed based on the available experimental data. This discussion in particular 
addresses the current hypothesis with regards to how polymeric nanoparticles can 
enhance percutaneous penetration and/or sustain drug release within dermal skin 
layers. Finally, the research gaps and future challenges of the research field are 
examined. 
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II. Technical advances in assessing skin penetration pathways 
 
II.1. Skin penetration pathways 
 
The skin is composed of a dermis and an epidermis consisting of several 
morphologically distinct layers. These are, from the inside to the outside, the stratum 
basale, stratum spinosum, stratum granulosum and stratum corneum. The first three 
layers constitute the viable epidermis which is a dynamic and constantly self-renewing 
tissue. Cells proliferate in the basal layer and differentiate while migrating towards the 
surface of the skin. At the interface between the stratum granulosum and SC, they 
undergo a major terminal differentiation and are transformed into flattened, dead and 
keratin-filled cells without nuclei (corneocytes). In the SC, the ultimately differentiated 
corneocytes are covered by a densely cross-linked protein layer, the cell envelope, and 
are embedded in lipid lamellar regions parallelly oriented to the corneocyte surface. 
This results in a densely packed structure [27]. 
Hair follicles and the sweat apparatus are important skin structures resulting from 
epidermal invaginations and which present orifices at the surface of the skin. 
 
Considering the general anatomy of the skin (Figure II.2), three penetration 
pathways potentially contribute to the transport of exogenous matter from the surface 
of the skin into epidermal or dermal layers. These consist of the intercellular space 
between corneocytes and of the two skin appendages mentioned above namely, hair 
follicles and sweat ducts. 
Historically, the intercellular path has first and foremost been considered the main skin 
penetration route and is by far the most studied and discussed pathway for the infusion 
of a variety of chemical substances [28]. 
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Epidermis
Dermis
Hair follicleSweat duct
Sebaceous gland
Sweat gland
Arrector pili muscle
Hair shaft
Blood vessel
Pacinian corpuscle
Stratum corneum
 
Figure II.2: Structure of mammalian skin and possible skin penetration pathways 
(adapted from [29]). 
The black arrows point to the potential skin penetration pathways. 
 
It is usually agreed that the barrier function of the skin is primarily provided 
by the SC. Due to the rather impermeable character of the cornified envelope around 
the corneocytes, substances entering the skin through this pathway are believed to 
penetrate along the tortuous intercellular space [27] (Figure II.3). 
 
           
Stratum corneum
Corneocyte
Intercellular space
Intercellular pathway
 
Figure II.3: Penetration through the intercellular space between corneocytes. 
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Although skin appendage orifices only represent a small fraction of the total 
surface of the skin, hair follicles and sweat ducts constitute possible additional skin 
penetration pathways.[30,31,32,33] 
An interest for drug delivery via hair follicles has existed for several decades [30-33] 
and recent reviews have addressed the potential of using this pathway for therapeutic 
purposes [34,35,36]. It is usually agreed, that the advantages of follicular delivery lie 
in the possibility to more directly access deep compartments of the skin and in the 
large and long-term storage capacity of the hair follicle reservoir [37] which has been 
estimated equal to that of the SC [38]. Interestingly, the follicular pathway is currently 
considered to play a significant role in particulate drug delivery [33,39]. 
 
In contrast to hair follicles, sweat ducts have been a relatively poorly studied 
system and attempts to elucidate their role in skin penetration processes remain sparse 
and at an early stage of investigation. Wilke et al. [40] have addressed the question of 
the sweat duct barrier function by studying the distribution of tight junction proteins 
such as occludin, claudin 1 and claudin 4 throughout the eccrine and apocrine 
apparatuses. They showed that the sweat duct barrier function was a non-homogeneous 
property throughout these two structures. Whereas the co-localisation of occludin and 
claudin 4 in sweat glands and dermal sweat ducts was considered to provide tight 
junctions (i.e. a good barrier function), the sole presence of occludin in intra-epidermal 
sweat ducts was recognised as being a sign of looser junctions (i.e. a reduced barrier 
function). The authors therefore speculated that the intra-epidermal region of sweat 
ducts could serve as an alternative penetration pathway. Although an important 
finding, this theory necessitates further confirmation by specific and quantitative 
penetration studies through sweat ducts. Some qualitative studies have been reported 
on this subject [41,42] with only a few examples of positive penetration [42]. 
 
For an extensive insight into the various skin penetration routes, the reader is 
invited to consult the excellent book chapter by Schaefer and Redelmeier [43]. 
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The existence of the three (potential) skin penetration pathways implies that 
chemical substances and formulated systems may penetrate through the skin by 
following different paths. However, in order to understand the penetration process(es) 
of a given system, a deconvolution of its parallel fluxes is necessary in order to reason 
out the main entry route for this system. 
Whereas microscopic imaging can provide a qualitative picture of penetration routes 
into and through the skin, selective diffusion experiments or diffusion experiments 
followed by selective extractions offer the possibility to quantify the amount of 
penetrated matter into the various compartments of the skin and establish a hierarchy 
between the different penetration routes observed by microscopy. 
 
II.2. Microscopic imaging 
 
Advances in microscopic imaging have crystallised into modern laser 
scanning microscopy (LSM) with two major variations, namely confocal and 
multiphoton laser scanning microscopy (CLSM and MPLSM). 
In LSM, the sample is illuminated by a beam of laser light focused into a point at the 
focal plane. This beam can be scanned in the X, Y and Z directions by a computer-
controlled scanning mirror. The fluorescence emission created at the successively 
scanned points is detected by a photon multiplier tube. This information is processed 
by computer hardware into an image. Spatial scanning of the sample allows 
reconstructing 3-dimension (3D) images [44]. 
 
II.2.1. Confocal laser scanning microscopy 
 
In CLSM, gas lasers are used as the illumination source. Since illumination of 
the focal plane is inherently accompanied by the creation of out-of-focus fluorescence 
above and below the focal plane, a pin hole is placed between the specimen and the 
photon multiplier tube to avoid blurring of the final images. This pin hole 
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discriminates out-of-focus information so that the focal plane of illumination and 
detection are confounded or confocal. Sharp images of the specimen can thus be 
derived [44]. 
 
II.2.2. Multiphoton laser scanning microscopy 
 
MPLSM uses solid state lasers as the illumination source. These lasers have 
the particularity to generate photons in pulses and light characterised by a longer 
wavelength than in CLSM. Due to technical considerations that are beyond the scope 
of this review, the region of the specimen excited by MPLSM is much more confined 
than that by CLSM. As a consequence, minimum or no out-of-focus fluorescence is 
generated in this mode and all the information arising from the focal plane directly 
reaches the photon multiplier tube without the need for a pin hole [44]. 
 
CLSM and MPLSM present decisive advantages over other more 
conventional microscopy techniques such as light microscopy, transmission electron 
microscopy: 
(i) the endogenous fluorescence of the skin allows achieving images on which the 
structural details of this tissue can clearly be identified, 
(ii) mechanical sectioning is no longer necessary which allows circumventing artefacts 
related to sample fixation and traditional histological investigations, 
(iii) samples are non-invasively studied and high-resolution 3D images can be derived 
[45]. 
However, some technical differences between CLSM and MPLSM give 
further advantages to MPLSM which is more sensitive than CLSM because all the 
information generated at the focal plane directly reaches the detector. Besides, the 
longer wavelength light used in MPLSM is less damaging to samples though more 
penetrating than the shorter wavelength light used in CLSM [44]. 
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For further technical information on CLSM and MPLSM, the reader is invited to 
consult the reviews by Oheim et al. [46] and Diaspro et al. [47], respectively. 
 
CLSM and MPLSM have allowed significant improvements in the 
observation and understanding of biological phenomena and have recently been used, 
as will be shown in part II, for the qualitative deconvolution of polymeric nanoparticle 
skin penetration pathways. 
The quantitative assessment of the different skin penetration pathways constitutes the 
second aspect in understanding the fate of topically applied formulations. Advances in 
this field are the subject of the following paragraph. 
 
II.3. Skin penetration quantification 
 
In the past, the distinction between SC and follicular penetration has been 
tackled by comparing penetration fluxes through skin containing follicles and skin 
devoid of these. However, interpretation of the results generated using such an 
approach is problematic as hairless and hairy skins can exhibit different barrier 
functions due to their structural and biochemical differences. 
Innovative approaches were recently proposed to circumvent this problem and allow to 
distinguish between SC and appendageal penetration. These are the skin sandwich 
model and differential stripping. 
 
II.3.1. The skin sandwich model 
 
The skin sandwich model is a composite skin system composed of a stack of a 
human whole epidermis (nucleated epidermis and SC) and of an additional SC 
membrane sampled from the same donor. As skin appendage orifices only represent 
0.1 % of the total skin surface [38], little chance exists that the shunts of the two 
different skin components superimpose. Therefore, in this composite skin tissue, the 
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appendages of both the superficial SC and the underneath whole epidermis are 
mechanically blocked for penetration (Figure II.4). 
 
Nucleated epidermis
Stratum corneum
Epidermis
Normal skin
Appendage
Nucleated epidermis
Superficial stratum corneum
Bottom stratum corneum
Epidermis
Skin sandwich
Appendage 
blocked
Appendage 
blocked
 
Figure II.4: Schematic representation of the skin sandwich model (adapted from [48]). 
 
A comparison of the penetration fluxes through normal skin and the skin 
sandwich can be used to isolate the contribution of the appendageal pathway in 
penetration processes. Indeed, if appendages represent an important pathway for a 
given system, its flux through the skin sandwich should be much reduced compared to 
that through normal skin. 
 
The skin sandwich model was first developed by El Maghraby et al. [49] to 
evaluate the importance of the appendageal pathway in the delivery of estradiol from 
various liposomes in human skin. The authors observed that the permeation of the drug 
through the skin sandwich was somewhat reduced compared to that through normal 
skin and that this tendency was independent on the liposomal system employed 
(ultradeformable or traditional liposomes). However, this reduced drug permeation 
flux was close to the expected theoretical flux arising from the thicker barrier provided 
by the skin sandwich. The latter, composed of a stack of two SC layers was indeed 
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twice as thick as the barrier provided by normal skin. The authors therefore excluded 
the appendageal pathway as the main penetration route for the delivery of estradiol 
from liposomes in human skin. 
 
Barry [48] later systematically evaluated the performances of the skin 
sandwich model using various model compounds such as estradiol (lipophilic), 
mannitol (hydrophilic) and L-glutamic acid (negatively charged) administered by 
iontophoresis. A repeated consistency between the theoretical and experimental 
behaviours of these compounds confirmed the accuracy and validity of the skin 
sandwich model. For instance, due to its negative charge, L-glutamic acid was 
expected to follow the path of least resistance and to penetrate through damaged 
regions of the skin and skin appendages. In addition, the creation of artificial pores due 
to the temporary disruption of the intercellular lipids was expected to contribute to the 
enhancement of its transport. Experimentally, the flux ratio between sandwiched skin 
and normal skin was close to zero for L-glutamic acid which confirmed that the 
appendageal pathway dominated the iontophoretic transport of L-glutamic acid. 
However, when electroporation was used the flux ratio did not fall to zero evidencing 
that the electrical pulses created transient aqueous pores in the intercellular lipids 
through which L-glutamic acid was transported across sandwiched skin. 
 
The identical source between the skin sandwich and normal skin and the 
mechanical shunt obstruction without exogenous material circumvent interpretational 
difficulties related to the different barrier functions of hairless and hairy skins. In 
addition, Barry [48] demonstrated using the Monte Carlo approach that results 
remained consistent even in the case of slightly imperfect adherence between the two 
different skin components in the skin sandwich. Interestingly, the author emphasised 
that the skin sandwich model could potentially be used to deconvolute the penetration 
pathways of colloidal particles. 
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II.3.2. Differential stripping 
 
Differential stripping is based on the combination of two existing techniques 
namely, tape stripping and the cyanoacrylate follicular biopsy. 
On the one hand, tape stripping is a frequently used method to investigate the 
penetration of topically applied substances into the skin [50]. After applying a 
formulation onto the skin, several successive skin layers are removed with adhesive 
films. Each skin strip contains corneocytes and variable amounts of the topically 
applied system which can further be extracted by adequate techniques. The correlation 
between the amount of extracted substance from each individual strip and the strip 
number allows tracking the penetration profile of a given system. 
On the other hand, the cyanoacrylate follicular biopsy uses a quick-setting polymer to 
extract the infundibular content of pilosebaceous units [51]. This technique is useful 
for studying the contents of follicles and can be employed for analysing the penetration 
of topically applied compounds or formulations through hair follicles. 
 
Teichmann et al. [52] were the first to combine the two above described 
techniques to selectively and non-invasively study the penetration of topically applied 
substances into the SC and follicular structures. This method called differential 
stripping uses tape stripping to first collect the amount of topically applied substances 
penetrated into the SC and the cyanoacrylate follicular biopsy to secondly collect the 
amount penetrated into follicular structures. 
By using these two successive stripping techniques, the authors determined the amount 
of sodium fluorescein penetrated in vivo in the SC and hair follicles of human back 
skin. After 30 min, 54 % ± 8.1 % of the dye was recovered of which 95 % ± 14 % in 
the SC and 5 % ± 0.9 % in the follicular infundibula. After 24 and 48 hours, sodium 
fluorescein was still detected in follicular structures although the concentration of the 
dye decreased over time. 
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Differential tape stripping therefore constitutes a novel method to selectively study 
skin penetration pathways. It gives a number of opportunities for the study of the 
pharmacokinetics of topically applied substances and more generally for research in 
the field of dermatology. 
 
The use of CLSM and MPLSM and/or selective extraction techniques has 
allowed new insights into the mechanisms underlying polymeric nanoparticle-
mediated drug delivery which are reviewed hereafter. 
 
III. Mechanisms underlying polymeric nanoparticle-mediated drug delivery 
 
III.1. Redistribution and accumulation of polymeric nanoparticles in the skin 
 
As shown in Table II.2, the redistribution of topically applied polymeric 
nanoparticles on the surface of the skin has been shown to occur towards the (i) skin’s 
superficial reliefs [26,53,54], (ii) hair follicles [55,56,57], (iii) intercellular space in the 
SC and (iv) subepidermal skin tissues [58]. 
In studies [53] and [54], for which the nanoparticles were founds in the skin 
furrows/dermatoglyphs, optical cross-sections of non-follicular skin regions further 
showed that the nanoparticle distribution was only superficial. This suggested that skin 
furrows/dermatoglyphs were not penetration pathways for the nanoparticles. 
Studies [55] to [57] reported that hair follicles constituted a significant penetration 
pathway for nanoparticles with a diameter between 40 and 320 nm. 
However, polymer-coated intrinsically fluorescent quantum dots with hydrodynamic 
diameters between 14 and 45 nm were localised in the SC and in the skin subepidermal 
layers [58]. This shows that the intercellular space constitute another penetration 
pathway for nanoparticles with small diameters. 
 
79
  
Ta
bl
e 
II
.2
: R
ed
is
tri
bu
tio
n 
of
 to
pi
ca
lly
 a
pp
lie
d 
po
ly
m
er
ic
 n
an
op
ar
tic
le
s o
n 
th
e 
su
rf
ac
e 
of
 th
e 
sk
in
. 
N
P 
st
an
ds
 fo
r n
an
op
ar
tic
le
. 
R
ef
er
en
ce
 
N
P 
ty
pe
/e
nc
ap
su
la
te
d 
su
bs
ta
nc
e/
si
ze
 
A
dm
in
is
tra
tio
n 
an
d 
de
te
ct
io
n 
co
nd
iti
on
s 
R
es
ul
ts
 
[2
6]
 
Po
ly
(la
ct
id
e-
co
-g
ly
co
lid
e)
/fl
uf
en
am
ic
 
ac
id
/3
30
 n
m
 

 3
0-
m
in
 in
cu
ba
tio
n 
w
ith
 h
um
an
 sk
in
 
in
 v
itr
o 

 M
PL
SM
 im
ag
in
g 

 U
ni
fo
rm
 N
P 
di
st
rib
ut
io
n 
on
 th
e 
su
rf
ac
e 
of
 th
e 
sk
in
 a
nd
 w
ith
in
 th
e 
sk
in
 d
er
m
at
og
ly
ph
s 

 N
o 
N
Ps
 fo
un
d 
be
tw
ee
n 
or
 w
ith
in
 c
or
ne
oc
yt
es
 
[5
3]
 
C
ar
bo
xy
la
te
-m
od
ifi
ed
 F
lu
oS
ph
er
es
®
 
(f
lu
or
es
ce
nt
 p
ol
ys
ty
re
ne
)/f
lu
or
es
ce
in
-
5-
is
ot
hi
oc
ya
na
te
/2
0 
or
 2
00
 n
m
 

 3
0-
, 6
0-
 o
r 1
20
-m
in
 in
cu
ba
tio
n 
w
ith
 
po
rc
in
e 
sk
in
 in
 v
itr
o 

  
C
LS
M
 im
ag
in
g 

 T
im
e 
de
pe
nd
en
t N
P 
ac
cu
m
ul
at
io
n 
ar
ou
nd
 th
e 
fo
lli
cu
la
r o
pe
ni
ng
s 
an
d 
in
 th
e 
fu
rr
ow
s o
f t
he
 sk
in
 

 T
he
 lo
ng
er
 th
e 
in
cu
ba
tio
n 
tim
e,
 th
e 
hi
gh
er
 th
e 
de
te
ct
ed
 
flu
or
es
ce
nc
e 
[5
4]
 
5-
flu
or
es
ce
in
am
in
e-
co
va
le
nt
ly
-
la
be
lle
d 
po
ly
(la
ct
id
e-
co
-
gl
yc
ol
id
e)
/T
ex
as
 R
ed
/3
00
 n
m
 

 5
-h
ou
r i
nc
ub
at
io
n 
w
ith
 h
um
an
 sk
in
 
in
 v
itr
o 

 M
PL
SM
 im
ag
in
g 

 N
P 
lo
ca
tio
n 
in
 th
e 
sk
in
 d
er
m
at
og
ly
ph
s 
[5
5]
 

 P
ol
y(
-
ca
pr
ol
ac
to
ne
)-
bl
oc
k-
po
ly
(e
th
yl
en
e 
gl
yc
ol
)/r
ub
re
ne
/4
0 
or
 
13
0 
nm
 

 1
2-
ho
ur
 in
cu
ba
tio
n 
w
ith
 g
ui
ne
a 
pi
g 
sk
in
 in
 v
iv
o 

 C
LS
M
 im
ag
in
g 
of
 b
io
ps
ie
d 
gu
in
ea
 
pi
g 
sk
in
 

 N
P 
ac
cu
m
ul
at
io
n 
in
 h
ai
r f
ol
lic
le
s a
nd
 th
ei
r s
ur
ro
un
di
ng
 ti
ss
ue
s 
[5
6]
 

 F
lu
oS
ph
er
es
®
 (f
lu
or
es
ce
nt
 
po
ly
st
yr
en
e/
40
 n
m
 

 1
5 
to
 1
6-
ho
ur
 in
cu
ba
tio
n 
w
ith
 
hu
m
an
 sk
in
 in
 v
itr
o 

 C
LS
M
 im
ag
in
g 
of
 fo
lli
cu
la
r 
cr
yo
se
ct
io
ns
 o
f c
ya
na
cr
yl
at
e 
st
rip
pe
d 
hu
m
an
 sk
in
 

 P
re
se
nc
e 
in
 
ha
ir 
fo
lli
cl
es
 
do
w
n 
to
 
a 
de
pt
h 
of
 
22
5±
34
 μ
m
 
(c
or
re
sp
on
di
ng
 to
 th
e 
oc
cu
rr
en
ce
 o
f s
eb
ac
eo
us
 g
la
nd
s)
 
80
  
Ta
bl
e 
II
.2
: R
ed
is
tri
bu
tio
n 
of
 to
pi
ca
lly
 a
pp
lie
d 
po
ly
m
er
ic
 n
an
op
ar
tic
le
s o
n 
th
e 
su
rf
ac
e 
of
 th
e 
sk
in
 (c
on
tin
ue
d)
. 
[5
7]
 

 R
es
om
er
®
/5
-
flu
or
es
ce
in
am
in
e/
32
0 
nm
 

 1
-h
ou
r i
nc
ub
at
io
n 
w
ith
 p
or
ci
ne
 sk
in
 
in
 v
itr
o 
LS
M
 im
ag
in
g 
of
 p
hy
si
ca
l s
ki
n 
cr
os
s-
se
ct
io
ns
 

 P
en
et
ra
tio
n 
al
on
g 
ha
ir 
fo
lli
cl
es
 d
ow
n 
to
 a
 d
ep
th
 o
f 
15
00
 μ
m
 
w
he
n 
th
e 
na
no
pa
rti
cl
es
 w
er
e 
m
as
sa
ge
d 
on
 th
e 
su
rf
ac
e 
of
 th
e 
sk
in
 
[5
8]
 
Po
ly
m
er
-c
oa
te
d 
in
tri
ns
ic
al
ly
 
flu
or
es
ce
nt
 q
ua
nt
um
 d
ot
s/
14
-4
5 
nm
 

 8
 o
r 2
4-
ho
ur
 in
cu
ba
tio
n 
w
ith
 p
or
ci
ne
 
sk
in
 in
 v
itr
o 

 C
LS
M
 im
ag
in
g 

 N
P 
pe
ne
tra
tio
n 
an
d 
lo
ca
lis
at
io
n 
in
 t
he
 S
C
 a
nd
 s
ub
ep
id
er
m
al
 
la
ye
rs
 
81
Development of soft nanocarriers from novel amphiphilic hyaluronic acid 
derivatives towards drug delivery 
Chapter II 
Review 
 
 
56 
In summary, according to the recent studies focusing on understanding the 
fate of topically applied nanoparticles, these can superficially redistribute to skin 
reliefs such as the skin furrows/dermatoglyphs and follicular openings. They can also 
penetrate along hair follicles down to macroscopic depths or through the intercellular 
space down to subepidermal layers. This last finding by Ryman-Rasmussen et al. [58] 
is unusual and in apparent contradiction with the results of Alvarez-Roman et al. [53], 
Shim et al. [55] and Vogt et al. [56]. However, it is not the only one of its kind since 
Menzel et al. [59] demonstrated using an ion beam analysis that lanceolate metal 
(titanium oxide) nanoparticles (45- to 150-nm long, 17- to -35-nm wide) penetrated 
porcine skin from the SC to the stratum granulosum through the intercellular space 
between corneocytes after an 8 hour incubation of the nanoparticles in vivo. 
 
Considering the similarity in size of 20- [53] and 40-nm [55,56] polystyrene 
nanoparticles on the one hand and 14- to 45-nm [58] polymer-coated quantum dots on 
the other hand and their different penetration profiles, polymeric nanoparticle skin 
penetration seems a more complex phenomenon than one just dependant on the size of 
the nanoparticles. Some possible mechanisms of their transport into the skin are 
presented in the following paragraph. 
III.2. Possible mechanisms underlying polymeric nanoparticle skin penetration 
 
Logically, it can be conceived that the dimensions of the penetration pathway 
is a major factor for the selective diffusion of polymeric nanoparticles. 
Penetration though the SC can therefore be imagined to require that the nanoparticle 
size complies with the narrow dimensions of the intercellular space between 
corneocytes. Bouwstra et al. [60] described the structure of the intercellular lipids as a 
stack of lamellae with characteristic periodicities of 6.4 and 13.4 nm [61] (the average 
thickness of the intercellular space is about 100 nm). Nanoparticles presenting at least 
one dimension within the order of magnitude of that of the periodic phases can 
hypothetically penetrate through the intercellular space [58]. 
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Penetration of larger particles may also be possible when the lipid organisation is 
disrupted such as in the case of high tissue hydration [62,63] and certain skin diseases 
[64]. 
In addition, the physicochemical properties of the nanoparticles can also be 
accountable for the penetration through the intercellular space of larger particles. For 
example, the poor solubility of the polymer matrix in the intercellular lipids can cause 
a decrease in the apparent hydrodynamic diameter of the nanoparticles facilitating their 
penetration through the intercellular space [58]. 
 
Nanoparticle penetration along hair follicles however seems to be less 
restricted than through the intercellular space due to larger dimensions of follicular 
infundibula [65,66]. Ossadnik et al. [57] explained that nanoparticle penetration along 
hair follicles might occur owing to a pumping effect by hair shafts caused by hair 
tilting. Indeed, the cuticles arising from keratinocyte desquamation form a structured 
surface, which can be assimilated to a zigzag relief. The latter is determined by the 
thickness of the keratin cells which is between 500 and 800 nm. With the continuous 
movement of hair, the cuticle cells may act as a geared pump and push particles down 
to the hair infundibulum. According to Ossadnik et al. [57], the structural 
characteristics of follicular infundibula imply that the optimum nanoparticle size for 
penetration along hair follicles is below 700 nm. 
 
Based on these general mechanisms, the study of the influence of 
characteristics such as the nanoparticle size, surface charge and shape can further give 
valuable insight in explaining the mechanism of their skin penetration. 
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III.2.1. Influence of nanoparticle size 
 
Shim et al. [55] correlated the efficiency of mixnoxidil permeation through 
hairy guinea pig skin to the size of the poly(-caprolactone)-block-poly(ethylene 
glycol) nanoparticles. They found that the in vitro permeation of mixnoxidil 
encapsulated in 40-nm nanoparticles was 1.7-fold higher than that of mixnoxidil 
encapsulated in 130-nm nanoparticles after 18 hours. Interestingly, no significant 
influence of the size of the nanoparticles on the permeation of mixnoxidil could be 
evidenced in hairless guinea pig skin. Moreover, mixnoxidil permeation was 
substantially lower in hairless than in hairy guinea pig skin. 
 
Alvarez-Roman et al. [53] observed that 20-nm fluorescent polystyrene 
nanoparticles (carboxylate-modified FluoSpheres®) redistributed more rapidly and 
selectively to the follicular openings of porcine skin in vitro than the 200-nm 
nanoparticles after 120 min. This phenomenon was attributed to the higher specific 
surface area developed by the smaller nanoparticles. 
 
Vogt et al. [56] detected 40-nm polystyrene nanoparticles (FluoSpheres®) in 
follicular CD1a+ cells in cyanoacrylate stripped human skin after 15 to 16 hours in 
vitro. By contrast, the 750- and 1,500-nm nanoparticles (FluoresbriteTM) were not 
detected in these cells. CLSM imaging of follicular cryosections evidenced the 
penetration of the 40-nm nanoparticles along hair follicles down to a maximum depth 
of 225 ± 34 μm whereas the larger nanoparticles (750 and 1,500 nm) remained in the 
uppermost part of the follicles. 
 
Ryman-Rasmussen et al. [58] however demonstrated a rather size-
independent penetration of differently sized (hydrodynamic diameters between 14 and 
45 nm) and coated (poly(ethylene glycol), carboxylic acids and poly(ethylene glycol 
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amine)) spherical quantum dots in porcine skin. All nanoparticle types penetrated 
down epidermal or dermal skin layers after 8 hour in vitro. 
 
These results suggest that the size of the nanoparticles is an important factor 
of the penetration kinetics [53,55] and pathway. Nanoparticles presenting dimensions 
incompatible with that of the penetration pathway are retained superficially [56] while 
those presenting dimensions under several tens of nanometres penetrate the SC 
through the intercellular space between corneocytes [58]. Larger nanoparticles but 
which diameters do not exceed 700 nm preferentially follow the follicular pathway 
[53,55,56]. Within this size range, differences in nanoparticle size result in differences 
in penetration velocity and extent: the smaller the nanoparticles, the faster and deeper 
their transport in the follicles. 
 
III.2.2. Influence of nanoparticle surface charge 
 
Ryman-Rasmussen et al. [58] observed a charge-independent penetration of 
spherical quantum dots and a charge-dependent penetration of ellipsoid quantum dots 
in porcine skin. Whether coated with neutral poly(ethylene glycol) (PEG), anionic 
carboxylic acids (CA) or cationic poly(ethylene glycol amine) (PEG-amine), similarly 
sized spherical quantum dots penetrated epidermal (PEG and CA) and dermal (PEG-
amine) skin layers after 8 hours in vitro. However, only PEG and PEG-amine coated 
ellipsoid quantum dots penetrated epidermal skin layers after 8 hours whereas CA 
ellipsoid quantum dots only penetrated epidermal skin layers after 24 hours. This 
suggested that the negatively charged ellipsoid quantum dots were more retained in the 
intercellular space than the neutral and positively charged ellipsoid quantum dots. 
 
Kohli and Alpar [67] however evidenced the in vitro penetration and 
accumulation in porcine SC and viable epidermis of negatively charged fluorescent 
latex nanoparticles (diameters 50 and 500 nm) after 6 hours. Although unable to fully 
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explain the mechanism by which these nanoparticles penetrated the in the SC, the 
authors speculated that the repulsive forces between the negatively charged 
nanoparticles and skin lipids might have resulted in the formation of temporary 
channels through which the 50- and 500-nm nanoparticles could be transported. 
 
The scarcity of specific studies on the influence of nanoparticle surface charge 
on their skin penetration makes it a difficult task to draw general conclusions about 
this phenomenon. The negative charge of the lipid bilayers in the intercellular space 
should logically favour the transport of positively charged species. However, the study 
by Kohli and Alpar [67] is in apparent contradiction with this hypothesis. Further 
investigation of this topic will be necessary to understand the electrokinetic 
interactions between polymeric nanoparticles and skin tissues. 
 
III.2.3. Influence of nanoparticle shape 
 
Ryman-Rasmussen et al. [58] observed that PEG-amine-coated spherical 
quantum dots penetrated down to dermal skin layers whereas similarly coated ellipsoid 
quantum dots only penetrated down to epidermal skin layers in porcine skin after 
8 hours in vitro. CA-coated spherical quantum dots penetrated and accumulated in the 
epidermis faster (after 8 hours) than similarly coated ellipsoid quantum dots (after 
24 hours). As the difference in hydrodynamic diameter between these spherical and 
ellipsoid quantum dots was minor (less than 5 nm) the variation in their penetration 
depths/times was attributed to their shape. The more homogenously shaped spherical 
quantum dots penetrated in deeper skin layers than their heterogeneously shaped 
ellipsoid analogues. 
These results suggest that the more homogeneous the shape of the nanoparticles the 
easier their penetration into the intercellular space. 
 
86
Development of soft nanocarriers from novel amphiphilic hyaluronic acid 
derivatives towards drug delivery 
Chapter II 
Review 
 
 
61 
With a better knowledge of the fate of topically applied nanoparticle and of 
the mechanisms underlying their penetration, it is now possible to formulate 
hypothesis with regards to how these enhance and/or sustain drug release. 
 
III.3. Hypothesis with regards to how polymeric nanoparticles enhance percutaneous 
penetration and/or sustain drug release 
 
In most of the cases, due to the relatively large dimensions of most of the 
currently available polymeric nanoparticles (> 40 nm), enhancement of the 
percutaneous penetration and/or sustained release of encapsulated substances through 
non-follicular regions of the skin cannot be attributed to the co-penetration of the 
carrier and the encapsulated substance through skin tissues. 
For example, Luengo et al. [26] observed an increase in the flufenamic acid in vitro 
transport through human abdominal skin when the drug was encapsulated in 
poly(lactide-co-glycolide) (PLGA) nanoparticles compared to that of the free drug 
after 12 hours. However, the PLGA nanoparticles remained homogeneously 
distributed on the surface of the skin and within skin dermatoglyphs and no 
nanoparticles were detected within or between corneocytes. 
Stracke et al. [54] followed the release, accumulation and penetration of Texas Red-
containing PLGA nanoparticles by MPLSM. Multi fluorescence labelling of this 
system enable the authors to follow the fate of both the nanoparticles and the 
encapsulated compound. The Texas Red concentration profiles over time in various 
skin compartment acquired by multiphoton spectral imaging showed that Texas Red 
started to be absorbed by the SC immediately after topical application. This suggested 
that release from the nanoparticle had probably already begun before the penetration 
experiment within the hydrogel used for the formulation. 
Alvarez-Roman et al. [53] have put forward that the penetration improvement 
achieved by using nanoparticles is due to an efficient liberation of the encapsulated 
substance into the SC. 
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Certain interactions between polymeric nanoparticles and the surface of the 
skin can explain the sustained release of the encapsulated substances. 
For example, Olvera-Martinez et al. [68] observed lower penetrated amounts of the 
sunscreen octyl methoxycinnamate into human skin in vivo from cellulose acetate 
phthalate nanocapsules (diameter 460 nm) than from a conventional oil-in-water 
emulsion or a nanoemulsion prepared with the non-ionic emulsifying agent poly(vinyl 
alcohol). The authors suggested that the slower and more superficial release achieved 
by the nanocapsules was probably due to the formation of a nanoparticle superficial 
depot from which the sunscreen was progressively infused to the outermost layers of 
the skin. 
Lboutounne et al. [24] showed that chlorhexidine-loaded poly(-caprolactone) 
nanoparticles partially wetted porcine skin. The contact angle determined by scanning 
electron microscopy and surface tension for these nanoparticles were 124 degrees and 
147 dyn/cm, respectively. The authors argued that this partial wetting was responsible 
for the sustained release, enhanced concentration within SC and reduced percutaneous 
absorption of chlorhexidine. Indeed, the sufficient flexibility of the nanoparticles 
allowed their adherence to the skin and their sufficient rigidity permitted avoiding 
rapid drug diffusion [69]. 
 
Other studies have shown that nanoparticles could penetrate through hair 
follicles [37,53,55,56] and could be stored in the follicular structures of human claves 
for up to 10 days [39]. However the different authors admit that the release 
mechanisms in such conditions remain unclear. 
 
Finally, nanoparticle penetration through non-follicular skin structures could 
be a possible mechanism to explain the penetration enhancement of encapsulated 
substances [58]. However, to the best of our knowledge, very few studies using 
microscopic imaging have specifically demonstrated this phenomenon. 
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Although recent advances have been achieved in the understanding of 
polymeric nanoparticles-mediated (trans)dermal drug delivery, this research field 
remains fraught with both scientific and regulatory challenges. These are examined 
hereafter. 
 
IV. Future challenges in polymeric nanoparticle-mediated (trans)dermal drug 
delivery 
 
IV.1. Nanoparticle design 
 
Polymeric nanoparticles possessing a high drug loading capacity and which 
can target diseased body sites, be triggered at the right moment and sustain drug 
release for an appropriate period of time, represent the Holy Grail of (trans)dermal 
drug delivery. 
However, drug loading in polymeric nanoparticles is limited by their size. It can 
therefore be expected that the improved skin penetration of small nanoparticles will be 
at the expense of the amount of encapsulated drug. For this reason, an optimal balance 
will have to be found for each given application between the desired extent of 
penetration (partly determined by the size of the nanoparticles) and the dose required 
to achieve a therapeutic effect. 
 
Nanoparticle targeting, triggering and sustained drug release represent other 
major challenges of polymeric nanoparticle design. 
Nanoparticle targeting is probably the most complex feature to achieve. It requires the 
modification of the nanoparticle surface in order to avoid non-specific interactions 
with cells and proteins and drug accumulation in non-target tissues [70]. 
Barry [21] commented that (trans)dermal drug delivery would be optimal if it could be 
coordinated with a continuous diagnosis of the actual physiological condition of each 
specific patient. Drugs could thus be delivered only when required and for the time 
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needed. The release of encapsulated substances from topically applied nanoparticles is 
however currently more often undergone than controlled. Studies on this subject have 
been limited to the observation of the fate of nanoparticulate systems when 
administered on the skin. Controlled triggering is not yet an achieved feature of 
polymeric nanoparticles. It will require the development of advanced devices able to 
respond to external stimuli. For dermal applications, these stimuli could consist in light 
illumination or the delayed application of a kick-off agent able to induce a therapeutic 
cascade effect [54]. 
 
Optimisation and conjugation of the above-described complex aspects of 
polymeric nanoparticle design are necessary to create “smart” nanoparticles. To 
appreciate the performances of these advanced devices, it will be necessary to 
overcome some of the remaining technical limitations in their detection for an accurate 
assessment of their in situ behaviour. 
 
IV.2. Nanoparticle performance assessment 
 
IV.2.1. Fate 
 
In the past, encapsulation of a fluorescent label into polymeric nanoparticles 
was usually used to follow their fate by fluorescence microscopy. However, this 
approach only truly allows monitoring the fate of the label and not specifically that of 
the whole system. Indeed, it can difficult to control the diffusion of the label outside 
the nanoparticles during the experiment. 
Alvarez-Roman et al. [53] circumvented this issue by covalently binding fluorescein 5-
isothiocyanate (FITC) to non-biodegradable polystyrene nanoparticles before 
following their fate in porcine skin. The covalent binding of the label to the 
nanoparticles and nanoparticle non-biodegradability ensured that the fluorescence 
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detected for FITC could unambiguously be attributed to the presence of intact 
polystyrene nanoparticles. 
Similarly, Stracke et al. [54] used a dually labelled system consisting of 5-
fluoresceinamine-bound PLGA nanoparticles and encapsulated Texas Red. 
 
In summary, intrinsic fluorescence or in the absence of thereof, covalent 
fluorescence labelling of the nanoparticles combined with fluorescence (labelling) of 
the encapsulated substance are means to ensure selective monitoring in skin tissues. 
Non-biodegradability of the nanoparticles is a further guarantee that these will be 
identified as integral structures. 
 
IV.2.2. Skin penetration 
 
The methods currently available for evaluating polymeric nanoparticle skin 
penetration still entail artefacts related to the nature of the analytical technique chosen. 
The lack of skin vasculature in in vitro penetration/permeation experiments, possible 
modification of the skin lipid organisation and redistribution of the penetrants while 
handling the samples, are aspects which can affect the veracity of the experimental 
results. 
However, systematic in vivo assessments in animals or humans involving biopsies 
represent invasive methods. Future analytical techniques will therefore have to focus 
on the development of systems mimicking or approaching actual in vivo conditions and 
analytical tools involving minimal disturbance of these systems. 
For skin visualisation, Stracke et al. [54] emphasise that samples should ideally be 
visualised in vivo, without fixation, non-invasively, on the same sample of human skin 
examined at different time in order to avoid the problem of sample variability in time-
dependent penetration studies. 
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The accurate assessment of polymeric nanoparticle penetration is essential to 
measure the benefits but also the risks of such systems. Risk assessment will in the 
future be a crucial step towards using polymeric nanoparticles for actual therapeutic 
applications. 
 
IV.3. Nanoparticle risk assessment 
 
Due to their unique properties, polymeric nanoparticles are expected in the 
near future to dramatically improve humans’ quality of life. However, unequalled 
features such as their size, specific area and surface properties make them potential 
triggering agents of reactions at the cellular levels that are currently unknown. As with 
many emerging and promising research fields there is a risk that the development of 
nanoparticle technologies overtakes investigations to assess their health and 
environment entailments. 
 
To date only little formal research exist on the health and environmental 
impact of nanoparticles and scientific reviews with only a few exceptions [71] mainly 
addressed the risk assessment of airborne nanoparticles [72,73,74]. Morgan [75] 
recently underlined that due to the scarcity of scientific data on nanoparticle risk 
assessment, scientific and regulatory workers have the opportunity to address this 
question strategically by driving research to selected crucial areas for the 
understanding of the risk involved in each given nanoparticle applications. Therefore, 
general screening strategies have been proposed [75,76]. 
 
The working group of Oberdorster et al. [76] proposed a general data 
gathering strategy for the hazard identification of engineered nanomaterials for the 
oral, dermal, inhalation and injection routes. The three key element of this strategy are 
physicochemical characterisation, in vitro (cellular and non-cellular) and in vivo 
assays. 
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Nanomaterial physico-chemical characterisation is indeed essential if experimental 
data are to be interpreted in relation with the material properties and should encompass 
particle size distribution, agglomeration state, shape, crystal structure, chemical 
composition surface area, surface chemistry, surface charge and porosity. 
Nanomaterial characterisation after administration in vitro or in vivo is considered 
ideal although it currently presents significant analytical challenges. Alternatively, 
characterisation of the material as administered can provide valuable information. 
Although there exists some well-documented issues with in vitro tests, these are 
considered important adjuncts to in vivo studies since they allow specific pathways to 
be isolated and tested under controlled conditions which is not feasible in vivo. Non-
cellular in vitro tests can provide information about nanomaterial biopersistence, free 
radical generation, interaction with proteins and activation of humoral systems. 
In vivo tests constitute a crucial step in nanomaterial risk assessment since they provide 
an evaluation of the systems’ performances in situ. However, these are currently 
limited by research gaps in the design of viable in vivo detection techniques and in the 
development of standardized and well characterized nanomaterial samples. 
Oberdorster et al. [76] further provide recommendations with regards to how these 
three key fields can be investigated. Their work is a major contribution to the emerging 
nanomaterial risk assessment. 
 
Morgan [75] also proposed a preliminary and general framework for 
nanomaterial hazard identification in the form of an influence diagram. The latter was 
developed based on expert elicitation and describes the presumed variables, their inter-
connexions and influence on the uptake, transport, fate, and toxicity of nanoparticles, 
four properties considered as closely related human health and ecological risk. The 
purpose of the expert elicitation was to collect and organise the knowledge of 
experienced people working with various aspects of nanoparticle technology in order 
to create a valuable tool for the systematic identification and prioritisation of crucial 
research areas. 
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For the (trans)dermal use of nanoparticles, the influence diagram spots nanoparticle 
size distribution, surface reactivity, shape and potential binding to a matrix as the main 
properties affecting nanoparticle uptake by the skin. It anticipates that nanoparticle size 
distribution, surface reactivity and coating (including added molecular groups), 
adsorption tendency and durability are likely to influence nanoparticle transport and 
fate. Finally nanoparticle size distribution, surface reactivity and coating, adsorption 
tendency and chemical composition are expected to impact nanoparticle toxicity. 
The advantages of Morgan’s approach lie in its capacity to incorporate new knowledge 
as it is generated and to remain in the long run a relevant tool for nanoparticle risk 
assessment. 
 
V. Conclusion 
 
The purpose of this article was to review the current knowledge about the 
mechanisms underlying polymeric nanoparticle-mediated (trans)dermal drug delivery, 
spot out research gaps and outline the challenges faced by this scientific field. 
 
From the data available today, it appears that topically applied polymeric 
nanoparticles on the skin redistribute towards its superficial reliefs or penetrate along 
hair follicles or through the intercellular space. The penetration pathways followed by 
the particles certainly depend on a variety of properties such as nanoparticle shape, 
surface composition and charge but a number of studies have reported that 
nanoparticle size is probably the most determining factor. However, it is difficult to 
draw general rules due to the behavioural variability of nanoparticles presenting 
similar properties. 
 
Although the mechanisms by which nanoparticles enhance and/or sustain drug 
release within the skin still remain partially questioned, there are some indications that 
the formation of a nanoparticle depot at the surface of the skin or in the hair follicles 
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from which drugs are efficiently released may be involved. Release in the intercellular 
space has not yet been unequivocally evidenced but is a priori not to be excluded. 
 
Many past studies have followed the fate of fluorescent encapsulated 
substances in the nanoparticles. This does not allow understanding release mechanisms 
and more recent studies have underlined the need for labelling each of the individual 
components of a given nanoparticulate system and performing selective penetration 
studies (skin sandwich model, differential stripping). 
 
Scientific limitations are mainly related to research gaps in the development 
of standardized and well characterized nanomaterial samples and in the design of 
viable in vivo non-invasive detection techniques. Nanoparticle targeting and release 
triggering will also represent major technical challenges. 
The future of polymeric nanoparticles-mediated (trans)dermal drug delivery will rely 
on how well our present and next generations of researchers will take up these 
challenges and coordinate interdisciplinary collaborations for the improvement of 
patient condition worldwide. 
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A. Investigation of novel modification methods for the preparation of 
amphiphilic hyaluronic acid derivatives 
 
 
Abstract 
Amphiphilic hyaluronic acid (HA) derivatives were prepared and structurally 
characterised by size exclusion chromatography–multi-angle laser light scattering 
(SEC-MALLS), Fourier transform infrared spectroscopy (FT-IR) and proton nuclear 
magnetic resonance spectroscopy (1H NMR). HA was chemically modified in 
aqueous alkaline media and at room temperature with on the one hand phenyl and 
ethyl vinyl sulfone and on the other hand octenyl and octadecenyl succinic anhydride. 
The influence of reaction parameters such as the reaction medium alkalinity, reagent 
concentration and type on the degree of substitution (DS) of the resulting HA 
derivatives was investigated. Amphiphilic HA derivatives with a maximum DS of 
55 % per disaccharide unit according to 1H NMR were obtained. A comparison 
between the versatility of the two modification methods ultimately led to the 
selection of the succinic anhydride-based technology for further study. 
 
 
I. Introduction 
 
Alteration of the physicochemical properties of HA and introduction of a 
self-associative behaviour of this biopolymer towards the preparation of nanocarriers 
requires modifying the hydrophilic/hydrophobic balance of HA. This can be achieved 
by covalently grafting hydrophobic moieties onto the hydrophilic HA backbone. 
Amphiphilic HA has mainly been prepared by modification of the HA carboxyl and 
hydroxyl groups [1] and a wide range of HA derivatives with a large number of 
chemistries is currently available (see Chapter I, § IV). 
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However, the modification methods currently available for the preparation 
of amphiphilic HA present some drawbacks, namely the (i) use of organic solvents, 
(ii) complexity and (iii) limited upscalability of the techniques and (iv) potential 
alteration of some of the fundamental biological and/or pharmacological properties of 
HA through modification of the polymer’s carboxyl groups (see Chapter I, § IV). 
 
With this in mind, the objective of this work was to design and implement a 
new and improved modification method for the preparation of amphiphilic HA based 
on simple and easily upscalable reactions in aqueous media exclusively involving the 
HA hydroxyl groups. Accordingly, two novel modification methods based on the 
reaction of HA with aryl/alkyl vinyl sulfone (Ar/AlVS) and alkenyl succinic 
anhydride (AlkSA) reagents were investigated. 
The first technique is an extension of the use of divinyl sulfone (DVS) to cross-link 
HA in aqueous alkaline media [2]. The method involves fast reaction of the HA 
hydroxyl groups and typically results in the formation of macroscopic solid HA 
hydrogels insoluble in water. The lone reactive site CH2=CH–SO2–R of 
monofunctional vinyl sulfone compounds is believed to react with the HA hydroxyl 
groups in the same fashion as DVS and yield HA derivatives with grafted R 
hydrophobic groups. 
The second technique is an application to HA of an existing method to 
hydrophobically modify starch with cyclic dicarboxylic acid anhydrides in aqueous 
alkaline media [3] (also see section B of this chapter, Foreword). This technology 
which also involves the modification of the HA hydroxyl groups is believed to be 
easily transferable to HA. 
The prepared HA derivatives were structurally characterised by size exclusion 
chromatography–multi-angle laser light scattering (SEC-MALLS), Fourier transform 
infrared spectroscopy (FT-IR) and proton nuclear magnetic resonance spectroscopy 
(1H NMR). 
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II. Materials and methods 
 
II.1. Materials 
 
Medium molecular weight (MW) HA (HyaCare®, MW~750,000 Da, HA750) was 
provided by Novozymes Biopolymer A/S (Bagsværd, Denmark). Low MW HA 
(HA300 and HA30) was prepared using the procedure described hereafter. Phenyl 
vinyl sulfone (PVS, 168.22 Da, purity  99 %) and ethyl vinyl sulfone (EVS, 
120.17 Da, purity  98 %) were purchased from Fluka (Buchs, Switzerland) and 
Sigma-Aldrich (Saint Louis, Missouri, United States), respectively. Octenyl succinic 
anhydride (OSA, 210.27 Da, purity  97 %, mixture of cis and trans) was obtained 
from Sigma-Aldrich (Saint Louis, Missouri, United States). Octadecenyl succinic 
anhydride (ODSA, 352.56 Da, mixture of molecules with a random distribution of 
the unsaturation along the octadecenyl chains) was a non-commercial product kindly 
provided by Pentagon (Workington, United Kingdom). The water used for the sample 
preparation and analysis was distilled and purified to a resistivity of 18.2 M.cm in a 
milli-Q apparatus (Millipore, Billerica, Massachusetts, United States). 
 
II.2. Methods 
 
II.2.1. Preparation of low molecular weight hyaluronic acid 
 
HA300 was prepared from HA750 by acid degradation using phosphoric acid 
(H3PO4), at 60 °C. HA750 (70 g) was first dissolved in milli-Q water (7 L) for 
16 hours (overnight), at 4 °C. H3PO4 (85 %, 30 mL) was added to HA750 and the 
resulting acidic solution was stirred for 10 min. This mixture was then incubated for 
3.5 hours, at 60 °C, in a water bath. 1 mL of the digestion mixture was sampled after 
1, 2.5 and 3 hours and used to determined the MW of HA by SEC-MALLS (see 
§ II.2.4). The degradation was stopped when the MW of HA was close to 
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300,000 Da. The pH of the mixture was then adjusted to 7.0 with sodium hydroxide 
(NaOH, 4 M). The resulting product was purified by filtration through glass 
microfiber filters (GF/F 1825 110, porosity 0.7 μm; Whatman, Maidstone, United 
Kingdom). The permeate was purified by ultra filtration (Centramate™ Tangential 
Flow Systems; Pall, East Hills, New York, United States) through a membrane 
cassette (Omega™ Centramate™, MW cut-off (MWCO) 3,000 Da; Pall, East Hills, 
New York, United States). The purification was monitored by conductivity 
measurements of the permeate and was stopped when the conductivity had reached a 
value inferior to 5 μS/cm. The purified retentate containing HA300 was finally 
freeze-dried. 
HA30 was prepared using the same method as that described for HA300 but with 
160 mL of H3PO4 and a 25-hour incubation time. 
Approximately 52 g of HA300 and 48 g of HA30, i.e. 74 and 69 %, respectively of 
the starting HA750 were recovered. 
 
SEC-MALLS 
The exact MW of HA300 and HA30 was 346,900 ± 1,387 and 33,930± 339 Da, 
respectively. 
FT-IR 
(KBr, 4000-500 cm-1) w 3431 (O–H and N–H st), 2931 (C–H st), 1700-1600 (COO- 
st as, N–H bd), 1423 (COO- st sy), 1392 (C–O–H bd), 1154 (C–O–C st as), 1077 and 
1038 (C–OH st), 954 and 900 (COO- bd), 808 (C–O–C st sy) (see Figure III.A.3). 
1H NMR 
(D2O, 400 MHz)  2.0 (s, 3 H, H-m), 3.2-4.2 (m, 10 H, H-2, H-5’, H-4’, H-3, H-3’, 
H-5, H-6’b, H-4, H-6’a, H-2), 4.3-4.6 (d, 2 H, H-1, H-1’) (see Figure III.A.4). 
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II.2.2. Preparation of aryl/alkyl vinyl sulfone-modified hyaluronic acid 
 
Phenyl vinyl sulfone-modified HA (PVS-HA) 
PVS-HA was prepared by reacting HA300 or HA750 with PVS in water/acetone 
mixtures, under alkaline conditions, at room temperature. HA (100 mg) was first 
dissolved in milli-Q water (10 mL) for 6 hours, at room temperature. A NaOH 
solution (0.2 M) was prepared from concentrated NaOH (4 M) by dilution in milli-Q 
water. PVS was dissolved in acetone (10 mL) for 10 min. NaOH (0.2 M) was added 
to the HA solution and mixed for 10 min. The PVS solution was added drop-wise to 
the alkaline HA solution using a separation funnel. The mixture was then stirred for 
16 hours (overnight), at room temperature. The resulting product was dialysed 
against milli-Q water (7.5 L), at 4 °C, using molecularporous membrane tubing 
(Spectra/Por®4, MWCO 12,000-14,000 Da; Spectrum Laboratories, Rancho 
Dominguez, California, United States). The surrounding milli-Q water was changed 
every third hour three times, then once after 16 hours (overnight) until the 
conductivity had reached a value inferior to 5 μS/cm. Purified PVS-HA was finally 
freeze-dried [4]. The number of molar equivalents of HA, NaOH and PVS used to 
prepare the PVS-HA derivatives and the reaction yields of the products are reported 
in Table III.A.1 and Table III.A.2, respectively. 
 
SEC-MALLS 
The MW values of PVS-HA300 (1) and PVS-HA300 (3) were 242,400 ± 4,848 and 
148,300 ± 2,966 Da, respectively. 
FT-IR 
(KBr, 4000-500 cm-1) w 3431 (O–H and N–H st), 2931 (C–H st), 1700-1600 (COO- 
st as, N–H bd, ar C=C st), 1450 (ar C=C st), 1423 (COO- st sy), 1392 (C–O–H bd), 
1308 (S=O st as), 1154 (C–O–C st as, S=O st sy), 1077 and 1038 (C–OH st), 954 and 
900 (COO- bd), 808 (C–O–C st sy), 730 and 690 (ar C–H bd oop) (see 
Figure III.A.3). 
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1H NMR 
(D2O, 400 MHz)  2.0 (s, 3 H, H-m), 3.0-4.2 (m, 12 H, H-2, H-5’, H-4’, H-3, H-3’, 
H-5, H-6’b, H-4, H-6’a, H-2, H-2’’), 4.2-4.6 (d, 4 H, H-1, H-1’, H-1’’), 7.6-8.0 (t, 
5 H, H-3’’-H-7’’) (see Figure III.A.5). 
 
Table III.A.1: Number of molar equivalents of HA, NaOH and PVS used to prepare 
the PVS-HA derivatives. 
PVS-HAX (A) stands for PVS-HA prepared from HAX (X = 300 or 750) with the combination of 
molar equivalents A. One molar equivalent of HA corresponded to 0.250 mmol of disaccharide units. 
For the calculations, the MW of one disaccharide unit was approximated to 400 Da. 
Number of molar equivalents
Sample 
HA NaOH PVS 
PVS-HAX (1) 1 1 1.5 
PVS-HAX (2) 1 5 1.5 
PVS-HAX (3) 1 10 1.5 
PVS-HAX (4) 1 1 5 
PVS-HAX (5) 1 1 10 
 
Table III.A.2: Reaction yields of the PVS-HA derivatives. 
Sample Yield (mg) 
PVS-HA300 (1) 93 
PVS-HA300 (2) 88 
PVS-HA300 (3) 85 
PVS-HA300 (4) 97 
PVS-HA300 (5) 118 
PVS-HA750 (1) 94 
PVS-HA750 (4) 96 
PVS-HA750 (5) 115 
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Ethyl vinyl sulfone-modified HA (EVS-HA) 
EVS-HA was prepared using the same method as that described for PVS-HA. EVS-
HA300 was obtained from 1, 1 and 1.5 molar equivalents of HA300, NaOH and 
EVS, respectively (1 molar equivalent of HA corresponded to 0.250 mmol of 
disaccharide units). The reaction yield of EVS-HA300 was 96 mg. 
 
FT-IR 
(KBr, 4000-500 cm-1) w 3431 (O–H and N–H st), 2931 (C–H st), 1700-1600 (COO- 
st as, N–H bd), 1423 (COO- st sy), 1392 (C–O–H bd), 1308 (S=O st as), 1154        
(C–O–C st as, S=O st sy), 1077 and 1038 (C–OH st), 954 and 900 (COO- bd), 808 
(C–O–C st sy). 
1H NMR 
(D2O, 400 MHz)  1.2-1.4 (s, 3 H, SO2–CH2–CH3),  2.0 (s, 3 H, H-m), 3.2-4.0 (m, 
14 H, H-2, H-5’, H-4’, H-3, H-3’, H-5, H-6’b, H-4, H-6’a, H-2, SO2–CH2–CH2–O, 
SO2–CH2–CH3), 4.2-4.6 (d, 4 H, H-1, H-1’, SO2–CH2–CH2–O). 
 
II.2.3. Preparation of alkenyl succinic anhydride-modified hyaluronic acid 
 
Octenyl succinic anhydride-modified HA (OSA-HA) 
OSA-HA was prepared by reacting HA30 with OSA in aqueous media, under 
alkaline conditions, at room temperature. HA30 was first dissolved in milli-Q water 
at a concentration of 5 mg/mL, for 6 hours, at room temperature. A NaOH solution 
(0.5 M) was prepared from concentrated NaOH (4 M) by dilution in milli-Q water. 
OSA was added drop-wise to the HA solution with a volumetric pipette, under 
vigorous agitation. The pH of the resulting mixture was adjusted to 8.5 with NaOH 
(0.5 M). The mixture was then stirred for 16 hours (overnight), at room temperature. 
The pH of the reaction mixture was maintained at 8.5 by a titration manager 
(TIM856; Radiometer analytical, Lyon, France) using NaOH (0.5 M). The resulting 
product was dialysed as described in § II.2.2. Purified OSA-HA was finally freeze-
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dried [5]. The number of molar equivalents of HA and OSA used to prepare the 
OSA-HA derivatives and the reaction yields of the products are reported in 
Table III.A.3 and Table III.A.4, respectively. 
 
Table III.A.3: Number of molar equivalents of HA and OSA used to prepare the 
OSA-HA derivatives. 
OSA-HA30 (A) stands for OSA-HA prepared from HA30 with the combination of molar equivalents 
A. One molar equivalent of HA corresponded to 0.125 mmol of disaccharide units. For the 
calculations, the MW of one disaccharide unit was approximated to 400 Da. 
Number of molar equivalents
Sample 
HA OSA 
OSA-HA30 (1) 10 2 
OSA-HA30 (2) 1 1 
OSA-HA30 (3) 10 20 
 
Table III.A.4: Reaction yields of the OSA-HA derivatives. 
Sample Yield (mg) 
OSA-HA30 (1) 4,840 
OSA-HA30 (2) 470 
OSA-HA30 (3) 4,780 
 
1H NMR 
(D2O, 400 MHz)  0.9 (s, 3 H, H-10), 1.3-1.5 (m, 6 H, H-7-H-9), 2.0 (s, 3 H, H-m), 
3.3-4.0 (m, 10 H, H-2, H-5’, H-4’, H-3, H-3’, H-5, H-6’b, H-4, H-6’a, H-2), 4.4-4.7 
(d, 2 H, H-1, H-1’) (see Figure III.A.8). 
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Octadecenyl succinic anhydride-modified HA (ODSA-HA) 
ODSA-HA was prepared using the same method as that described for OSA-HA. The 
number of molar equivalents of HA and ODSA used to prepare the ODSA-HA 
derivatives and the reaction yields of the products are reported in Table III.A.5 and 
Table III.A.6, respectively. 
 
Table III.A.5: Number of molar equivalents of HA and ODSA used to prepare the 
ODSA-HA derivatives. 
ODSA-HA30 (A) stands for ODSA-HA prepared from HA30 with the combination of molar 
equivalents A. One molar equivalent of HA corresponded to 0.125 mmol of disaccharide units. For the 
calculations, the MW of one disaccharide unit was approximated to 400 Da. 
Number of molar equivalents
Sample 
HA ODSA 
ODSA-HA30 (1) 5 1.25 
ODSA-HA30 (2) 5 12.5 
 
Table III.A.6: Reaction yields of the ODSA-HA derivatives. 
Sample Yield (mg) 
ODSA-HA30 (1) 2,060 
ODSA-HA30 (2) 2,130 
 
1H NMR 
(D2O, 400 MHz)  1.0 (s, 3 H, ODSA terminal methyl protons), 1.2-1.5 (m, 26 H, 
ODSA methylene protons), 2.0 (s, 3 H, H-m), 3.3-4.0 (m, 10 H, H-2, H-5’, H-4’, H-3, 
H-3’, H-5, H-6’, H-4, H-6’a, H-2), 4.4-4.7 (d, 2 H, H-1, H-1’). 
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II.2.4. Characterisation techniques 
 
SEC-MALLS 
Each sample (10 mg) was dissolved in the mobile phase (10 mL) which was prepared 
as followed: NaCl (45.0 g), NaH2PO4 (7.8 g) and NaN3 (1.25 g) on the one hand and 
NaCl (45.0 g), Na2HPO4 (22.4 g) and NaN3 (1.25 g) on the other hand were first 
dissolved in milli-Q water (5.0 L) in two volumetric flasks to constitute two distinct 
solutions (S1 and S2). S1 and S2 were mixed. The pH of the mixture was measured 
and, if necessary, adjusted to 7.0 with either HCl (4 M) or NaOH (4 M). The resulting 
mobile phase was finally filtered through glass microfiber filters (GF/F 1825 110, 
porosity 0.7 μm; Whatman, Maidstone, United Kingdom). Each sample was first 
fractionated by high performance liquid chromatography (HPLC, Alliance Waters 
2695; Waters, Milford, Massachusetts, United States) through a HPLC column 
(7.8 x 300 mm TSK-GEL®, G5000PWXL; Tosoh Corporation, Tokyo, Japan). The 
various sample fractions were then analysed by the MALLS (DAWN EOS; Wyatt 
Technology Corporation, Santa Barbara, California, United States) and refractive 
index (Optilab Rex; Wyatt Technology Corporation, Santa Barbara, California, 
United States) detection instruments. The flow rate was kept constant at 0.5 mL/min. 
The values of the osmotic second virial coefficient and of the variation of the 
polymer solution refractive index n as a function of the polymer concentration c 
(dn/dC) were 0.0023 mol.mL/g2 and 0.153 mL/g, respectively. The HPLC on the one 
hand and the MALLS and RI instruments on the other hand were piloted by the 
softwares Empower 1154 (Waters, Milford, Massachusetts, United States) and 
ASTRA 5.3.1.4 (Wyatt Technology Corporation, Santa Barbara, California, United 
States). 
The MW loss of the PVS-HA derivatives was calculated as followed: 
100
)300(
)300()300(



HAMW
HAMWHAPVSMWMWloss                         Equation III.A.1 
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Thin layer chromatography (TLC) 
Drops of PVS (1 mg/mL in acetone) and of the crude and purified PVS-HA products 
(10 mg/mL in milli-Q water) were spotted on the bottom line of a TLC plate (Silica 
gel 60 F254; Merck, Whitehouse Station, New Jersey, United States). The 
compounds were eluted using a heptane/ethyl acetate mixture (50:50, v/v). The plate 
was revealed under ultraviolet light (254 nm). The retention time of each spot was the 
ratio between the distance travelled by the spot and that travelled by the elution 
system (control). 
 
FT-IR 
Each sample (1 mg) was ground in potassium bromide (KBr, ~25 mg) and a pellet 
was prepared using a Qwik Handi-Press (P/N 0016-125; Thermo Spectra-Tech, 
Shelton, Connecticut, United States) and a 3-mm Die Set (P/N 0016-115; Thermo 
Spectra-Tech, Shelton, Connecticut, United States). The spectra were acquired at 
room temperature, in the wavelength range 4000-500 cm-1 (Nicolet Nexus      
470 FT-IR, equipped with a Smart ARKTM system; Thermoelectron, Copenhagen, 
Denmark). Each spectrum was an overlap of 64 scans. 
The spectra of native HA and of the HA derivatives were assigned based on 
Alkrad et al. [6], Haxaire et al. [7] and Pretsch et al. [8]. 
 
1H NRM 
Each sample (10 to 30 mg) was dissolved in D2O (0.8 mL) and transferred into an 
NMR glass tube. The spectra were acquired at 80 °C and 400 MHz (Varian Mercury 
TX 400 MHz; Varian, Palo Alto, California, United States). The DS of the 
derivatives, which corresponds to the number of grafted reagent molecules per 100 
disaccharide units, was calculated by comparing the intensity per proton of the 
phenyl protons (PVS-HA,  = 7.6-8.0 ppm), the terminal methyl protons close to the 
sulfonyl group (EVS-HA,  = 1.2-1.4 ppm) or the terminal methyl protons on the 
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alkenyl chain ( = 0.9 ppm for OSA-HA and  = 1.0 ppm for ODSA-HA) to that of 
the methyl protons on native HA ( = 2.0 ppm). 
The spectra of native HA and of the HA derivatives were assigned based on 
Welti et al. [9], Pavia et al. [10] and Pretsch et al. [8]. 
 
III. Results and discussion 
 
III.1. Characterisation of aryl/alkyl vinyl sulfone-modified hyaluronic acid 
 
HA was reacted with phenyl and ethyl vinyl sulfone in water/acetone 
mixtures, under alkaline conditions, at room temperature and the influence of the 
NaOH/HA and PVS/HA molar ratios, reagent type and HA MW on the DS of the 
resulting derivatives was investigated. 
The reaction between HA and Ar/AlVS is illustrated in Figure III.A.1 and its 
mechanism is presented in Figure III.A.2. 
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Figure III.A.1: Modification of HA with Ar/AlVS. 
 
118
Development of soft nanocarriers from novel amphiphilic hyaluronic acid 
derivatives towards drug delivery 
Chapter III 
Preparation and structural characterisation of amphiphilic hyaluronic acid derivatives 
 
 
93 
HA OH HA O H
+NaOH
HA O R'S
O
O
HA O CH2 CH S
O
O
R' HA O CH2 CH2 S
O
O
R'
H
+
+
-
-
-
+
+
 
Figure III.A.2: Mechanism of the reaction between HA and Ar/AlVS. 
 
The products obtained were white spongy materials partially soluble in milli-Q water. 
At concentrations above 1 mg/mL in milli-Q water, all products gave slightly turbid 
solutions. This was not the case for native HA which evidenced that the products had 
different properties than the starting HA. 
 
Residual ungrafted PVS in the crude and purified PVS-HA products was 
assessed by TLC. The results showed that the crude PVS-HA products contained 
phenyl-based compounds while the purified PVS-HA products were free of these. 
This demonstrated that ungrafted PVS was eliminated during the purification step. 
Dialysis was thereby proved efficient to purify the products of the reaction between 
HA and PVS and by extension HA and EVS. 
 
The MW values of HA300, PVS-HA300 (1) and PVS-HA300 (3) were 
determined by SEC-MALLS to evaluate the extent of HA degradation during the 
preparation of PVS-HA (Table III.A.7). 
 
Table III.A.7: Molecular weight of HA300 and selected PVS-HA300 derivatives. 
Sample MW (Da) MW loss (%)
HA300 346,900 ± 1387 - 
PVS-HA300 (1) 242,400 ± 4848 30 
PVS-HA300 (3) 148,300 ± 2966 57 
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The results showed that the alkaline treatment needed to activate the HA hydroxyl 
groups led to a manifest polymer degradation and that the latter was an increasing 
function of the NaOH/HA molar ratio between 1 (PVS-HA300 (1)) and 10 (PVS-
HA300 (3)). The treatments with NaOH/HA molar ratios equal to 1 and 10 led to 
30 % and 57 % HA degradation, respectively, suggesting that NaOH/HA molar ratios 
lower than 1 are more suitable to limit the degradation of HA and retain its MW. This 
was taken into consideration when preparing PVS-HA300 (4) and (5) and PVS-
HA750 (1), (4) and (5) (see Table III.A.1). 
 
The structure of the vinyl sulfone-based HA derivatives was qualitatively 
confirmed by FT-IR by comparing the spectra of native HA300 and of the 
derivatives. As an example, the spectra of HA300 and PVS-HA300 (1) are shown in 
Figure III.A.3. 
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Figure III.A.3: FT-IR spectra of HA300 and PVS-HA300 (1). 
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Compared to the spectrum of HA300, additional bands at 1450, 1308, 730 and 
690 cm-1 were found on the spectrum of PVS-HA300 (1). These correspond to 
aromatic C=C stretching (second band), S=O asymmetric stretching and aromatic C–
H out-of-plane bending (bands at 730 and 690 cm-1), respectively. In addition, the 
two bands at 730 and 690 cm-1 were typical of monosubstituted aromatic rings. 
The intensity of the broad band between 1700 and 1600 cm-1 and that of the band at 
1154 cm-1 was significantly higher in the case of PVS-HA300 (1). On the spectrum 
of HA300, the band between 1700 and 1600 cm-1 was most likely due to COO- 
asymmetric stretching and N–H bending. However, on the spectrum of PVS-
HA300 (1), this band probably also additionally resulted from aromatic C=C 
stretching (first absorption). Similarly, the sharp band at 1154 cm-1 most certainly 
arose from C–O–C asymmetric stretching on the spectrum of HA300 and to a 
combination of the latter and S=O symmetric stretching on the spectrum of PVS-
HA300 (1) (see § II.2.2). 
The univocal presence of aromatic C=C and C–H and S=O bands on the spectrum of 
PVS-HA300 (1) qualitatively confirmed the modification of HA with PVS. 
 
Similar spectra were observed for the other PVS-HA derivatives while only 
S=O asymmetric stretching around 1300 cm-1 on the spectrum of EVS-HA300 could 
confirm the modification of HA with EVS (see § II.2.2). 
 
1H NMR was used to quantitatively confirm the structure of the vinyl 
sulfone-based HA derivatives and calculate their DS. As an example, the spectra of 
native HA300 and PVS-HA300 (1) are shown in Figure III.A.4 and Figure III.A.5, 
respectively. 
Due to the large MW of HA300 and to peak overlapping in the region 3.2 to 4.2 ppm, 
it was not possible to clearly assign the shifts of protons 3 to 5 and 2’ to 6’ (see 
§ II.2.1). For this reason, lower MW HA was used to prepare the succinic anhydride-
modified HA derivatives (see § II.2.3). 
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Figure III.A.4: 1H NMR spectrum of HA300. 
m stands for methyl. For the multiplet occurring between 3.2 and 4.2 ppm, protons are written in the 
order of their spectral occurrence according to [9]. 
 
Compared to the spectrum of HA300, an additional triplet was found between 7.6 and 
8.0 ppm on the spectrum of PVS-HA300 (1). It corresponds to the aromatic protons 
of grafted PVS (H-3’’ to H-7’’). In addition, the intensities of the resonances between 
3.0 and 4.2 ppm and 4.2 and 4.6 ppm were relatively more important compared to 
those found in the same regions on the spectrum of HA300 (see Figure III.A.4). This 
was due to the contribution of the methylene protons vicinal to the sulfonyl group  
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(H-2’’) and those vicinal to the ether bond (H-1’’), respectively (see § II.2.2). The DS 
of PVS-HA300 (1) was 11 % per disaccharide unit. 
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Figure III.A.5: 1H NMR spectrum of PVS-HA300 (1). 
 
Similar spectra were observed for the other PVS-HA derivatives. However, 
the relative intensity of the triplet between 7.6 and 8.0 ppm and therefore the DS of 
the derivatives were dependent on the reaction conditions. The DS values of the PVS-
HA derivatives are reported in Table III.A.8. 
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Table III.A.8: Degree of substitution of the PVS-HA derivatives. 
Sample DS (%) 
PVS-HA300 (1) 11 
PVS-HA300 (2) < 1 
PVS-HA300 (3) < 1 
PVS-HA300 (4) 19 
PVS-HA300 (5) 55 
PVS-HA750 (1) 3 
PVS-HA750 (4) 18 
PVS-HA750 (5) 52 
 
When the NaOH/HA molar ratio was increased from 1 to 10 (PVS-HA300 (1), (2) 
and (3)), the DS of PVS-HA decreased from 11 to values inferior to 1 % (the 
PVS/HA molar ratio was 1.5). Formation of inert moieties by hydrolysis of DVS 
under alkaline conditions has been reported [11]. The probability of forming this by-
product being naturally proportional to the alkaline strength of the reaction medium, 
it is likely that this side reaction extensively occurred while preparing PVS-
HA300 (2) (NaOH/HA molar ratio = 5) and PVS-HA300 (3) (NaOH/HA molar 
ratio = 10) yielding derivatives with very low DS. 
As expected, the DS of PVS-HA increased when the PVS/HA molar ratio was 
increased from 1.5 to 10 (PVS-HA300 (1), (4) and (5), on the one hand and PVS-
HA750 (1), (4), (5), on the other hand, the NaOH/HA molar ratio was 1). This 
increase was from 11 to 55 % for PVA-HA300 and from 3 to 52 % for PVS-HA750. 
The DS of PVA-HA300 (4) (19 %) and PVS-HA750 (4) (18 %) (the PVS/HA molar 
ratio was 5) and of PVA-HA300 (5) (55 %) and PVS-HA750 (5) (52 %) (the 
PVS/HA molar ratio was 10) were very similar suggesting that at fixed NaOH/HA 
and PVS/HA molar ratios, the DS of the resulting PVS-HA derivatives was rather 
independent of the MW of native HA for MW values of 300,000 and 750,000 Da. 
This was not the case for the low PVS/HA molar ratio (1.5) since the DS of PVS-
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HA300 (1) (11 %) was much higher compared to that of PVS-HA750 (1) (3 %). This 
could be due to the higher viscosity of HA750 aqueous solutions which might have 
limited the mixing and diffusion of small quantities of PVS. 
 
The spectrum of EVS-HA300 showed an additional triplet between 1.2 and 
1.4 ppm corresponding to the terminal methyl protons close to the sulfonyl group 
(SO2–CH2–CH3). In addition, as for PVS-HA, the intensities of the resonances 
between 3.2 and 4.2 ppm and 4.2 and 4.6 ppm was relatively more important 
compared to that found in the same regions on the spectrum of HA300. This was due 
to the contribution of the methylene protons vicinal to the sulfonyl group (SO2–CH2–
CH2–O and SO2–CH2–CH3) and of those vicinal to the ether bond (SO2–CH2–CH2–
O), respectively (see § II.2.2). 
The DS of EVS-HA300 was 13 % per disaccharide unit. This value was close to that 
obtained for PVS-HA300 (1) (11 %) suggesting that at fixed NaOH/HA and vinyl 
sulfone reagent/HA molar ratios the DS of the resulting derivatives was rather 
independent of the pendant group attached for the substituents PVS and EVS. 
 
III.2. Characterisation of alkenyl succinic anhydride-modified hyaluronic acid 
 
HA was reacted with octenyl and octadecenyl succinic anhydride in aqueous 
media, under alkaline conditions, at room temperature and the influence of the 
reagent/HA molar ratio and succinic anhydride reagent type on the DS of the 
resulting derivatives was investigated. 
The reaction between HA and AlkSA is illustrated in Figure III.A.6 and its 
mechanism is presented in Figure III.A.7. 
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Figure III.A.6: Modification of HA with AlkSA. 
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Figure III.A.7: Mechanism of the reaction between HA and AlkSA. 
 
As for PVS- and EVS-HA, the products obtained gave slightly turbid solutions when 
dissolved at concentrations above 1 mg/mL in milli-Q water. 
 
The MW of the OSA-HA derivatives was studied by SEC-MALLS. 
However, the MW measurement was impeded by the strong retention of the 
derivatives on the stationary phase of the fractionation column of the SEC 
instrument. This phenomenon has been reported for alkylated HA with dodecyl and 
octadecyl bromide [12]. Circumvention of this limitation was investigated in section 
C of this chapter. 
 
The structure of the succinic anhydride-based HA derivatives was 
qualitatively studied by FT-IR by comparing the spectra of native HA30 and of the 
derivatives. However, these spectra did not show any significant differences, 
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independently of the DS of the derivatives. This lack of difference was probably due 
the overlapping of the characteristic bands of HA, OSA- and ODSA-HA. Indeed, 
vinyl C–H stretching was most likely indiscernible from HA O–H stretching. 
Likewise, C=C stretching and C=O (ester) stretching were certainly hidden by HA 
C=O stretching. However, in the region 800-500 cm-1, which was free of any bands 
on the HA spectrum, CH2 bending/rocking along the octenyl succinate (OS) chains 
and vinyl C–H out-of-plane bending could not clearly be detected, probably due to 
the low DS of the OSA- and ODSA-HA derivatives (see Table III.A.9 and below). 
As a result, FT-IR could not confirm the modification of HA with OSA or ODSA. 
 
1H NMR, however, confirmed grafting of OSA onto HA and was used to 
calculate the DS of the OSA-HA derivatives. As an example, the spectrum of OSA-
HA30 (2) is shown in Figure III.A.8. 
Compared to the spectrum of HA30, an additional singlet and a multiplet were found 
at 0.9 ppm and between 1.3 and 1.5 ppm, respectively on the spectrum of OSA-
HA30 (2). The former corresponds to the terminal methyl protons (H-10) and the 
latter to the methylene protons (H-7 to H-9) on the octenyl chain of grafted OS. Due 
to the low signal intensity in the regions 2.2-3.0 and 4.8-5.8 ppm, it was not possible 
to clearly assign the chemical shifts of protons 1 to 6 (see § II.2.3). The DS of OSA-
HA30 (2) was approximately 3 % per disaccharide unit. 
 
Similar spectra were observed for the other OSA-HA derivatives. However, 
the relative intensity of the singlet at 0.9 ppm and therefore the DS of the derivatives 
were dependent on the reaction conditions. The DS values of the OSA-HA 
derivatives are reported in Table III.A.9. 
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Figure III.A.8: 1H NMR spectrum of OSA-HA30 (2). 
 
Table III.A.9: Degree of substitution of the OSA-HA derivatives. 
Sample DS (%) 
OSA-HA30 (1) < 1 
OSA-HA30 (2) 3 
OSA-HA30 (3) 4 
 
As expected, the DS of OSA-HA increased when the OSA/HA molar ratio was 
increased from 0.2 (OSA-HA30 (1)) to 2 (OSA-HA30 (3)). This increase was from 
< 1 to 4 %. 
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The spectra of the ODSA-HA derivatives showed two additional singlets at 
1.0 ppm and between 1.2 and 1.5 ppm (broad). The former corresponds to the 
terminal methyl protons and the latter to the 26 methylene protons localised after the 
unsaturation on the octadecenyl chain of grafted ODSA. As for OSA-HA, the 
chemical shifts of the remaining protons (H-1 to H-6) were difficult to clearly assign. 
The DS of ODSA-HA30 (1) and ODSA-HA30 (2) were < 1 and 2 % per disaccharide 
unit, respectively. Increasing the ODSA/HA molar ratio from 0.25 (ODSA-
HA30 (1)) to 2.5 (ODSA-HA30 (2)) did not result in a substantial increase of the DS. 
This might be due to the low solubility in the aqueous reaction medium of ODSA 
which in both cases limited the number of reagent molecules available for reaction. 
 
The DS of the ODSA-HA derivatives were lower compared to those of the 
OSA-HA derivatives when using comparable reaction conditions. This might be due 
to the lower solubility in aqueous media of ODSA. 
 
III.3. Comparison between the two preparation methods 
 
In summary, the modification of HA with vinyl sulfone and succinic 
anhydride reagents was not only proved feasible but also efficient under alkaline 
conditions, at room temperature. In addition, the reactions exclusively involved the 
HA hydroxyl groups, were simple, well controlled and yielded HA derivatives with 
high DS (vinyl sulfone-based HA derivatives). 
Ar/AlVS-HA derivatives with a DS up to 52-55 % per disaccharide unit according to 
1H NMR were prepared from HA300 and HA750. The DS of the derivatives was an 
increasing function of the reagent/HA molar ratio and was rather independent on the 
HA MW. In addition, the same reaction conditions (same NaOH/HA and reagent/HA 
molar ratios) yielded derivatives with a similar DS, independently of the reagents 
(PVS or EVS). The alkaline treatment with NaOH causing a substantial degradation 
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of native HA, NaOH/HA molar ratios below 1 were subsequently used to limit the 
degradation of HA and retain its MW. 
AlkSA-HA derivatives with a DS up to 4 % per disaccharide unit according to 
1H NMR were obtained from HA30. The DS of the AlkSA-HA derivatives was an 
increasing function of the reagent/HA molar ratio and was dependent on the reagent 
type: the use of ODSA yielded derivatives with lower DS most likely due to the 
lower solubility in the reaction medium of the longer octadecenyl chains. 
The DS of the AlkSA-HA derivatives was lower than that of the Ar/AlVS-HA 
derivatives at comparable reagent/HA molar ratios most likely due to the lower 
solubility and higher sensitivity to hydration of the AlkSA reagents. 
 
A comparison between the two modification methods is presented in 
Table III.A.10. 
Although both preparation methods involve the HA hydroxyl groups and are easily 
upscalable, the preparation of AlkSA-HA is more environmentally friendly than that 
of Ar/AlVS-HA. Indeed, the former is conducted in aqueous media while the latter is 
achieved in water/acetone mixtures. However, a higher through-put is possible in the 
case of Ar/AlVS-HA since only one sample of AlkSA-HA can be prepared at a time 
due to the use of a titration manager to control the pH of the reaction medium. 
The vinyl sulfone reagents are fewer, relatively more expensive and less available 
compared to the succinic anhydride reagents which are very diversified, relatively 
less expensive and largely available according to three major chemical databases 
[13]. Vinyl sulfone reagents with substituted groups other than methyl, ethyl and 
phenyl are scarce. Some suppliers list compounds with larger aliphatic groups or 
more complex molecular arrangements containing heteroatoms but these are often 
rare and non commercial compounds with a small production volume [13]. 
Alternatively, more diverse vinyl sulfone reagents could be prepared by the selective 
addition of nucleophilic compounds such as secondary amines, alcohols or thiols with 
various chain lengths on one double bond of divinyl sulfone, as described by 
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Prilezhaeva and Shapiro [14]. However, these reactions are by nature difficult to 
control and inevitably result in mixture of mono- and disubstituted sulfone 
compounds. 
 
Table III.A.10: Advantages and drawbacks associated to the preparation of the 
Ar/AlVS-HA and AlkSA-HA derivatives. 
  Advantages Drawbacks 
Reaction 

 Involves HA –OH 

 Easily upscalable 

 Higher through-put 

 Water/acetone based 
 
Reagents 

 Less sensitive to 
hydration 

 Fewer 

 More expensive 

 Less available 
Ar/AlVS-HA 
Derivatives 

 Partially water soluble 

 Higher DS 
- 
Reaction 

 Involves HA –OH 

 Easily upscalable 

 Water based 

 Lower through-put 
Reagents 

 More numerous 

 Less expensive 

 More available 

 Poorly soluble in aqueous 
media 

 More sensitive to 
hydration 
AlkSA-HA 
Derivatives 

 Partially water soluble 

 Introduction of additional 
negative charges 

 Lower DS 
 
By contrast, the succinic anhydride reagents present a large variability of substituted 
groups ranging, for aliphatic chains, from methyl to tetratetracontenyl (44 carbon 
atoms) and other more complex molecular arrangements containing heteroatoms are 
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also listed [13]. However, the modification of HA with succinic anhydride reagents is 
limited by their relative poor solubility in aqueous media and high sensitivity to 
hydration. As a result, the derivatives exhibit lower DS values than the vinyl sulfone-
based HA derivatives. 
Both types of derivatives present a partial solubility in aqueous media but AlkSA-HA 
possesses a higher charge density than Ar/AlVS-HA at neutral pH. This is due the 
additional carboxyl groups introduced upon ring opening of AlkSA (see 
Figure III.A.6) which increases the repulsion between the polymer chains. This 
property could advantageously be exploited for the electrostatic stabilisation of future 
nanocarriers based on AlkSA-HA. 
Due to the additional advantages of the succinic anhydride-based technology, namely 
(i) the environmental friendliness, (ii) large variability and availability of the succinic 
anhydride reagents and (iii) increase of the negative charge density on the polymer, 
this method was selected for further study. 
 
IV. Conclusion 
 
Aryl/alkyl vinyl sulfone- and alkenyl succinic anhydride-modified HA were 
prepared and structurally characterised and their preparation methods were compared 
on the basis of their versatility. 
The environmental friendliness of the preparation method of AlkSA-HA, the large 
variability and availability of the AlkSA reagents and the increase of the negative 
charge density on the polymer motivated the selection of the succinic anhydride-
based technology for further study. Indeed, these properties provide the AlkSA-HA 
derivatives with a potential higher versatility and functionality compared to the 
Ar/AlVS-HA derivatives. 
 
However, the lower preparation through-put of AlkSA-HA, poorer solubility 
and higher sensitivity to hydration of the AlkSA reagents limiting the DS of the HA 
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derivatives were aspects which remained to be addressed. In addition, the preparation 
method of AlkSA-HA needed to be optimised in order to develop a reproducible and 
robust process for the routine production of HA derivatives with a controlled DS. 
This optimisation work is reported in the following section. 
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B. Optimisation of the preparation of octenyl succinic anhydride-modified 
hyaluronic acid 
 
Foreword 
 
In order to define the frame of the optimisation work, a preliminary literature 
study on the preparation of alkenyl succinic anhydride (AlkSA)-modified starch was 
achieved. The most important conclusions of this study are summarised hereafter. 
 
The succinic anhydride-based modification technology was first patented in 
1953 by Caldwell and Wurzburg [1] for the modification of starch with cyclic 
dicarboxylic acid anhydrides (succinic and glutaric anhydrides). Typically, starch and 
the reagents were reacted in alkaline sodium carbonate buffers (pH < 11) and at room 
temperature [1] which led to starch derivatives modified at the polymer’s hydroxyl 
groups. 
However, due to competitive reactions, the degree of substitution (DS) of the 
succinate/glutarate starch derivatives is usually low. Indeed, the modification of starch 
with anhydrides in aqueous alkaline media is inevitably accompanied by the 
simultaneous hydrolysis of the reagent molecules and the reverse cleavage of the 
bonds between starch and the grafted moieties (Figure III.B.i for succinic anhydrides). 
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Figure III.B.i: Competitive reactions accompanying the modification of starch with 
succinic anhydrides in aqueous alkaline media. 
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In order to improve the DS of succinate/glutarate starch and allow the grafting 
of a variety of anhydride reagents, it is necessary to limit the extent of the side 
reactions presented in Figure III.B.i. This can be achieved by finely controlling the 
reaction conditions and supposes that their influence on the grafting of the anhydride 
reagents be known. 
 
Most of the literature available on the optimisation of the preparation of 
modified starch with cyclic dicarboxylic acid anhydrides concerns AlkSA-modified 
starch. For example, Jeon et al. [2], Bhosale and Singhal [3] and Song et al. [4] have 
systematically studied the influence of reaction parameters such as the starch 
concentration, reagent/starch weight ratio, reaction pH, temperature and time and 
reagent type on the reaction efficiency (RE*) and DS of AlkSA-starch. Indeed, these 
parameters potentially all affect, in a more or less complex and/or contradictory 
fashion, the extent of starch modification. 
For example, it may seem desirable to work at high starch concentrations to increase 
the probability that AlkSA be esterified with starch instead of being hydrolysed. 
However, concentrated starch suspensions are viscous and can hinder the mixing and 
diffusion of the AlkSA molecules in the reaction medium. Similarly, one could think 
that high values of the reaction pH and temperature would enhance the reactivity of the 
starch hydroxyl groups and the solubility and diffusivity of the AlkSA molecules. 
However, these conditions can also favour the hydrolysis of AlkSA. It is obvious that 
sufficiently long reaction times be applied in order to allow the completion of the 
esterification reactions. Nevertheless, past a certain time the reverse cleavage of the 
bonds created between starch and alkenyl succinate (AlkS) can occur due to the 
                                                          
*RE is defined as the ratio between the experimental and theoretical DS of the starch 
derivatives. The theoretical DS is calculated in the hypothetical case where all the 
reagent molecules added react with starch. 
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consumption of AlkSA in the esterification and hydrolysis reactions. Finally, the 
reactivity of AlkSA most likely depends on its chain length. 
Consequently, in order to improve the DS of AlkSA-starch, optima for the above-
mentioned parameters need to be found. 
 
The reaction parameters tested in references [2] to [4], their range and optima 
are summarised in Table III.B.i. 
 
Table III.B.i: Optimisation of the preparation of AlkSA-starch. 
C(starch), WR, T, t, DDSA and OSA stand for starch concentration, weight ratio, temperature, time, 
dodecyl succinic anhydride and octenyl succinic anhydride, respectively. 
  
Jeon et al. [2] 
Bhosale and 
Singhal [3] 
Song et al. [4] 
 
Starch origin 
Waxy corn 
starch 
Amaranth and 
waxy corn starch 
Indica rice starch
R
ea
ct
io
n 
pa
ra
m
et
er
s C(starch) 
AlkSA/starch WR 
pH 
T 
t 
Alkenyl chain length 
25-65 % w/w 
5-40 % (DDSA) 
7.5-10.5 
15-45 °C 
5-95 hours 
8-18 C atoms 
25 % w/w 
1-3 % (OSA) 
7.0-11.0 
20-60 °C 
6-30 hours 
8 C atoms 
20-40 % w/w 
3-15 % (OSA) 
7.0-10.0 
25-45 °C 
2-6 hours 
8 C atoms 
O
pt
im
a 
C(starch) 
AlkSA/starch WR 
pH 
T 
t 
Alkenyl chain length 
Maximum DS 
no influence 
10 % (DDSA) 
8.5-9.0 
23 °C 
24 hours 
8 C atoms 
4.0 % 
- 
3 % (OSA) 
8.0 
30 °C 
6-24 hours 
- 
2.5 % 
35 % w/w 
15 % (OSA) 
8.5 
35 °C 
6 hours 
- 
4.6 % 
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The modification methods used in references [2] to [4] were very similar to the 
original method by Caldwell and Wurzburg [1] and only differed from the latter with 
regards to the pH control. Typically, AlkSA was progressively added to the starch 
suspension for 2 hours. The pH was maintained at the desired value by the continuous 
addition of sodium hydroxide (NaOH). At the end of the reaction, the pH was adjusted 
to 6.5 with HCl. The resulting AlkSA-starch was filtered, washed and dried. 
Despite differences in the starch botanical origin and granule morphology, the results 
of the studies presented in Table III.B.i were consistent and showed that: 
(i) C(starch) had a variable influence on the DS of the derivatives, 
(ii) the higher the AlkSA WR, the higher the DS, but the lower the RE, 
(iii) the optimal ranges for the reaction pH, T and t were 8.0-9.0, 23-35 °C and 6-
24 hours, respectively, 
(iv) T above 23 °C did not allow a significant improvement of the DS of the 
derivatives, 
(v) RE and DS decreased rapidly when the alkenyl chain length was increased above 8 
carbon atoms, 
(vi) finally, the maximum DS of the starch derivatives was approximately 5 % per 
starch repeating unit. 
 
In references [2] to [4], the reaction parameters tested were varied 
independently from each other. This method requires that all parameters but one are 
kept constant and that this parameter is varied until an optimal value is found for it. 
After the parameter has been set to the optimal value, a second parameter is varied. 
This is repeated until an optimal value has been found for each of the tested 
parameters. Although rigorous, this technique exhibits some drawbacks. Firstly, 
changing one separate parameter at a time does not always lead to the real optimum 
and gives different implications with different starting points. Secondly, the approach 
requires a large number of experiments which in turn bring relatively little information 
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due to the inefficient distribution of the experiments. Finally, this method does not 
allow detecting interactions between parameters [5]. 
By contrast, the construction of a carefully prepared set of representative experiments 
(experimental plan) in which all parameters are simultaneously varied allows drawing 
more information from fewer experiments and uncovering interactions and synergies 
between parameters. In addition, this method still permits to evaluate the influence of 
each separate parameter [5]. Therefore, it is more suitable when screening the 
parameters mostly influencing the extent of a given chemical reaction. 
With this in mind, an experimental plan was used in the following optimisation study 
which frame was defined based on the conclusions drawn from the optimisation of the 
preparation of AlkSA-starch. 
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Abstract 
Amphiphilic octenyl succinic anhydride-modified hyaluronic acid (OSA-HA) was 
prepared in aqueous alkaline media, at room temperature and was structurally 
characterised by Fourier transform infrared spectroscopy (FT-IR) and proton nuclear 
magnetic resonance spectroscopy (1H NMR). The influence of reaction parameters 
such as the HA and buffer concentrations, OSA/HA molar ratio and reaction time on 
the degree of substitution (DS) of the OSA-HA derivatives was studied by means of an 
experimental plan. The results showed that the OSA/HA molar ratio, NaHCO3 
concentration and interaction between these had the largest influence on the DS of the 
derivatives while the HA concentration and reaction time only had a negligible effect. 
The maximum DS achieved was 44 % per disaccharide unit according to 1H NMR. 
Moreover, optimal reaction conditions were identified for the preparation of versatile 
OSA-HA derivatives with a DS between 1.5 and 44 %. 
 
Keywords amphiphilic hyaluronic acid derivative, octenyl succinic anhydride, degree 
of substitution, experimental plan. 
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I. Introduction 
 
Hyaluronic acid (HA) is a natural linear polysaccharide consisting of D-
glucuronic acid and N-acetyl-D-glucosamine linked through -1,3 glycosidic bonds 
while consecutive repeating disaccharide units are linked through -1,4 bonds [1] 
(Figure III.B.1). 
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Figure III.B.1: Molecular structure of the HA repeating unit. 
 
HA is found in all vertebrate organs and fluids and is particularly abundant in the 
extracellular matrix of soft connective tissues [2]. 
 
Due to its natural biocompatibility and resorbability, HA is currently one of 
the most attractive building blocks for the preparation of novel biomaterials with 
applications in the cosmetic, pharmaceutical and medical industries. However, native 
HA has limited applications in these fields due to its intrinsic poor mechanical and 
physicochemical properties [3]. Chemical modifications of HA have therefore been 
developed to prepare mechanically robust HA derivatives with tailored 
physicochemical properties. 
For example, amphiphilic HA derivatives have been obtained by grafting hydrophobic 
moieties onto the hydrophilic HA backbone using the carboxyl and hydroxyl functions 
of the polymer [3]. The resulting derivatives, which possess an altered aqueous 
solubility compared to native HA [4,5,6], potentially represent attractive starting 
materials for the formulation of self-associative HA-based systems towards drug 
encapsulation and delivery. 
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However, the modification methods currently available for the preparation of 
amphiphilic HA present some drawbacks. Firstly, the modification reactions are often 
conducted in organic solvents or organic solvent/water mixtures [7,8,9]. In addition to 
raise occupational and environmental issues and limit the upscalability of the 
preparation method, the use of organic solvents or mixtures of these often requires 
converting HA into its tetraalkylammonium salt [10,11] or preparing reactive 
intermediates [10,12]. This not only adds complex steps to the preparation method but 
also often results in HA degradation [4,8]. Secondly, the modification reactions 
involving HA carboxyl groups modify the distribution of negative charges along the 
polymer backbone at neutral pH. This could potentially affect some of the attractive 
biological and/or pharmacological properties of native HA [13]. 
Therefore, simple modification reactions in aqueous media, under mild conditions and 
exclusively involving HA hydroxyl groups could represent advantageous alternatives 
for the preparation of amphiphilic HA derivatives. 
 
In this regard, a novel, simple and easily upscalable modification method for 
the preparation of amphiphilic HA was previously developed in our laboratories which 
is based on the reaction between HA and octenyl succinic anhydride (OSA) in aqueous 
mild alkaline media [14]. 
The objective of the present work was to optimise this method and prepare versatile 
HA derivatives with tailored and extended degrees of substitution (DS). To achieve 
this, an experimental plan was implemented in which four different reaction 
parameters were simultaneously varied and their influence on the DS of the OSA-HA 
derivatives was detailedly studied. The chemical structure of the derivatives was 
characterised by Fourier transform infrared spectroscopy (FT-IR) and proton nuclear 
magnetic resonance spectroscopy (1H NMR). 
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II. Materials and methods 
 
II.1. Materials 
 
Medium molecular weight (MW) HA (HyaCare®, MW~750,000 Da, HA750) was 
provided by Novozymes Biopolymer A/S (Bagsværd, Denmark). Low MW HA 
(HA20) was prepared using the procedure described hereafter. Octenyl succinic 
anhydride (OSA, 210.27 Da, purity  97 %, mixture of cis and trans) was obtained 
from Sigma-Aldrich (Saint Louis, Missouri, United States). Sodium bicarbonate 
(NaHCO3) and potassium bromide (KBr) were used as purchased without further 
purification. The water used for the sample preparation and analysis was distilled and 
purified to a resistivity of 18.2 M.cm in a milli-Q apparatus (Millipore, Billerica, 
Massachusetts, United States). 
 
II.2. Methods 
 
II.2.1. Preparation of low molecular weight hyaluronic acid 
 
HA20 was prepared using the same method as that described for HA300 (see section A 
of this chapter, § II.2.1) but with 250 mL of H3PO4 and a 24-hour incubation time. 
Approximately 56 g of HA20, i.e. 80 % of the starting HA750 were recovered. 
 
SEC-MALLS 
The exact MW of HA20 was 19,090 ± 191 Da. 
FT-IR 
(KBr, 4000-500 cm-1) w 3431 (O–H and N–H st), 2931 (C–H st), 1700-1600 (COO- st 
as, N–H bd), 1423 (COO- st sy), 1392 (C–O–H bd), 1154 (C–O–C st as), 1077 and 
1038 (C–OH st), 954 and 900 (COO- bd), 808 (C–O–C st sy). 
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1H NMR 
(D2O, 400 MHz)  2.0 (s, 3 H, H-m), 3.2-4.0 (m, 10 H, H-2, H-5’, H-4’, H-3, H-3’, H-
5, H-6’b, H-4, H-6’a, H-2), 4.3-4.7 (d, 2 H, H-1, H-1’) (see Figure III.B.3). 
 
II.2.2. Preparation of octenyl succinic anhydride-modified hyaluronic acid 
 
HA20 was first dissolved in milli-Q water (50 mL) for 6 hours, at room temperature. 
NaHCO3 was added to the HA solution and mixed for 1 hour, at room temperature. A 
NaOH solution (0.5 M) was prepared from concentrated NaOH (4 M) by dilution in 
milli-Q water. The pH of the HA solution was measured and, if necessary, adjusted to 
8.5 with NaOH (0.5 M). OSA was added drop-wise to the alkaline HA solution with a 
volumetric pipette, under vigorous agitation. The mixture was then stirred for the 
desired time, at room temperature. The resulting product was dialysed against milli-Q 
water as described in section A of this chapter, § II.2.2. 
The reaction parameters studied in the experimental plan and their ranges are reported 
in Table III.B.1. 
 
Table III.B.1: Reaction parameters and ranges used in the experimental plan. 
C(HA), C(NaHCO3), OSA/HA MR and t stand for the HA and NaHCO3 concentrations, OSA/HA molar 
ratio and reaction time, respectively. The number of moles of HA was expressed in terms of number of 
moles of repeating disaccharides units. For the calculations the MW of one disaccharide unit was 
approximated to 400 Da. 
Reaction parameter Range 
C(HA) 5-25 mg/mL 
C(NaHCO3) 0.2-1.0 M 
OSA/HA MR 1-20 
t 6-24 hours 
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The combinations of reaction conditions tested (see Table III.B.2) were determined 
using an experimental planning software (MODDE 8; Umetrics, Umeå, Sweden) and a 
two-level interaction full factorial design. The experimental DS values were fitted with 
a “linear plus interaction model” using a partial least square (PLS) regression analysis. 
The accuracy of the model was determined by separating the residual sum of squares 
into pure error (experimental error) and lack of fit. 
 
1H NMR 
(D2O, 400 MHz)  0.9 (s, 3 H, H-10’’), 1.3 (m, 6 H, H-7’’-H-9’’), 1.4-1.8 (m, 2 H, H-
6’’), 2.0 (s, 3 H, H-m), 2.2-3.0 (m, 5 H, H-1’’-H-3’’), 3.4-4.2 (m, 10 H, H-2, H-5’, H-
4’, H-3, H-3’, H-5, H-6’b, H-4, H-6’a, H-2), 4.6-4.8 (d, 2 H, H-1, H-1’), 4.9-5.7 (m, 
2 H, H-4’’, H-5’’) (see Figure III.B.4). 
 
II.2.3. Characterisation methods 
(see section A of this chapter, § II.2.4 for SEC-MALLS, FT-IR and 1H NMR) 
 
III. Results and discussion 
 
III.1. Characterisation of octenyl succinic anhydride-modified hyaluronic acid 
 
OSA-HA was prepared by reacting HA and OSA in aqueous mild alkaline 
media, at room temperature (see section A of this chapter, Figure III.A.6). 
Due to the linear structure of HA, the products obtained can be regarded as fishbone-
like polymers consisting of a hydrophiphilic HA backbone and a number of 
hydrophobic octenyl succinate (OS) side chains which depends on the degree of 
substitution of the derivative (Figure III.B.2). 
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Hydrophobic OSA side chain
Hydrophilic HA backbone  
Figure III.B.2: Scheme of the fishbone structure of OSA-HA. 
 
The structure of the OSA-HA derivatives was qualitatively studied by FT-IR 
by comparing the spectra of native HA20 and of the derivatives. However, these 
spectra did not show any significant differences, independently of the DS of the 
derivatives. This lack of difference was probably due the overlapping of the 
characteristic bands of HA20 and OSA-HA (see section A of this chapter, § III.2). As a 
result, FT-IR could not confirm the modification of HA with OSA. 
 
1H NMR, however, proved efficient in demonstrating the grafting of OSA 
onto HA and was used to calculate the DS of the OSA-HA derivatives. The spectrum 
of native HA20 is presented in Figure III.B.3 while that of OSA-HA (8) (see 
Table III.B.2 for a definition of the notation) is shown as an example in Figure III.B.4. 
Due to peak overlapping in the region 3.2-4.0 ppm, it was not possible to clearly assign 
the shifts of protons 3 to 5 and 2’ to 6’. 
The spectrum of OSA-HA (8) showed an additional singlet at 0.9 and a multiplet at 
1.3 ppm. The former corresponds to the terminal methyl protons 10’’ and the latter to 
the methylene protons 7’’ to 9’’ on the octenyl chain of grafted OS. Due to the low 
signal intensity in the regions 1.4-1.8, 2.2-3.0 and 4.9-5.7 ppm, it was not possible to 
clearly assign the chemical shifts of protons 1’’ to 6’’. 
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Figure III.B.3: 1H NMR spectrum of HA20. 
 
However, in the group of protons 1’’ to 3’’ and 6’’, the methylene protons 6’’ are 
expected to occur most upfield, possibly in the region 1.4-1.8 ppm due their 
farthermost position with respect to the anisotropic fields of the carboxylate and ester 
groups. Conversely, the methylene protons 1’’ and the methine proton 2’’ are expected 
to occur most downfield in the region 2.2-3.0 ppm due their closest position with 
respect to these fields. Finally, the vinyl proton 4’’ should appear downfield of the 
vinyl proton 5’’ for a similar reason. 
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Figure III.B.4: 1H NMR spectrum of OSA-HA (8). 
 
It is noteworthy that the signal of protons 1’’ to 6’’ is higher than that observed for 
OSA-HA30 (2) (see section A of this chapter, Figure III.A.8). This is probably due to 
the higher DS of OSA-HA (8) which was 18 % per disaccharide unit (see 
Table III.B.2). 
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Similar spectra were observed for the other OSA-HA derivatives. However, 
the relative intensity of the singlet at 0.9 ppm and therefore the DS of the derivatives 
were dependent on the reaction conditions. 
 
III.2. Influence of the reaction conditions on the degree of substitution of octenyl 
succinic anhydride-modified hyaluronic acid 
 
In order to identify the reaction parameters mostly influencing the DS of the 
OSA-HA derivatives, an experimental plan (2-level interaction full factorial design) 
was implemented in which four different reaction parameters were simultaneously 
varied. 
The frame of this experimental plan was defined based on a preliminary literature 
study on the optimisation of the preparation of alkenyl succinic anhydride (AlkSA)-
modified starch [15,16,17] (see Foreword). According to the conclusions of this study, 
the following settings were applied: 
(i) the reaction pH was set to 8.5 and was maintained at this value using a sodium 
bicarbonate (NaHCO3) buffer, 
(ii) the reaction temperature was between 20 and 23 °C (room temperature), 
(iii) the reaction parameters studied were the HA and buffer concentrations, OSA/HA 
molar ratio and reaction time, 
(iv) these were varied between 5 and 25 mg/mL, 0.2 and 1.0 M, 1 and 20 and 6 and 
24 hours, respectively (see Table III.B.1), 
(v) the starting HA used had a molecular weight of 20,000 Da. 
 
The choice of working with low MW HA was made in the perspective of the 
potential future applications of the OSA-HA derivatives, namely their use for the 
formulation of nanocarriers. 
Kawaguchi et al. [7] have indeed shown that the emulsification capacity of palmitoyl 
chloride-modified HA prepared from 20,000-Da HA (P-HA20, DS = 3 % per 
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disaccharide unit) was clearly superior to that of the same HA derivative prepared from 
2,000,000 Da-HA (P-HA2000). The emulsification of soybean oil and liquid paraffin 
(5 % w/v) with P-HA20 yielded stable emulsions in which the average oil droplet size 
was 315 ± 98 and 341 ± 79 nm, respectively. However, when P-HA2000 was used 
rather instable emulsions were formed which almost immediately phase-separated in 
the case of liquid paraffin. P-HA20 had a better emulsification capacity than P-
HA2000 most likely due to its ability to move faster to interfaces and stabilise smaller 
oil droplets. 
Similarly, Mohapatra et al. [18] experienced that the use of 20,000- to 40,000-Da HA 
for the production of HA nanoparticles by cross-linking in w/o emulsions could reduce 
the particle size from 160 nm to between 10 to 40 nm. This size reduction was most 
likely due to the formation of smaller HA-containing water droplets owing to the lower 
viscosity of low MW HA solutions. 
Therefore, it is believed that the use of low MW HA as starting material will be an 
important factor for the formation of future nanocarriers from OSA-HA. 
 
The low, medium and high levels of the four reaction parameters studied were 
associated into 17 different combinations including a centre point which was replicated 
four times in order to calculate the experimental error. This brought the total number of 
samples to 20. The DS of the resulting OSA-HA derivatives was determined by 
1H NMR (see § II.2.3 and Table III.B.2). 
The DS of the OSA-HA derivatives was between 1.5 and 18 % per disaccharide unit 
and the two combinations of reaction conditions allowing a DS of 18 % were those of 
OSA-HA (8) and OSA-HA (15) (also highlighted in grey in Table III.B.2), i.e. when 
the OSA/HA MR and buffer concentration were the highest. 
The DS values of the four replicates OSA-HA (17), (18), (19) and (20), which were 
prepared on different days, were very similar which indicated a general good 
reproducibility of the experiments. 
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Table III.B.2: Reaction conditions and degree of substitution of the OSA-HA 
derivatives. 
C(NaHCO3), C(HA), OSA/HA MR and t stand for the NaHCO3 and HA concentrations, OSA/HA molar 
ratio and reaction time, respectively. 
Reaction conditions 
Sample name 
C(NaHCO3) (M) C(HA) (mg/mL) OSA/HA MR t (hours) 
DS
OSA-HA (1) 0.2 5 1 6 3.5 
OSA-HA (2) 0.2 25 1 6 2.5 
OSA-HA (3) 0.2 5 20 6 10 
OSA-HA (4) 0.2 25 20 6 7 
OSA-HA (5) 1.0 5 1 6 1.5 
OSA-HA (6) 1.0 25 1 6 2 
OSA-HA (7) 1.0 5 20 6 16 
OSA-HA (8) 1.0 25 20 6 18 
OSA-HA (9) 0.2 5 1 24 3 
OSA-HA (10) 0.2 25 1 24 4 
OSA-HA (11) 0.2 5 20 24 13 
OSA-HA (12) 0.2 25 20 24 8 
OSA-HA (13) 1.0 5 1 24 4 
OSA-HA (14) 1.0 25 1 24 2 
OSA-HA (15) 1.0 5 20 24 18 
OSA-HA (16) 1.0 25 20 24 17 
OSA-HA (17) 0.6 15 10.5 15 6 
OSA-HA (18) 0.6 15 10.5 15 7 
OSA-HA (19) 0.6 15 10.5 15 6 
OSA-HA (20) 0.6 15 10.5 15 7.5 
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The initial coefficient plot showed that only a few parameters and 
combinations of parameters had a significant influence on the DS of the OSA-HA 
derivatives, namely the OSA/HA molar ratio, NaHCO3 concentration and interaction 
between these. Indeed, the amplitude of the confidence intervals for these parameters 
was much lower than the magnitude of their associated coefficients. This was due to 
the fact the OSA/HA molar ratio is directly related to the number of available reagent 
molecules and the NaHCO3 concentration is associated to the buffering capacity of the 
reaction medium which needs to be sufficient in order to maintain an alkaline pH (8.5) 
for the activation of the HA hydroxyl groups. 
The HA concentration and reaction time had little influence on the DS of the OSA-HA 
derivatives (see for example OSA-HA (7) and OSA-HA (8) on the one hand and OSA-
HA (8) and OSA-HA (16) on the other hand). This suggested that the viscosity of the 
25-mg/mL HA solutions did not hinder the mixing and diffusion of the OSA molecules 
nor limit the competitive hydrolysis of OSA more than the 5-mg/mL HA solutions. 
This means that OSA-HA can be prepared from relatively concentrated HA solutions 
without compromising the extent of the modification. Finally, increasing the reaction 
time from 6 to 24 hours did not result in higher DS values which suggested that the 
reactions between HA and OSA were already completed after 6 hours. 
 
After elimination of the parameters and combinations of parameters 
insignificantly influencing the DS of the OSA-HA derivatives, the experimental DS 
values were fitted with a linear plus interaction model using a PLS regression analysis. 
The model was evaluated by means of calculating four different coefficients: the 
regression (R2) and prediction (Q2) coefficients, the model validity (MV) and the 
reproducibility coefficient (RC) (Figure III.B.5). The high values of R2, Q2, MV and 
RC suggested that the choice of the mathematical model used to modelise the influence 
of the reaction conditions on the DS of the OSA-HA derivatives was justified and 
suitable. 
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Figure III.B.5: Evaluation of the model used to fit the DS of the OSA-HA derivatives. 
R2 and Q2 are measures of fit and prediction of new data from the model according to cross-validations, 
respectively. MV is a measure of the validity of the model. When MV is larger than 0.25 (which is the 
case here), the model error is in the same range as the experimental error. RC is an assessment of the 
reproducibility of the response under the same conditions (experimental error). 
 
Therefore, a contour plot of the DS of the OSA-HA derivatives as a function 
of the OSA/HA molar ratio and NaHCO3 concentration was computed and is presented 
in Figure III.B.6. 
As already observed, the contour plot predicts that the highest DS values are obtained 
for the highest OSA/HA molar ratio and buffer concentration, typically 20 and 1.0 M, 
respectively. Indeed, the higher the OSA/HA molar ratio, the larger the number of 
OSA molecules available for reaction. Likewise, the higher the NaHCO3 
concentration, the greater the buffering capacity and consequently the longer the 
activation of HA hydroxyl groups. 
 
Interestingly, when a higher OSA/HA molar ratio (50) and NaHCO3 
concentration (2.0 M) were used (the HA concentration and reaction time were 
25 mg/mL and 24 hours, respectively), the DS of the resulting OSA-HA derivatives 
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could be increased to 44 % which demonstrated that the OSA modification technology 
was very versatile. Moreover, this maximum DS was much higher than that reported 
for OSA-starch which does not exceed 5 % per repeating unit [15,16,17] (see 
Foreword). 
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Figure III.B.6: Contour plot of the DS of the OSA-HA derivatives 
(C (HA) = 15 mg/mL). 
 
IV. Conclusion 
 
Amphiphilic hyaluronic acid derivatives were prepared using a simple water-
based modification method targeting the HA hydroxyl groups thus preserving the 
carboxyl groups of the polysaccharide. 
HA was alkenylated with octenyl succinic anhydride to yield fishbone-like OSA-HA 
polymers and the influence of reaction parameters such as the HA and buffer 
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(NaHCO3) concentrations, OSA/HA molar ratio and reaction time on the degree of 
substitution of the OSA-HA derivatives was studied by means of an experimental plan. 
The results showed that the OSA/HA molar ratio, NaHCO3 concentration and 
interaction between these had the largest influence on the DS of the derivatives while 
the HA concentration and reaction time only had a negligible effect. 
 
Combinations of reaction conditions allowing the preparation of OSA-HA 
derivatives with a DS between 1.5 and 44 % per disaccharide unit according to 
1H NMR were identified. This represents a wide DS range compared to that reported 
for OSA-starch (DS < 5 % per repeating unit) and shows that the OSA modification 
technology is very versatile. 
Moreover, it was demonstrated that the reactions were fast (6 hours) and could be 
conducted in relatively concentrated HA solution (25 mg/mL). These aspects could 
potentially represent advantages in terms of volume and through-put in the perspective 
of upscaling the method. 
 
The introduction of octenyl chains onto HA is expected to alter the properties 
of the native polymer and especially its solution properties. These, together with the 
detailed structure of OSA-HA, were investigated in the following section. 
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C. Additional characterisation of octenyl succinic anhydride-modified hyaluronic 
acid – Substitution pattern, molecular weight and conformation in aqueous media 
 
 
Abstract 
 
The substitution pattern, molecular weight (MW) and conformation in aqueous media 
of octenyl succinic anhydride-modified hyaluronic acid (OSA-HA) were investigated 
by high performance liquid chromatography (HPLC), matrix-assisted laser 
desorption/ionisation–time-of-flight–mass spectrometry (MALDI-TOF-MS), nuclear 
magnetic resonance spectroscopy (NMR) and multi-angle laser light scattering 
(MALLS). Although these studies were not performed under optimal conditions due to 
experimental difficulties related to the purification and/or intrinsic nature of the 
samples, the results suggested that the substitution pattern of OSA-HA was most likely 
(i) random at the molecular level, i.e. all HA hydroxyl groups were potential targets for 
the grafting of OSA, and (ii) heterogeneous at the macromolecular level due to the 
biphasic nature of the reaction between HA and OSA. It was also shown that OSA-HA 
underwent a major conformation change in aqueous media at a concentration which 
was dependent on its degree of substitution. However, it was not possible to 
unequivocally evidence the presumed randomness of the grafting of OSA at the 
molecular level or determine the MW, monomolecular size and affinity for the solvent 
of the OSA-HA derivatives. 
 
 
I. Introduction 
 
Previously in this chapter, the grafting of octenyl succinic anhydride (OSA) 
onto hyaluronic acid (HA) was represented as potentially occurring on any of the four 
hydroxyl groups of the HA repeating disaccharide unit (see section A of this chapter, 
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Figure III.A.6). However, this had not analytically been confirmed. Likewise, the 
macromolecular distribution of the octenyl succinate (OS) chains along the HA 
backbone had not been investigated. Knowledge of the substitution pattern of OSA-
HA would yet be useful in order to understand the reaction mechanism between HA 
and OSA and could potentially be exploited to describe some aspects of the solution 
and physicochemical behaviour of OSA-HA. 
 
Also reported earlier, the molecular weight (MW) of the OSA-HA derivatives 
could not be determined by size exclusion chromatography–multi-angle laser light 
scattering (SEC-MALLS) due to their strong retention on the stationary phase of the 
fractionation column (see section A of this chapter, § III.2). Knowledge of the MW of 
the OSA-HA derivatives would yet be valuable in order to assess MW degradation 
during their preparation and could be used to both evidence the modification of HA 
with OSA and cross-validate the degree of substitution (DS) values determined by 
proton nuclear magnetic resonance spectroscopy (1H NMR). 
 
The introduction of OSA onto HA is expected to alter the solution properties 
of the native polymer and in particular the compactedness of its conformation in 
aqueous media, in the dilute regime, due to the intramolecular hydrophobic 
interactions between the grafted OS chains of the same OSA-HA molecule and the 
lower affinity of OSA-HA for aqueous solvents. It is important to evidence these new 
solutions properties and put them into perspective with that of semi-dilute and 
concentrated OSA-HA solutions (see Chapter IV) in order to get a continuous 
understanding of the polymers’ behaviour in aqueous media. 
 
In view of the above-mentioned unknowns, the objectives of this work were 
to study the substitution pattern of OSA-HA and determine the MW, monomolecular 
size and affinity for aqueous solvents of the OSA-HA derivatives. 
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Focus was drawn on uncovering which type of HA hydroxyl groups are involved in the 
reaction with OSA and how the OS chains are distributed along the HA backbone. It 
was also attempted to develop a method allowing the measurement of intrinsic 
properties such as MW, root mean square radius (Rrms) and osmotic second virial 
coefficient (A2) but avoiding the use of the SEC-MALLS fractionation column. 
 
The structural study at the molecular level was performed by master student, 
Sara Sparre Kofoed, co-supervised by associate professor Charlotte Held Gotfredsen 
(Technical University of Denmark, Department of Chemistry, Lyngby, Denmark) and 
Ph.D. student Corinne Eenschooten. The reader is referred to the master thesis [1] for 
the extensive study and only a few illustrative elements and the main conclusions of 
the work will be presented hereafter. 
 
II. Materials and methods 
 
A detailed Materials and methods section is available from [1] and only the materials 
and methods used for the SEC-MALLS study are described hereafter. 
 
II.1. Materials 
 
The 20,000-Da HA (HA20) and the OSA-HA derivatives (OSA-HA6, -18 and -44) 
used were prepared as described in section B of this chapter, § II.2.1 and II.2.2. 
Sodium chloride (NaCl), potassium chloride (KCl), disodium hydrogen phosphate 
(Na2HPO4) and potassium dihydrogen phosphate (KH2PO4) were used as purchased 
without further purification. The water used for the sample preparation and analysis 
was distilled and purified to a resistivity of 18.2 M.cm in a milli-Q apparatus 
(Millipore, Billerica, Massachusetts, United States). 
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II.2. Methods 
 
The MW, Rrms and A2 of HA20 and of the OSA-HA derivatives were determined in a 
phosphate buffer saline (PBS, pH = 7.4) which was prepared as followed: NaCl 
(8.0 g), KCl (0.2 g), Na2HPO4 (1.4 g) and KH2PO4 (0.2 g) were first dissolved in  
milli-Q water (1 L) for 1 hour, at room temperature. The pH of the mixture was then 
measured and, if necessary, adjusted to 7.4 with HCl (0.2 M) or NaOH (0.2 M). The 
resulting buffer was finally filtered through glass microfiber filters (GF/F 1825 110, 
porosity 0.7 μm; Whatman, Maidstone, United Kingdom). HA20 was dissolved in PBS 
for 16 hours (overnight) at the following concentrations: 0.5, 1, 1.5, 2, 3 and 4 g/L. 
OSA-HA was dissolved in PBS for 16 hours (overnight) at concentrations between 
0.001 and 1 g/L. The OSA-HA solutions with a concentration superior or equal to 
0.1 g/L were prepared from the 1-g/L solution. Each of the remaining solutions was 
prepared from the 10-fold more concentrated solution by mixing 1 g of the latter with 
9 g of PBS. The dilutions of each HA and OSA-HA sample were injected in a queue 
directly in the MALLS cell (DAWN EOS; Wyatt Technology Corporation, Santa 
Barbara, California, United States) using a 5-mL plastic syringe mounted on a filter 
(Minisart®plus, porosity 0.45 μm; Sartorius, Göttingen, Germany). During each 
injection, the flow rate was maintained at 25 mL/h using a syringe pump (A-99; Razel 
Scientific Instruments, Stanford, Connecticut, United States). After injection of about 
2 mL of the dilution to be tested, the flow was then stopped and measurements were 
allowed to take place for 2 min or until voltage plateaus were stable over 2 consecutive 
minutes. Experiments were repeated 3 times per sample. The variation of the polymer 
solution refractive index n as a function of the polymer concentration c (dn/dc) was set 
to 0.153 mL/g for HA. As a first approximation, the same dn/dc value was used for 
OSA-HA. The MALLS instrument was piloted by the software ASTRA 5.3.1.4 (Wyatt 
Technology Corporation, Santa Barbara, California, United States). The MW, Rrms and 
A2 of HA20 and of the OSA-HA derivatives were calculated from Equation III.C.1 by 
extrapolation at a low scattering angle and concentration [2]: 
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for which n is the refractive index of the polymer solution, c the polymer 
concentration, n0 the refractive index of the solvent, NA Avogadro's number and 0 the 
wavelength of the laser light in vacuum, 
(ii) R(,c) is the excess Rayleigh ratio of the solution as a function of the scattering 
angle  and the polymer concentration c, 
(iii) MWw is the weight-averaged molecular weight, 
(iv) P() is the angular dependence of the scattered intensity as a function of the 
particle size. The expansion of P() to the first order gives: 
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	                                                              Equation III.C.3 
for which Rrms is the root mean square radius of the particles, 
(v) A2 is the osmotic second virial coefficient. 
 
III. Results and discussion 
 
III.1. Structural study 
 
The substitution pattern of OSA-HA is twofold; first the type of HA hydroxyl 
groups involved in the reaction with OSA (molecular level) and secondly the 
distribution of the OS chains along the HA backbone (macromolecular level). 
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III.1.1. Molecular level 
 
It is usually assumed that the primary hydroxyl groups of saccharides are 
appreciably more reactive than the secondary ones [3]. This suggests that the grafting 
of OSA preferentially occurs at the HA primary hydroxyl groups. However, the 
grafting of OSA onto starch has been reported to occur both at the starch primary and 
secondary hydroxyl groups [4,5]. Therefore, it was judged relevant to investigate 
which HA hydroxyl groups are involved in the reaction with OSA in order to improve 
the understanding of the reaction mechanism between HA and OSA and the properties 
of the OSA-HA derivatives. 
 
The grafting of OSA onto HA was investigated by various NMR techniques. 
Indeed, the replacement of HA hydroxyl protons with OSA is expected to alter the 
chemical shifts of the axial and hydroxymethylene protons and those of the sugar ring 
carbon atoms on HA. However, these shift differences cannot be identified on the 
spectra of the ~20,000-Da OSA-HA derivatives due the broad and overlapping 
resonances yielded by these macromolecules. Therefore, the NMR study was 
conducted on OSA-HA oligosaccharides. These were obtained by either reacting HA 
oligosaccharides and OSA or enzymatically digesting OSA-HA into oligosaccharides. 
Prior to the NMR study, the various OSA-HA fractions were characterised by high 
performance liquid chromatography (HPLC) and matrix-assisted laser 
desorption/ionisation–time-of-flight–mass spectrometry (MALDI-TOF-MS). 
 
In order to obtain HA oligosaccharides on which OSA would be grafted, 
medium MW HA (MW~650,000 Da) was enzymatically digested with Streptomyces 
hyaluronlyticus hyaluronidase in a sodium acetate (NaOAc) buffer, at pH 6.0 and 
50 degrees, for 8 hours. The digestion mixture was sampled after 4, 6 and 8 hours of 
digestion and analysed by HPLC (Figure III.C.1). 
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Figure III.C.1: HPLC chromatograms of the digestion mixture. 
4-, 6-, 8-, 10-, 12-, 14-HA stand for HA tetra-, hexa-, octa-, deca-, dodeca- and tetradecasaccharide, 
respectively. 
 
An analysis of a mixture of the NaOAc buffer and deactivated enzyme showed that the 
peaks between 0 and 3.5 min could be attributed to the digestion system. Those 
between 3.5 and 9.5 min most probably corresponded to the elution of the HA 
oligosaccharides in the order 4-, 6-, 8-, 10-, 12- and 14-HA. Indeed, it has been shown 
that the shortest HA oligosaccharide produced by Streptomyces hyaluronlyticus 
hyaluronidase consist of four sugar units [6]. The expanded portion of the 
superimposed chromatograms showed that the proportion of the oligosaccharides 
larger than 4-HA decreased over time and that almost only 4- and 6-HA were left in 
the digestion mixture after 8 hours which evidenced that the digestion method used 
was fairly selective. 
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The composition of the digestion mixture after 8 hours was confirmed by 
MALDI-TOF-MS in positive reflective mode using a desalted sample. The HA 
oligosaccharides were mainly detected as their sodium salts (Table III.C.1). 
 
Table III.C.1: MALDI-TOF-MS analysis of the digestion mixture after 8 hours. 
Expected mass (Da) Experimental mass (m/z) 
HA oligosaccharide 
[M + Na]+ [M – H + 2Na]+ [M + Na]+ [M – H + 2Na]+
4-HA 781.62 803.60 781.15 803.43 
6-HA 1160.94 1182.92 1160.26 1182.25 
8-HA 1540.25 1562.24 1539.37 1561.36 
 
The experimental masses of the HA oligosaccharides were in very good agreement 
with their expected masses. This confirmed the presence of 4-, 6- and 8-HA in the 
digestion mixture (see Figure III.C.1). 
 
A separation of the HA oligosaccharides using low pressure gas 
chromatography (LPGC) was attempted in order to isolate 4-HA on which the reaction 
with OSA would be performed. However, given the large quantity of material involved 
compared to the capacity of the LPGC column, this process was fastidious and due to 
time limitation during the master’s project, the grafting of OSA was eventually 
performed on a desalted mixture of 4-, 6- and 8-HA. 
 
After reaction of the HA oligosaccharides with OSA in a NaHCO3 buffer, at 
pH 9.0 and room temperature, for 16 hours (overnight), the resulting desalted product 
was again analysed by MALDI-TOF-MS (Figure III.C.2) 
 
165
Development of soft nanocarriers from novel amphiphilic hyaluronic acid 
derivatives towards drug delivery 
Chapter III 
Preparation and structural characterisation of amphiphilic hyaluronic acid derivatives 
 
 
140 
 
Figure III.C.2: MALDI-TOF-MS spectrum of the product of the reaction between the 
HA oligosaccharides and OSA. 
 
The spectrum displayed in Figure III.C.2 was detailedly assigned in [1] and only key 
elements are summarized hereafter. The product of the reaction between the HA 
oligosaccharides and OSA was a mixture of non-modified and modified HA 
oligosaccharides. The various HA and OSA-HA oligosaccharides were detected as 
alkali salts such as [M + Na]+, [M + K]+, [M – H + 2Na]+, [M –H + Na + K]+,        
[M – H + 2K]+ and [M – H + Na + 2K]+ which explains the numerous peaks observed 
for each of the oligosaccharides. 
The spectrum indicated that only one OS chain was grafted on each of the modified 
oligosaccharides. This was surprising as a large excess of OSA was used and should 
have resulted in a larger number of grafted OS substituents per oligosaccharide. 
Several explanations for this are possible: either the extent of the reaction between the 
HA oligosaccharides and OSA was actually low evidencing a poor reaction efficiency 
or it may not have been possible to ionise, with the matrix used, and thus detect by 
MALDI-TOF-MS OSA-HA oligosaccharides bearing more than one OS substituent. 
The first explanation could be consistent with the fact that solutions of HA 
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oligosaccharides are much less viscous than those of several thousand-Da HA leaving 
OSA much more sensitive to competitive hydration. However, a comparison between 
the intensity of protons H-4 of the terminal glucuronate and H-4 on grafted OS (see 
section A of this chapter, Figure III.A.8 for the definition of the notation H-4) in the 
NMR spectrum of the product of the reaction between the HA oligosaccharides and 
OSA revealed that there were almost as much of these two protons. Given the presence 
of unmodified HA oligosaccharides in the mixture analysed, this means that some 
OSA-HA oligosaccharides must have had more than one OS substituent. Therefore, it 
is more likely that OSA-HA oligosaccharides with more than one OS substituent 
cannot be ionised with the matrix used which rules out the first hypothesis. 
 
The various HA and OSA-HA oligosaccharides were finally analysed by 7 
different NMR techniques (1D 1H, DQF-COSY, TOCSY, NOESY, gHSQC and 
gHMBC) at 500 and 800 MHz. 
Interestingly, a combination of these techniques uncovered structural alterations such 
as the change in configuration of the terminal N-acetylglucosamine, which for some 
oligosaccharides had shifted from a beta to an alpha configuration and the creation of 
an unsaturation between protons 4 and 5 of the terminal glucuronate. These changes 
were attributed to the enzymatic action [7,8]. 
Although it could be expected that the substitution of HA hydroxyl protons with –COR 
groups would result in adjacent proton shifts of about 0.5 ppm downfield, alterations in 
neither the proton nor the carbon resonances of the OSA-HA oligosaccharides could be 
observed. 
 
For comparison a ~20,000-Da OSA-HA derivative (with a DS of 
approximately 16 % per disaccharide unit) was digested into oligosaccharides and 
characterised as described before. However, as for the OSA-HA oligosaccharides 
prepared by reaction between HA oligosaccharides and OSA, the NMR spectra did not 
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display any shift differences. As a result, it was not possible to determine which type 
of HA hydroxyl groups bore the OS substituents. 
 
A combination of the following reasons can be put forward to explain the lack 
of difference between the chemical shifts of the HA and OSA-HA oligosaccharides: 
(i) despite the low polymerisation degree of the fractions analysed, there was still a 
heavy overlap of the carbohydrate resonances, 
(ii) the NMR analysis was conducted on a mixture of oligosaccharides. Therefore, 
multiple similar spin systems were present and had a broadening effect on the 
resonances, 
(iii) the extent of modification of the oligosaccharides was low and it is likely that the 
HA resonances dominated in the NMR spectra, 
(iv) the grafting of OSA was probably random and many different OSA-HA 
oligosaccharides were most likely obtained. The low abundance of single species 
resulted, as in point (ii), in resonance broadening. 
In the absence of determining proofs, there were however more indications that the 
grafting of OSA onto HA was more random than otherwise. It is therefore believed 
that all HA hydroxyl groups are potential targets for the grafting of OSA. 
 
III.1.2. Macromolecular level 
 
The reaction between HA and OSA is not homogeneous since it occurs 
between an aqueous phase containing HA and a dispersed oil phase consisting of OSA. 
The grafting of OSA is therefore believed to occur at the surface of the OSA oil 
droplets which size diminishes as OSA is consumed in the esterification and hydrolysis 
reactions. 
Each time an OSA molecule is grafted onto HA, an anchoring site is most likely 
created which maintains the modified polymer adsorbed at the surface of the OSA 
droplet like a surfactant due to hydrophobic interactions between grafted OS and free 
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OSA. The polymer eventually desorbs when the OSA molecules in the droplets have 
completely been consumed. Adsorbed HA at the surface of the OSA droplets probably 
adopts tail-train-loop configurations such as those described by Kawaguchi et al. at 
the surface of soybean oil droplets [9] (Figure III.C.3). 
 
train
tail
loop
OSA
HA
Dispersion of OSA in aqueous HA 
Figure III.C.3: Putative reaction mechanism between HA and OSA. 
 
As a result, it is possible that the degree of freedom of the polymer be reduced and that 
certain polymer regions be excluded for reaction. 
 
This putative reaction mechanism implies that the distribution of OS on HA is 
most likely non-homogenous at the macromolecular level and that the distribution of 
the DS of the OSA-HA derivatives is probably fairly broad. This could explains the 
size polydispersity of the OSA-HA polymeric micelles (see Chapter IV, § III.2 and 
III.3). 
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III.2. Molecular weight and conformation study 
 
Due to the strong retention of the OSA-HA derivatives on the stationary phase 
of the SEC-MALLS fractionation column, their MW, Rrms and A2 in PBS were 
determined directly by MALLS (batch mode). Sample dilutions with increasing 
concentrations were simply injected in the MALLS cells and light scattering 
measurements were taken on unfractionated samples. 
 
Provided that the preparation of OSA-HA is not accompanied by a significant 
HA MW decrease, the introduction of OSA chains onto HA is expected to increase the 
MW of the native polymer. According to the DS values determined by 1H NMR, the 
MW of OSA-HA6, -18 and -44 should approach 19,600, 20,800 and 23,400 Da, 
respectively since the MW of the starting HA (HA20) was about 19,000 Da (see 
section B of this chapter, § II.2.1). 
 
Due to the presence of hydrophobic groups on OSA-HA, the aqueous 
solubility of HA and of the OSA-HA derivatives should be different and the 
conformation, in the dilute regime, of OSA-HA should be all the more compact that 
the DS of OSA-HA is high. 
Taglienti et al. [10] for example showed that the higher the DS of methylprednisolone-
modified HA (45 and 60 % of grafted substituents, respectively), the lower the values 
of intrinsic viscosity ([]) of these modified polymers in water (~8.0 and 4.8 L/g, 
respectively). Considering that the MW of the two polymers is almost the same and 
that the quantity MW[] is proportional to the hydrodynamic radius (RH), these results 
suggested that the higher the DS of methylprednisolone-modified HA, the lower its RH 
and the more compact its conformation due to the increasing hydrophobic interactions 
between the grafted substituents. 
Similarly, Pelletier et al. [11] observed that the introduction of dodecyl (5 %) and 
octadecyl (1 %) chains onto HA (HA-C12 and HA-C18, respectively) resulted in a 
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decrease of [] from 0.93 L/g (unmodified HA, MW~480,000 Da) to 0.27 L/g (HA-
C12) or 0.17 L/g (HA-C18) in 0.15 M NaCl. In this case, the longer the hydrophobic 
chains, the more compact the conformation of modified HA due to the stronger 
interactions between the longer alkyl chains. 
Pravata et al. [12] demonstrated, using SEC-MALLS and the Mark-Houwink-Kunh-
Sakurada (MHKS) relationship, a change in the conformation of HA modified with 
DL-lactic acid oligomers. The conformation of the native polymer was a random coil 
while that of the modified polymer was a sphere. This was again attributed to the 
hydrophobic interactions between the grafted substituents. 
 
In this work, the conformation of HA and of the OSA-HA derivatives was 
assessed by means of two physical quantities, namely Rrms and A2. Based on the 
studies above, it was expected that Rrms and A2 would decrease with increasing the DS 
of OSA-HA. Indeed, the higher the DS of OSA-HA, the greater the possibility for 
hydrophobic interactions and thus the lower the Rrms and the affinity of OSA-HA for 
aqueous solvents. The values of MW, Rrms and A2 obtained are presented in 
Table III.C.2. 
 
Table III.C.2: Molecular weight, root mean square radius and osmotic second virial 
coefficient of HA20 and of the OSA-HA derivatives. 
Sample MW (Da) Rrms (nm) A2×103(mol.mL/g2) 
HA20 19,100 ± 200 (± 1.0 %) 28.9 ± 1.5 (± 5.2 %) -3.836 ± 0.164 (± 4.2 %) 
OSA-HA6 27,300 ± 500 (± 1.8 %) 47.8 ± 1.8 (± 3.8 %) -35.990 ± 0.790 (± 2.2 %) 
OSA-HA18 244,100 ± 15,300 (± 6.3 %) 83.8 ± 4.8 (± 5.7 %) -3.638 ± 0.328 (± 9.0 %) 
OSA-HA44 15,830,000 ± 170,000 (± 1.1 %) 60.9 ± 1.0 (± 1.6 %) -3.503 ± 0.123 (± 3.5 %) 
 
The MW of HA20 was 19,100 ± 200 Da which was very close to the value determined 
by SEC-MALLS (19,090 ± 191 Da, see section B of this chapter, § II.2.1). The MW 
values of the OSA-HA derivatives were higher than that of HA20 and increased with 
increasing the DS of OSA-HA. However, the MW values of OSA-HA18 and OSA-
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HA44 were far much larger than expected. This suggested that OSA-HA18 and OSA-
HA44 were aggregated and that the MALLS measurements were not performed in the 
dilute regime of these polymers. However, due to the low intensity of light scattered by 
lower polymer concentrations, it was not possible to acquire further measurements (see 
below). 
Rrms increased as a function of DS except for OSA-HA44 and A2 was relatively 
constant except for OSA-HA6. The negativity of A2 meant that PBS was a poor 
solvent for both HA20 and the OSA-HA derivatives. In general, these results were in 
disagreement with our predictions and with the known good affinity between HA and 
aqueous solvents. 
 
The inconsistency observed between the expected and experimental results 
most likely arose from the technical difficulties encountered when performing the 
MALLS experiments. These difficulties were related to both the nature of the 
derivatives and to experimental limitations. 
It is noteworthy that the OSA-HA concentration window in which light scattering 
measurements were possible was very narrow and varied with the DS of the OSA-HA 
derivatives. The light scattering signal (voltage) was characterised for each OSA-HA 
sample by three phases from the injection of the most diluted solution (0.001 g/L) to 
the most concentrated solution (1 g/L): 
(i) for each sample, up to a certain OSA-HA concentration which was dependent on 
the DS of the derivative, no light scattering different from that of the control (PBS) 
was observed, 
(ii) then, an increasing value of the voltage was detected with increasing the OSA-HA 
concentration (narrow concentration window), 
(iii) finally, high voltage values above the detection limit of the equipment were 
observed for more concentrated OSA-HA solutions. 
The first phase was due to the dilution of the solutions injected which was too high for 
the objects present in solution to scatter enough detectable light. In the second phase, 
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the presence of a sufficient amount of objects yielded a measurable signal which 
intensity was a continuous and increasing function of the OSA-HA concentration. The 
third phase was related to an important transition occurring in concentrated OSA-HA 
solutions, most likely the creation of macromolecular OSA-HA structures scattering 
large amounts of light which saturated the MALLS detectors. 
As a consequence, light scattering measurements were performed in the second phase 
of each sample. The concentration window of this second phase was dependent on the 
DS of the OSA-HA derivatives: the higher the DS, the less concentrated the OSA-HA 
solutions at which measurements were possible. This was due to the fact the higher the 
DS, the lower the concentration range at which the transition occurred. Accordingly, 
measurements were recorded from 0.005 to 0.008 g/L for OSA-HA44, 0.01 to 0.04 g/L 
for OSA-HA18 and 0.05 to 0.08 g/L for OSA-HA6. 
However, in the optimal concentration windows, the voltage intensity was quite low 
(< 4 V) due to the low molecular weight of the OSA-HA derivatives. Moreover, the 
difference in intensity between the voltage plateaus corresponding to the various 
concentrations tested was equally small. 
Finally, by-passing the fractionation column resulted in a rather unstable signal due to 
the polydispersity of the OSA-HA MW fractions present in each sample and it was 
difficult to obtain a stable signal. 
All the above-mentioned aspects, which are also illustrated Figure III.C.4, affected the 
quality of the raw data used to determine the MW, Rrms and A2 of the OSA-HA 
derivatives and it is likely that the experimental error was important. 
 
Obviously, the conditions in which the MW and conformation study were 
performed were not optimal and it was not possible to draw conclusions with respect to 
the MW degradation during the preparation of OSA-HA and the solution properties of 
OSA-HA in the dilute regime since the measurements were not performed in the same 
conditions of concentration. 
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Figure III.C.4: Illustration of the experimental difficulties encountered when 
performing MALLS. 
The computer interface is sketched for a given OSA-HA sample and MALLS detector. 
 
However, a positive outcome was that the concentration ranges at which the sharp 
increases in the intensity of light scattered occurred were consistent with the values of 
critical aggregation concentration later found for the OSA-HA derivatives (see 
Chapter IV, § III.1). 
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IV. Conclusion 
 
The substitution pattern, molecular weight and conformation in aqueous 
media of octenyl succinic anhydride-modified hyaluronic acid were investigated by 
HPLC, MALDI-TOF-MS, NMR and MALLS. 
Although these studies were not not performed under optimal conditions due to 
experimental difficulties related to the purification and/or intrinsic nature of the 
samples, the results suggested that the substitution pattern of OSA-HA was most likely 
(i) random at the molecular level, i.e. all HA hydroxyl groups were potential targets for 
the grafting of OSA, and (ii) heterogeneous at the macromolecular level due to the 
biphasic nature of the reaction between HA and OSA. It was also shown that OSA-HA 
underwent a major conformation change in aqueous media at a concentration which 
was dependent on its degree of substitution. However, it was not possible to 
unequivocally evidence the presumed randomness of the grafting of OSA at the 
molecular level or determine the MW, monomolecular size and affinity for the solvent 
of the OSA-HA derivatives. 
 
In order to improve the conditions for the determination of the substitution 
pattern of OSA-HA at the molecular level, it would be advisable to perform the 
structural study on a unique oligosaccharide length, for example on OSA-modified 
tetrasaccharides in order to avoid resonance broadening. This supposes separating the 
HA oligosaccharides using a preparative technique such as high performance anion-
exchange chromatography (HPAEC) [13]. A higher degree of modification and 
separation of the unmodified HA oligosaccharides from the product would improve the 
proportion of neighbouring protons to the octenyl succinate grafts and thus the 
detection of chemical shift differences. Finally, the performance of edited H2BC 
experiments could allow determining the shifts of methylene protons H-6 and H-6’ on 
the glucuronate moieties. This would bring additional valuable information. 
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As for the MW and conformation study by MALLS, a higher MW of the 
OSA-HA derivatives would increase the intensity of light scattered and the voltage 
span between consecutive dilutions. It could also be advantageous to precisely 
determine the boundaries of the polymers’ dilute regimes, for example using intrinsic 
viscosity measurements in order to work under the critical overlap concentration 
(provided that the latter can be evidenced), i.e. when monomolecular coils occur in 
solution. 
Ideally, one should perform experiments on a range of OSA-HA derivatives with 
different MW values but the same DS and derivatives with the same MW but different 
DS values and apply the MHKS relationship in order to determine the monomolecular 
shape of the OSA-HA derivatives [12]. In this way, more reliable information about 
the conformation of the OSA-HA derivatives could be obtained. 
 
The major conformation change of the OSA-HA derivatives suspected during 
the MALLS experiments (see above) and the physicochemical properties of the 
derivatives were subsequently studied. This work is reported in the following chapter. 
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Abstract 
The physicochemical properties of water soluble amphiphilic octenyl succinic 
anhydride-modified hyaluronic acid (OSA-HA) were evaluated in aqueous media. The 
self-associative properties of OSA-HA were studied by fluorescence spectroscopy 
using Nile Red as fluorophore. The morphology, size and surface charge of the OSA-
HA assemblies were determined by transmission electron microscopy, dynamic light 
scattering and by means of measuring their electrophoretic mobility, respectively. 
OSA-HA was shown to self-associate in aqueous media into negatively charged multi-
phasic spherical nanostructures with a hydrodynamic diameter between 170 and 
230 nm and to solubilise hydrophobic compounds such as Nile Red. This is a good 
indication that OSA-HA could be used as building blocks for the formulation of soft 
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nanocarriers towards the encapsulation and controlled delivery of hydrophobic active 
ingredients or drugs. 
 
Keywords amphiphilic hyaluronic acid derivative, octenyl succinic anhydride, self-
associative polysaccharide, critical aggregation concentration, polymeric micelle, 
colloidal size distribution 
 
 
I. Introduction 
 
Hyaluronic acid (HA) is a natural linear polysaccharide consisting of D-
glucuronic acid and N-acetyl-D-glucosamine linked through -1,3 glycosidic bonds 
while consecutive disaccharide units are linked through -1,4 glycosidic bonds [1] 
(Figure IV.1). 
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Figure IV.1: Molecular structure of the HA repeating unit. 
 
HA is found in all mammalian tissues and is particularly abundant in the vitreous 
humor of the eye, the synovial fluid and the skin [2]. 
 
Due to its biocompatibility and resorbability, HA constitutes an interesting 
building block for applications in drug delivery [3]. However, the development of HA 
carriers is impeded by the high hydrophilicity and the poor biomechanical properties of 
the native molecule [4]. A variety of chemical modifications have been devised to 
provide HA with new improved physicochemical properties [4]. In particular, the 
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introduction of alkyl chains onto the HA backbone has shown that the resulting HA 
derivatives exhibit significantly different physicochemical properties compared to the 
native polymer and that new associative systems can be created [5,6]. 
 
We previously developed a novel, simple and easily upscalable modification 
method for the preparation of amphiphilic HA derivatives based on the reaction 
between HA and octenyl succinic anhydride (OSA) in aqueous mild alkaline media 
[7]. 
 
The objective of this study was to evaluate the physicochemical properties of 
a selection of OSA-HA derivatives. This investigation was conducted in the 
perspective of using these derivatives to formulate nanocarriers towards the 
encapsulation and controlled delivery of hydrophobic active ingredients or drugs. 
 
II. Materials and methods 
 
II.1. Materials 
 
The OSA-HA derivatives with a degree of substitution (DS) of 6, 18 and 44 % (OSA-
HA6, OSA-HA18 and OSA-HA44) were prepared as described in Chapter III, B. 
Sodium chloride (NaCl), potassium chloride (KCl), disodium hydrogen phosphate 
(Na2HPO4), potassium dihydrogen phosphate (KH2PO4), tetrahydrofurane (THF), 
acetone, Nile Red and uranyl acetate were used as purchased without further 
purification. The water used for sample preparation or analysis was distilled and 
purified to a resistivity of 18.2 M.cm in a milli-Q apparatus. The physicochemical 
properties of the OSA-HA derivatives were investigated in a phosphate buffer saline 
(PBS, pH = 7.4) which was prepared as followed: NaCl (8.0 g), KCl (0.2 g), Na2HPO4 
(1.4 g) and KH2PO4 (0.2 g) were first dissolved in milli-Q water (1 L) for 1 hour, at 
room temperature. The pH of the resulting mixture was then measured and, if 
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necessary, adjusted to 7.4 with HCl (0.2 M) or NaOH (0.2 M). The resulting buffer 
was finally filtered through glass microfiber filters (GF/F 1825 110, porosity 0.7 μm; 
Whatman, Maidstone, United Kingdom). The uranyl acetate solution used to stain the 
OSA-HA polymeric micelles was a distilled water/saturated uranyl acetate mixture 
(60:40 v/v). 
 
II.2. Methods 
 
II.2.1. Critical aggregation concentration of the OSA-HA derivatives 
 
The critical aggregation concentration (CAC) of the OSA-HA derivatives was 
determined in PBS (pH = 7.4) at 25 °C by fluorescence spectroscopy (FluoroMax; 
HORIBA Jobin Yvon Inc, Edison, New Jersey, United States) using Nile Red as 
fluorophore. OSA-HA was dissolved in PBS at the following concentrations: 0.001, 
0.002, 0.004, 0.006, 0.008, 0.01, 0.02, 0.04, 0.06, 0.08, 0.1, 0.2, 0.4, 0.6, 0.8 and 1 g/L. 
The 0.2, 0.4, 0.6 and 0.8-g/L OSA-HA solutions were prepared from the 1-g/L OSA-
HA solution by mixing 2, 4, 6 and 8 g of the latter into 8, 6, 4 and 2 g of PBS. Each of 
the remaining OSA-HA solutions was prepared from the 10-fold more concentrated 
OSA-HA solution by mixing 1 g of the solution into 9 g of PBS. Nile Red (3.184 mg) 
was dissolved in a THF/acetone mixture (50:50 v/v, 10 mL). A fraction of the resulting 
solution (0.01 mL) was added to each OSA-HA sample (10 mL) so that the final 
concentration of Nile Red in each sample was 1 μmol/L. The OSA-HA samples were 
stirred overnight, at room temperature and in the dark. Cuvettes were rinsed prior to 
use with 0.5 mL of the sample to be tested. Nile Red was excited at 543 nm and 
emission spectra were recorded from 580 to 700 nm. Three consecutive fluorescence 
spectra per sample were recorded. The emission spectra were fitted with a polynomial 
function (order 6) to determine the wavelength corresponding to the maximum 
intensity of the fluorescence emission. The averaged wavelengths were plotted as a 
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function of the OSA-HA concentration and the CAC was derived at the abscissa of the 
inflexion point of the plot. 
 
II.2.2. Morphology of the OSA-HA polymeric micelles 
 
The morphology of the OSA-HA polymeric micelles was studied in PBS (pH = 7.4), at 
room temperature, by transmission electron microscopy (TEM, EM 410; Philips 
Electronic Instruments, Eindhoven, The Netherlands) using ionized carbon-coated 
copper grids and a uranyl acetate negative staining. OSA-HA (10 mg) was dissolved in 
PBS (10 mL) at room temperature, overnight. The carbon-coated copper grids were 
ionized for 20 s, under a pressure of 0.3 Torr and a voltage of 400 V and then 
deposited onto a 30-μL drop of the OSA-HA micellar solution for 30 s. Excess of the 
solution was drained from the grid which was then deposited onto a first 100-μL drop 
of uranyl acetate solution for a few seconds and immediately after onto a second    
100-μL drop of uranyl acetate for 30 s. Excess of the solution was drained and the grid 
was dried prior to observation. Three grids per OSA-HA micellar solution were 
prepared and a minimum of four micrographs per grid were acquired at an accelerating 
voltage of 60 kV. 
 
II.2.3. Size distribution of the OSA-HA polymeric micelles 
 
The size distribution of the OSA-HA polymeric micelles was determined by extracting 
micelle diameters on TEM micrographs. The diameters of more than 600 micelles 
were individually and manually measured using the software ImageJ (United States 
National Institutes of Health, Bethesda, Massachusetts, United States). The size 
distribution obtained was fitted with the Schulz [8] and log-normal [9] distributions. 
The hydrodynamic diameter of the OSA-HA polymeric micelles was determined in 
PBS (pH = 7.4), at room temperature, by dynamic light scattering (DLS, ALV-CGS-8, 
equipped with eight-fibre optic detectors and a 532 nm solid-state laser as light source, 
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ALV, Langen, Germany). OSA-HA (10 mg) was first dissolved in PBS (10 mL), at 
room temperature, overnight. The resulting solution was then filtered to remove dust 
particles. Four consecutive measurements of the diffusion coefficient per scattering 
angle were recorded from 20 to 120 degrees. 
The hydrodynamic diameter of the OSA-HA polymeric micelles was also simulated, 
based on the size distribution obtained by TEM, by applying the Rayleigh-Gans-Debye 
(RGD) theory of dynamic light scattering [10] which most relevant relationship is 
presented in Equation IV.1. 
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	                                                                              Equation IV.1 
In Equation IV.1, dH, , di, and fi represent the average hydrodynamic diameter of the 
micelles (nm), the scattering angle (degrees), the diameter of the micelle class i (nm) 
and the probability density of the micelle class i (nm-1), respectively. P is a function 
defined in Equation IV.2 and the relationship between the modulus of the scattering 
vector q (nm-1) and the scattering angle  is presented in Equation IV.3. 
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nq                                                                                                  Equation IV.3 
In Equation IV.3, n and  represent the refractive index of the dispersion medium and 
the wavelength of light in vacuum (nm), respectively. 
The diameter values of the micelle classes on the size distribution obtained by TEM 
were adjusted so as to take into account micelle swelling. Micelle swelling was 
characterised by means of a swelling coefficient  which was defined as the ratio 
between the volume of water and the volume of OSA-HA making up the fully 
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hydrated micelles. The diameter values of the micelle classes on the size distribution 
obtained by TEM were accordingly multiplied by the constant 3 1 . 
 
II.2.4. Zeta potential of the OSA-HA polymeric micelles 
 
The zeta potential of the OSA-HA polymeric micelles (1 g/L) was determined in a 
diluted NaCl solution (0.001 mol/L), at 25 °C, by means of measuring their 
electrophoretic mobility (Zetasizer 3000 HS, Malvern, Worcestershire, United 
Kingdom). Three consecutive measurements of the zeta potential were recorded per 
OSA-HA micellar solution. 
 
III. Results and discussion 
 
III.1. Critical aggregation concentration of the OSA-HA derivatives 
 
The introduction of OSA chains onto HA is expected to alter the 
physicochemical properties of the native HA and in particular the intra- and 
intermacromolecular interactions between the HA chains. 
The CAC of OSA-HA was determined in PBS (pH = 7.4) at 25 °C by fluorescence 
spectroscopy using Nile Red as fluorophore. 
 
The fluorescence of Nile Red and more specifically its maximum 
fluorescence emission wavelength is dependent on the polarity of its surrounding 
environment. This wavelength is lower in non-polar environments than in polar 
environments [11]. Due to this intrinsic property, Nile Red can be used to determine 
the CAC of associative amphiphilic polymers in aqueous media. Indeed, this physical 
transition typically involves the formation of segregated non-polar colloidal domains 
where Nile Red can readily be incorporated. 
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Nile Red was dissolved in a range of OSA-HA PBS-buffered solutions with 
increasing OSA-HA concentration from 0.001 to 1 g/L. The PBS was used to buffer 
both ionic strength and acidity variations among the different OSA-HA samples. The 
maximum fluorescence emission wavelength of Nile Red was followed as a function 
of the OSA-HA concentration for OSA-HA derivatives with a DS of 6, 18 and 44 % 
(Figure IV.2). 
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Figure IV.2: Maximum fluorescence emission wavelength of Nile Red as a function of 
the OSA-HA concentration. 
 
On Figure IV.2, the maximum fluorescence emission wavelength of Nile Red suddenly 
decreases from about 650 to 610 nm when the OSA-HA concentration increases. 
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This abrupt wavelength change indicates that the immediate environment of the dye 
changes from polar to less polar owing to the interactions between Nile Red and the 
octenyl succinate (OS) chains upon formation of OSA-HA polymeric micelles. 
Furthermore, the concentration at which this rapid transition is observed depends on 
the DS of the OSA-HA derivative. A plot of the CAC as a function of the DS of the 
OSA-HA derivatives indicated that the CAC linearly decreased with increasing DS 
(Figure IV.3). 
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Figure IV.3: Critical aggregation concentration as a function of the degree of 
substitution of OSA-HA. CAC = -0.0022DS + 0.1104; R2 = 0.99. 
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Indeed, the increased attraction between the OS chains at high DS resulted in the 
formation of OSA-HA polymeric micelles at lower concentrations. 
Interestingly, the trend observed between the CAC and the DS of the OSA-HA 
derivatives validated the determination of DS by proton nuclear magnetic resonance 
spectroscopy in Chapter III, B. 
 
The polymer concentration values corresponding to the formation of 
hydrophobic domains found in the present work (0.015-0.1 g/L) were of the same 
order of magnitude than those previously reported for alkylated HA derivatives. For 
instance, Pelletier et al. [5] have shown using fluorescence spectroscopy and pyrene as 
probe that 480,000-Da HA modified with alkyl chains containing 12 carbon atoms 
(C12, DS = 5 %) and 18 carbon atoms (C18, DS = 2 %) self-associated and formed 
hydrophobic domains in which pyrene was solubilised at polymer concentrations of 
0.05 g/L (HA-C12) and 0.01 g/L (HA-C18). Likewise Creuzet et al. [6] have shown 
using a similar experimental procedure that 300,000-Da HA modified with alkyl 
chains containing 10 carbon atoms (C10, DS = 5 %) and 12 carbon atoms (C12, 
DS = 4 %) rearranged into polymeric aggregates at polymer concentrations between 
0.01 and 0.1 g/L. Although a direct comparison between these results and those of the 
present study is made difficult by the differences in HA molecular weight (MW), 
modification chemistry, nature of the hydrophobic pendant groups and DS, the order of 
magnitude of the OSA-HA concentrations at which self-association occurred indicates 
a relatively good consistency with the literature. 
 
In summary, OSA-HA was demonstrated to self-associate in aqueous media 
and solubilise Nile Red above a CAC which was dependent on the DS of the OSA-HA 
derivative. Micellisation of OSA-HA is therefore a controllable property through the 
DS of the OSA-HA derivative and can be predicted for derivatives with DS between 6 
and 44 %. 
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Due to its higher hydrophobic character, OSA-HA44 was chosen as a model 
compound for the detailed study of the morphology, size distribution, surface charge 
and molecular structure of the polymeric micelles. 
 
III.2. Morphology of the OSA-HA polymeric micelles 
 
The morphology of the OSA-HA polymeric micelles was studied in PBS 
(pH = 7.4), at room temperature, by transmission electron microscopy using a uranyl 
acetate negative staining (Figure IV.4). 
 
500 nm
500 nm
 
Figure IV.4: Selected TEM micrographs of the OSA-HA polymeric micelles. 
 
The micrograph on the left of Figure IV.4 shows that the OSA-HA polymeric micelles 
are relatively polydisperse spherical assemblies with a diameter between 10 and 
120 nm. The difference in size between the micelles was most likely due to the 
difference in the number of OSA-HA molecules involved in the micelles and to the 
potential non-homogenous DS of OSA-HA44 (see Chapter III, C, § III.1.2). 
The set of four micrographs on the right of Figure IV.4 shows that the micelle structure 
is non-homogenous which suggests that the micelles are composed of distinct colloidal 
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domains which could consist of segregated non-polar poaches embedded into a polar 
polymeric matrix (also see § III.5. and Figure IV.9). 
 
III.3. Size distribution of the OSA-HA polymeric micelles 
 
In order to determine the size distribution of the OSA-HA polymeric micelles 
more precisely, a statistical analysis of the micelle diameters on TEM micrographs was 
conducted in parallel to dynamic light scattering measurements. 
Microscopy and light scattering (LS) can both give information about the size of 
colloids, although in a different manner, as they are based on different physical 
principles. 
When studied by microscopy, the size of the colloids is directly obtained. However, 
the sample preparation can alter the properties of the colloids and therefore the size 
observed. 
When studied by LS, the size of the colloids is indirectly obtained as it is derived from 
colloidal diffusion in solution by means of the Stokes-Einstein equation. However, no 
sample preparation other than suspending the colloids in solution is required and the 
colloids are analysed as they truly occur in solution. 
Given these principles, microscopy and LS were used in combination to obtain 
statistical and reliable information about the size of the OSA-HA polymeric micelles. 
 
The size distribution of the OSA-HA polymeric micelles obtained by 
statistically extracting micelle diameters from TEM micrographs with the software 
ImageJ is presented in Figure IV.5. The size distribution showed that the OSA-HA 
polymeric micelles were polydisperse objects with an arithmetic average micelle 
diameter of 26 nm (standard deviation = 15 nm) and a mean diameter between 10 and 
20 nm. 
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Figure IV.5: Number-weighed size distribution of the OSA-HA polymeric micelles 
based on micelle diameter extraction from TEM micrographs. 
 
The cumulative size distribution of the OSA-HA polymeric micelles 
(Figure IV.6) revealed that 80 % of the micelles had a diameter below 25 nm. It was 
fitted with the Schulz and log-normal models [8,9]. The best fits were obtained with 
the following parameters: 	 = 4.82 and  = 16.02 for the Schulz and 	 = 0.43 and 
 = 2.71 for the log-normal fit. The experimental data were well fitted up to a 
cumulative frequence of 0.80. However both models failed to represent the 
contribution of the larger micelle population due to the relatively high polydispersity 
of the micelles (see Figure IV.5). 
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Figure IV.6: Number-weighed cumulative size distribution of the OSA-HA polymeric 
micelles based on micelle diameter extraction from TEM micrographs. 
 
The hydrodynamic diameter of the OSA-HA polymeric micelles was 
determined in PBS (pH = 7.4), at room temperature, by DLS and was simulated from 
the micelle size distribution obtained by TEM. Figure IV.7 presents the variation of the 
hydrodynamic diameter as a function of the scattering angle as measured by DLS and 
as simulated from the micelle size distribution obtained by TEM for two different 
values of the swelling coefficient  ( = 0 for dehydrated micelles and  = 12 for 
hydrated micelles). 
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Figure IV.7: Experimental and simulated hydrodynamic diameter of the OSA-HA 
polymeric micelles as a function of the scattering angle. 
 
The values of the hydrodynamic diameter measured by DLS were 
considerably higher than those simulated from the crude microscopy data, i.e. when 
 = 0. Indeed, the OSA-HA polymeric micelles were hydrated during the DLS 
analysis, whereas they had lost their water content before the TEM analysis. Taking 
into account micelle hydration in the simulation ( = 12), a better fit between the 
values of the hydrodynamic diameter obtained by DLS and those obtained by TEM 
was observed over most of the scattering angles. This indicated that the micelles 
analysed by DLS contained a volume of water of up to 12 times larger than the volume 
of OSA-HA making up the fully hydrated micelles. 
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The swelling coefficient found in this study was of the same order of 
magnitude as previously reported values of the swelling ratio in chemically cross-
linked HA hydrogels. 
Srinivas and Ramamurthi [12] have namely reported that the swelling ratio of HA 
hydrogels obtained by cross-linking with divinyl sulfone (DVS) (HA/DVS weight 
ratio = 3) could reach values up to 7. In this study, the swelling ratio was defined as the 
ratio of the difference between the weight of the swollen and the dried gel and the 
weight of the dried gel when the latter was obtained by freeze-drying. Since TEM 
micrographs are acquired under vacuum, this degree of dehydration of the hydrogel is 
comparable to that of the OSA-HA polymeric micelles observed by TEM. It could be 
demonstrated that the definition of the swelling ratio by Srinivas and Ramamurthi is 
equivalent to that of the present study if the density of OSA-HA is close to 1.0. 
Therefore the value of the swelling coefficient found in this study (12) can directly be 
compared to that found by Srinivas and Ramamurthi (7). 
Similarly, Smeds et al. [13] observed that HA hydrogels obtained by photocross-
linking of methacrylated HA could swell up to 11 times their dry weight when the 
dried gels were obtained by freeze drying. This swelling ability was dependent on the 
degree of cross-linking (DS between 3 and 17 %). The gels with the highest degree of 
cross-linking had the least ability to swell due to their tight polymeric networks. In this 
study, the swelling coefficient was defined as the ratio of the weight of the swollen gel 
and that of the dried gel. It could be shown that the relationship between this swelling 
ratio A and the swelling ratio  defined in the present study is  = A – 1 if the density 
of OSA-HA is close to 1.0. In other words, the value of the swelling coefficient found 
in the present study (12) is to be compared with an adjusted value of 10 [13]. 
 
Interestingly, the OSA-HA polymeric micelles exhibited comparable swelling 
properties as chemically cross-linking HA but with the difference that they were not 
stabilised by chemical cross-linking but by hydrophobic interactions. Therefore they 
can be regarded as physically cross-linked nanogels. 
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The fairly large deviation of the hydrodynamic diameter measured by DLS 
from that simulated by microscopy (with  = 12) at low scattering angles indicated that 
a few structures with dimensions superior to the detection range of the DLS instrument 
were present in solution. These few structures could be micelle aggregates although 
micelle aggregation could not clearly be identified on the TEM micrographs. 
 
In summary, the data provided by the microscopy and DLS analysis showed 
that the OSA-HA polymeric micelles were highly hydrated structures in solution with 
a mean hydrodynamic diameter falling between 170 and 230 nm. 
 
III.4. Zeta potential of the OSA-HA polymeric micelles 
 
The zeta potential of the OSA-HA polymeric micelles was determined in PBS 
(pH = 7.4), at 25 °C, by means of measuring their electrophoretic mobility. The results 
showed that the surface of the OSA-HA polymeric micelles was negatively charged 
with a zeta potential of approximately -28 mV under the applied conditions (pH ~ 3.0-
4.0, Figure IV.8). This negative charge was due to the presence of carboxylate groups 
on OSA-HA, arising from both the native HA backbone and the hemiesters generated 
during the reaction between HA and OSA. 
 
III.5. Molecular structure of the OSA-HA polymeric micelles 
 
Chen et al. [14] have described the structure of polymeric micelles based on 
hydrophobically modified HA with 2300 Da poly(caprolactone) chains as a spherical 
HA hydrophilic corona surrounding a poly(caprolactone) hydrophobic core. Given the 
relatively short length of the OS chains, the aggregation of OSA-HA is unlikely to 
occur in this fashion. 
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Figure IV.8: Zeta potential of the OSA-HA polymeric micelles. 
 
Substituted disaccharide units on OSA-HA were assumed to behave like 
monomeric surfactant moieties capable of self-associating into conventional spherical 
monomeric micellar domains. OSA-HA polymeric micelles were therefore believed to 
consist of a dispersion of hydrophobic domains formed by the modified HA units in a 
hydrophilic matrix structured by the remaining unmodified HA units (Figure IV.9). In 
this multi-vesicular model, the OS chains involved in the hydrophobic domains 
potentially can originate from the same or different OSA-HA molecules and the 
micelle structure is believed to be stabilized by a combination of hydrophobic 
interactions between the OS chains and the three fundamental HA structures in 
solution discussed in Chapter I. 
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Figure IV.9: Putative representation of the structure of the OSA-HA polymeric 
micelles. 
 
The number of substituted HA units per hydrophobic domains, of 
hydrophobic domains per micelle and the average distance between vicinal 
hydrophobic domains were calculated for the most occurring micelle, i.e. a micelle 
with a radius of approximately 8 nm in the dehydrated state (cf. Figure IV.5) or 19 nm 
in the hydrated state. The dimensions of the modified disaccharide unit used in the 
calculations were the following: the length and width of the disaccharide unit were 
approximated to 1 and 0.5 nm, respectively [15]. The length of the OS chains was 
approximated to 1 nm as it consists of about 10 carbon-to-carbon bonds. It should be 
noted that the influence of the geometric isomerism of the OS chains (cis/trans) on the 
packing of the hydrophobic domains was disregarded as the distribution of the cis and 
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trans OS moieties on HA is unknown. In the following calculations, the densities of 
HA and OSA-HA were considered to be close to 106 g/m3. 
 
The number of OSA-HA units per hydrophobic domain was calculated by 
dividing the volume of one hydrophobic domain by the volume of one OSA-HA unit. 
The volume of one OSA-HA unit can further be decomposed as the sum of the volume 
of one HA unit and the volume of the cone deployed by one OS chain. Substitution 
with more elementary physical quantities led to Equation IV.4: 
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                     Equation IV.4 
where N(OSA-HAu)/domain, w(HAu), l(OS), MW(HAu), (HA), NA and l(HAu) 
represent the number of OSA-HA units per hydrophobic domain, the width of the HA 
unit, the length of the OS chain, the molecular weight of the HA unit, the density of 
HA, the Avogadro number and the length of the HA unit, respectively. 
 
The number of hydrophobic domains per micelle was calculated by dividing 
the number of OSA-HA units per micelle by the number of OSA-HA units per 
hydrophobic domain. The number of OSA-HA units per micelle corresponds to the 
number of OSA-HA molecules per micelle multiplied by the number of OSA-HA units 
per OSA-HA molecule. This number is related to the DS of OSA-HA. The number of 
OSA-HA molecules per micelle can further be calculated by dividing the volume of 
one micelle by the volume of one OSA-HA molecule. Subsequent substitutions and 
rearrangements led to Equation IV.5: 
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                               Equation IV.5 
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where N(domains)/micelle, R(micelle), (OSA-HA), NA, MW(HAu), DS, MW(OSA) 
and N(OSA-HAu)/domain stand for the number of hydrophobic domains per micelle, 
the average radius of the most occurring micelle, the density of OSA-HA, the 
Avogadro number, the molecular weight of the HA unit, the degree of substitution of 
OSA-HA, the molecular weight of OSA and the number of OSA-HA unit per 
hydrophobic domain, respectively. 
 
Finally, the distance between vicinal hydrophobic domains was calculated by 
applying the relation shown in Equation IV.6. 
 
3
1).(
domainC
domainsbetweenl                                                                 Equation IV.6 
In Equation IV.6, l(between.domains) and C(domain) correspond to the distance 
between vicinal hydrophobic domains and concentration of hydrophobic domains 
inside the micelle, respectively. The latter can be expressed as the ratio between the 
number of hydrophobic domains per micelle and the volume of the hydrated micelle 
(Equation IV.7). 
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                                             Equation IV.7 
In Equation IV.7, l(between.domains), , R(micelle) and N(domains)/micelle represent 
the distance between vicinal hydrophobic domains, the swelling coefficient, the radius 
of the most occurring micelle and the number of hydrophobic domains per micelle, 
respectively. 
 
According to our calculations, the most occurring OSA-HA micelle consisted 
of about 72 hydrophobic domains separated by a distance of 6-9 nm, with a diameter 
of 3 nm, each involving 16 OSA-HA units. Although approximate, this model is 
believed to provide a rough but realistic picture of the internal structure of the micelles. 
201
Development of soft nanocarriers from novel amphiphilic hyaluronic acid 
derivatives towards drug delivery 
Chapter IV 
Physicochemical characterisation of amphiphilic hyaluronic acid derivatives 
 
 
176 
IV. Conclusion 
 
The physicochemical properties of water soluble amphiphilic octenyl succinic 
anhydride-modified hyaluronic acid were investigated in aqueous media. OSA-HA 
was shown to self-associate and solubilise Nile Red into the hydrophobic domains 
formed by the OS chains above a critical aggregation concentration which was 
dependent on the degree of substitution of the derivatives. The CAC of OSA-HA was a 
linear decreasing function of the derivatives’ DS between 6 and 44 % per disaccharide 
unit and can be predicted for OSA-HA derivatives with a DS in this range. 
 
The OSA-HA polymeric micelles were negatively charged polydisperse 
spherical physically cross-linked nanogels characterised by a high degree of hydration 
(typically 12 g of water per g of polymer) and a hydrodynamic diameter between 170 
and 230 nm. 
The molecular structure of the OSA-HA polymeric micelles is most probably a 
distribution of OS-rich hydrophobic monomeric micellar nanodomains into a HA-rich 
hydrophilic polymeric matrix. 
 
The nanoengineered structures of the OSA-HA polymeric nanogels constitute 
biocompatible and resorbable multi-functional systems which could be used to 
solubilise and carry poorly soluble active ingredients in aqueous media. It is believed 
that the presence of multiple hydrophobic nanodomains in the nanogels could be useful 
for the controlled release of hydrophobic active ingredients or drugs. 
The formulation of stabilised OSA-HA nanoparticles insensitive to dilution and study 
of the release of model hydrophobic substances in vitro and in vivo will be the subject 
of future investigations. 
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I. Summary 
 
This project was initiated in the perspective of providing biocompatible and 
resorbable nanocarriers based on hyaluronic acid (HA) towards drug delivery and in 
particular dermal drug delivery (see Chapter I). 
A literature review (see Chapter II) about polymeric nanoparticle-mediated 
(trans)dermal drug delivery reaffirmed the high potential of using the skin as an 
administration route and identified new approaches to better understand the fate of 
particulate systems in this tissue. It also took inventory of the current hypothesis with 
regards to how polymeric nanoparticles can enhance drug uptake and/or sustain drug 
release and spotted the challenges faced by this branch of research. Interestingly, the 
studies reported mostly concern synthetic polymeric nanoparticles which by nature 
are not truly biocompatible. For this reason, systems based on the naturally occurring 
glycosaminoglycan hyaluronic acid were developed in this project. 
Whereas most of the currently available methods for the preparation of HA 
nanoparticles rely on random collisions in the medium to create structures, a novel 
molecular technique was here developed which relies on the controlled self-assembly 
of amphiphilic HA leading to multiphasic nanoarchitectured HA templates. 
Such properties of HA were obtained by modifying the biopolymer’s 
hydrophilic/lipophilic balance via the covalent grafting of hydrophobic groups onto 
the HA backbone. After a preliminary evaluation of two novel proprietary methods to 
hydrophobically modify HA, octenyl succinic anhydride-modified HA (OSA-HA) 
was chosen as starting material for the preparation of the HA-based nanostructures 
(see Chapter III, A). Its preparation process was optimised so as to develop a 
reproducible and robust technique for the routine laboratory production of OSA-HA. 
With the reaction conditions tested, HA derivatives with a maximum degree of 
substitution (DS) of 44 % per disaccharide unit according to proton nuclear magnetic 
resonance spectroscopy were prepared (see Chapter III, B). 
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Although it was not possible to precisely determine the substitution pattern and 
measure the molecular weight and monomolecular size of the OSA-HA derivatives, 
there were some indications that the substitution pattern of OSA-HA was most likely 
random at the molecular level and heterogeneous at the macromolecular level and 
that OSA-HA undergoes a major conformation change in aqueous media at a 
concentration which is dependent on its degree of substitution (see Chapter III, C). 
The self-assembly in aqueous media of OSA-HA was due to hydrophobic 
interactions between the grafted octenyl succinate (OS) chains on HA and was 
controlled by the DS of the derivatives. The critical aggregation concentration (CAC) 
of OSA-HA was indeed all the more low that its DS was high. Self-assembling of 
OSA-HA was therefore a controllable and predictable property for derivatives with a 
DS up to 44 %. In addition, it was demonstrated that OSA-HA could solubilise the 
model hydrophobic compound Nile Red. Above the CAC, the OSA-HA assemblies 
were rather polydisperse spherical and negatively charged polymeric micelles with a 
hydrodynamic diameter between 170 and 230 nm. They were characterised by a high 
degree of hydration (on averaged 12 g of water per g of polymer). This suggested that 
the fundamental mechanism of their stabilisation was a physical cross-linking 
mediated by the hydrophobic interactions between the grafted OS chains. The 
internal structure of the OSA-HA nanogels was believed to consist of a dispersion of 
hydrophobic monomeric micellar domains formed by the OS chains embedded in a 
hydrophilic polymeric matrix composed of the unmodified HA segments (see 
Chapter IV). 
 
The development of OSA-HA nanogels described herein is believed to 
constitute a valuable first step towards formulating HA-based nanoparticles with 
more complex configurations than single ingredient or core-shell structures. In 
particular, the presence of multiple vesicle-like substructures inside the nanogels 
could be an interesting feature for sustaining drug delivery as these could delay drug 
release in biological environments. 
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Moreover, it should be emphasised that the methods underlying the OSA-HA 
nanogels are simple, aqueous and easily upscalable thus potentially valuable for the 
industry. The modification with OSA preserves and even increases the distribution of 
negative charges along the modified polymer at neutral pH which could constitutes 
an advantageous property for the electrostatic stabilisation of future nanoparticles 
from OSA-HA. 
 
II. Future work 
 
As for now, the OSA-HA nanogels only exist above their CAC. This sets the 
lower limit of their concentration when incorporated into formulations. In addition, it 
is unlikely that they maintain their shape when administered and/or exhibit higher in 
vivo residence times compared to native HA unless they are stabilised. The next main 
challenge therefore concerns the preparation of stable OSA-HA nanoparticles. 
 
For an application such as dermal drug delivery, it could be necessary to 
reduce the size of the OSA-HA nanogels down to several tens of nanometres and 
better control their polydispersity (see Chapter II). 
 
 In the perspective of using the stabilised OSA-HA nanogels for concrete 
applications, it is foreseeable that future work will also involve biocompatibility tests 
and release studies in vitro and in vivo. Incorporation and stability in final 
formulations will also constitute an important challenge. 
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Educational activities 
 
I. Training 
 
I.1. Courses 
 
 Chemical and Biochemical Product Design, Technical University of Denmark, 
Lyngby, Denmark, autumn 2003 (10 ECTS). 
 
 Patents and patent search, Novozymes A/S, Bagsværd, Denmark, June 17, 2005 
(0.6 ECTS). 
 
 Design of experiment, Umetrics, Bagsværd, Denmark, September 1, 2005 
(2.2 ECTS). 
 
 Intensive course in dermato-cosmetic sciences, Faculty of Medicine and Pharmacy, 
Brussels, Belgium, September 12-16, 2005 (3.6 ECTS). 
 
 Polymeric surfactants, Institute for Surface Chemistry, Stockholm, Sweden, 
December 12-14, 2005 (3 ECTS). 
 
 Fundamentals of percutaneous penetration, pre-conference course of the 10th 
International Conference in Perspectives in Percutaneous Penetration, La Grande 
Motte, France, April 18, 2006 (0.6 ECTS). 
 
 Spectroscopy of organic compounds, Technical University of Denmark, Lyngby, 
Denmark, spring 2006 (5 ECTS). 
 
 Business course, Danish Ministry of Science, Technology and Innovation through 
mandated Copenhagen Business School and Haslund & Alsted, Pharmakon, Hillerød, 
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Denmark, October 16-17, 2006, February 12-13, 2007, September 11-12, 2007 
(5 ECTS). 
 
I.2. Conferences 
 
 Kick-off meeting Nano-DTU/Nano-Science Centre, Hørsholm, Denmark, March 2, 
2006. 
 
 6th European Workshop on Particulate Systems, Geneva, Switzerland, March 23-24, 
2006. 
 
 10th International Conference in Perspectives in Percutaneous Penetration, La 
Grande Motte, France, April 18-22, 2006. 
 
 Skin and Formulation 2nd Symposium, Versailles, France, October 8-10, 2006. 
 
 8th Annual Meeting of Skin Forum, London, United Kingdom, March 3-4, 2007. 
 
 7th International Conference on Hyaluronan, Charleston, South Carolina, United 
State, April 22-27, 2007. 
 
 21st Conference of the European Colloid and Interface Society, Geneva, 
Switzerland, September 10-14, 2007. 
 
I.3. External study trips 
 
The external study trips were carried out at the University of Geneva, University of 
Lausanne, School of Pharmaceutical Sciences, Department of Pharmaceutics and 
Biopharmaceutics, 30 quai Ernest-Ansermet, CH-1211 Geneva 4, Switzerland under 
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the supervision of Professor Robert Gurny and Associate Professor Florence Delie in 
the periods July 3-August 31, 2006 and March 12-June 29, 2007. 
 
II. Dissemination of knowledge 
 
II.1. Publications 
 
II.1.1. Posters 
 
 Eenschooten, C.; Guillaumie-Longin, F.; Kontogeorgis, G. M.; Schwach-
Abdellaoui, K. Synthesis and formulation of modified hyaluronic acid (HA) for 
cosmetic applications. Annual discussion meeting 2005 of the Centre for Phase 
Equilibria and Separation Processes, Roskilde, Denmark, May 25-27, 2005. 
 
 Eenschooten, C.; Guillaumie-Longin, F.; Gurny, R.; Kontogeorgis, G. M.; 
Schwach-Abdellaoui, K.; Stenby E. H. Development and formulation of hyaluronic 
acid-based nanoparticles for cosmetic applications. Kick-off meeting Nano-
DTU/Nano-Science Centre, Hørsholm, Denmark, March 2, 2006. 
 
 Eenschooten, C.; Delie, F.; Guillaumie-Longin, F.; Gurny, R.; Kontogeorgis, G. M.; 
Schwach-Abdellaoui, K.; Stenby, E. H. Development of colloidal carriers from 
modified hyaluronic acid. Skin and Formulation 2nd Symposium, Versailles, France, 
October 8-10, 2006. 
 
 Eenschooten, C.; Delie, F.; Guillaumie-Longin, F.; Kontogeorgis, G. M.; Stenby, E. 
H.; Schwach-Abdellaoui, K.; Gurny, R. Development of colloidal carriers from 
modified hyaluronic acid. 8th Annual Meeting of the Skin Forum, London, United 
Kingdom, March 3-4, 2007. 
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 Eenschooten, C.; Delie, F.; Guillaumie-Longin, F.; Kontogeorgis, G. M.; Stenby, E. 
H.; Schwach-Abdellaoui, K.; Gurny, R. Development of colloidal carriers from 
modified hyaluronic acid. 7th International Conference on Hyaluronan, Charleston, 
South Carolina, United State, April 22-27, 2007. 
 
 Eenschooten, C.; Vaccaro, A.; Delie, F.; Guillaumie-Longin, F.; Kontogeorgis, G. 
M.; Stenby, E. H.; Schwach-Abdellaoui, K.; Borkovec, M.; Gurny, R. Development of 
colloidal carriers from a novel amphiphilic hyaluronic acid. 21st Conference of the 
European Colloid and Interface Society, Geneva, Switzerland, September 10-14, 2007. 
 
II.1.2. Oral presentations 
 
Seminars of the Centre for Phase Equilibria and Separation Processes 
 
 Eenschooten, C. Development of derivatized hyaluronic acid and formulation of 
nanoparticles for the delivery of cosmetic actives and drugs. Centre for Phase 
Equilibria and Separation Processes, Department of Chemical and Biochemical 
Engineering, Technical University of Denmark, Lyngby, Denmark, May 18, 2006. 
 
 Eenschooten, C. Development of colloidal carriers from modified hyaluronic acid. 
Centre for Phase Equilibria and Separation Processes, Department of Chemical and 
Biochemical Engineering, Technical University of Denmark, Lyngby, Denmark, 
February 15, 2007. 
 
Annual discussion meetings of the Centre for Phase Equilibria and Separation 
Processes 
 
 Eenschooten, C. Development of derivatized hyaluronic acid and formulation of 
nanoparticles for the delivery of cosmetic actives and drugs. Annual discussion 
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meeting 2006 of the Centre for Phase Equilibria and Separation Processes, Elsinore, 
Denmark, June 26-28, 2006. 
 
 Eenschooten, C. Development of novel colloidal carriers from chemically modified 
hyaluronic acid. Annual discussion meeting 2007 of the Centre for Phase Equilibria 
and Separation Processes, Elsinore, Denmark, May 30-June 1, 2007. 
 
 Eenschooten, C. Development of soft nanocarriers from novel amphiphilic 
hyaluronic acid derivatives towards topical drug delivery. Annual discussion meeting 
2008 of the Centre for Phase Equilibria and Separation Processes, Værløse, Denmark, 
June 16-18, 2008. 
 
II.1.3. Manuscript contributions 
 
 Eenschooten, C.; Guillaumie, F.; Kontogeorgis, G. M.; Stenby, E. H.; Schwach-
Abdellaoui, K. Development of hyaluronic acid-based nanoparticles for topical 
delivery of cosmetic actives. In Department of Chemical Engineering, Technical 
University of Denmark, Graduate schools yearbook; Dam-Johansen K.; Bøjer, M., 
Eds.; BookPartner, Nørhaven Digital: Copenhagen, 2006. 
 
 Eenschooten, C.; Guillaumie, F.; Kontogeorgis, G. M.; Stenby, E. H.; Schwach-
Abdellaoui, K. Development of hyaluronic acid-based nanocarriers towards the topical 
delivery of cosmetic active ingredients or pharmaceutical drugs. In Department of 
Chemical Engineering, Technical University of Denmark, Graduate schools yearbook; 
Dam-Johansen K.; Bøjer, M., Eds.; BookPartner, Nørhaven Digital: Copenhagen, 
2007. 
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II.1.4. Patents 
 
 Tømmeraas, K.; Eenschooten, C. Aryl/alkyl succinic anhydride hyaluronan 
derivatives. WO2007/033677 A1, March 29, 2007. 
 
 Eenschooten, C.; Christensen, M. W. Aryl/Alkyl vinyl sulfone hyaluronic acid 
derivatives. WO2007/098770 A1, September 7, 2007. 
 
II.1.5. Articles in preparation 
 
 Eenschooten, C.; Guillaumie, F.; Delie, F.; Kontogeorgis, G. M.; Schwach-
Abdellaoui, K. Towards an understanding of the mechanisms underlying polymeric 
nanoparticle-mediated (trans)dermal drug delivery (based on Chapter II). 
 
 Eenschooten, C.; Guillaumie, F.; Kontogeorgis, G. M.; Stenby, E. H.; Schwach-
Abdellaoui, K. Preparation and structural characterization of novel and versatile 
amphiphilic hyaluronic acid derivatives (based on Chapter III, section B). 
 
 Eenschooten, C.; Vaccaro, A.; Delie, F.; Guillaumie, F.; Tømmeraas, K.; 
Kontogeorgis, G. M.; Schwach-Abdellaoui, K.; Borkovec, M.; Gurny, R. Novel self-
associative multi-phase nanostructured soft carriers based on amphiphilic hyaluronic 
acid derivatives (based on Chapter IV). 
 
II.2. Teaching 
 
II.2.1. Assistantship in master’s courses 
 
 Soft Nanotechnology in Colloid and Surface Chemistry, master’s course, Technical 
University of Denmark, DTU Department of Chemical and Biochemical Engineering, 
Autumn 2005 and 2006. 
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II.2.2. Co-supervision 
 
 Structural characterization of a novel amphiphilic derivative of hyaluronic acid, 
master’s project, Technical University of Denmark, Department of Chemistry, Autumn 
2007. 
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